Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
The act, process, or result of passing from one place or position to another. It differs from LOCOMOTION in that locomotion is restricted to the passing of the whole body from one place to another, while movement encompasses both locomotion but also a change of the position of the whole body or any of its parts. Movement may be used with reference to humans, vertebrate and invertebrate animals, and microorganisms. Differentiate also from MOTOR ACTIVITY, movement associated with behavior.
An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)
Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES.
Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families (i.e., familial tremor). (Mov Disord 1988;13(1):5-10)
A condition characterized by focal DYSTONIA that progresses to involuntary spasmodic contractions of the muscles of the legs, trunk, arms, and face. The hands are often spared, however, sustained axial and limb contractions may lead to a state where the body is grossly contorted. Onset is usually in the first or second decade. Familial patterns of inheritance, primarily autosomal dominant with incomplete penetrance, have been identified. (Adams et al., Principles of Neurology, 6th ed, p1078)
A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of dyskinesia as a primary manifestation of disease may be referred to as dyskinesia syndromes (see MOVEMENT DISORDERS). Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.
Voluntary or reflex-controlled movements of the eye.
Involuntary shock-like contractions, irregular in rhythm and amplitude, followed by relaxation, of a muscle or a group of muscles. This condition may be a feature of some CENTRAL NERVOUS SYSTEM DISEASES; (e.g., EPILEPSY, MYOCLONIC). Nocturnal myoclonus is the principal feature of the NOCTURNAL MYOCLONUS SYNDROME. (From Adams et al., Principles of Neurology, 6th ed, pp102-3).
Excessive periodic leg movements during sleep that cause micro-arousals and interfere with the maintenance of sleep. This condition induces a state of relative sleep deprivation which manifests as excessive daytime hypersomnolence. The movements are characterized by repetitive contractions of the tibialis anterior muscle, extension of the toe, and intermittent flexion of the hip, knee and ankle. (Adams et al., Principles of Neurology, 6th ed, p387)
Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.
A dyskinesia characterized by an inability to maintain the fingers, toes, tongue, or other body parts in a stable position, resulting in continuous slow, sinusoidal, and flowing involuntary movements. This condition is frequently accompanied by CHOREA, where it is referred to as choreoathetosis. Athetosis may occur as a manifestation of BASAL GANGLIA DISEASES or DRUG TOXICITY. (From Adams et al., Principles of Neurology, 6th ed, p76)
An inherited autosomal disorder that is characterized by neurodegeneration; orofacial and buccal DYSKINESIAS; CHOREA; and thorny-looking red cells (ACANTHOCYTES). This disorder is due to mutations of chorein which is important in protein trafficking and is encoded by Vps13a on chromosome 9q21.
Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
Large subcortical nuclear masses derived from the telencephalon and located in the basal regions of the cerebral hemispheres.
Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
Motor behavior that is repetitive, often seemingly driven, and nonfunctional. This behavior markedly interferes with normal activities or results in severe bodily self-injury. The behavior is not due to the direct physiological effects of a substance or a general medical condition. (DSM-IV, 1994)
Therapy for MOVEMENT DISORDERS, especially PARKINSON DISEASE, that applies electricity via stereotactic implantation of ELECTRODES in specific areas of the BRAIN such as the THALAMUS. The electrodes are attached to a neurostimulator placed subcutaneously.
Persistent and disabling ANXIETY.
A symptom, not a disease, of a twisted neck. In most instances, the head is tipped toward one side and the chin rotated toward the other. The involuntary muscle contractions in the neck region of patients with torticollis can be due to congenital defects, trauma, inflammation, tumors, and neurological or other factors.
Those disorders that have a disturbance in mood as their predominant feature.
Techniques used mostly during brain surgery which use a system of three-dimensional coordinates to locate the site to be operated on.
Parasomnias characterized by behavioral abnormalities that occur during the transition between wakefulness and sleep (or between sleep and wakefulness).
Disorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor movements or vocalizations which may be exacerbated by stress and are generally attenuated during absorbing activities. Tic disorders are distinguished from conditions which feature other types of abnormal movements that may accompany another another condition. (From DSM-IV, 1994)
Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
A condition associated with the use of certain medications and characterized by an internal sense of motor restlessness often described as an inability to resist the urge to move.
A group of disorders characterized by physical symptoms that are affected by emotional factors and involve a single organ system, usually under AUTONOMIC NERVOUS SYSTEM control. (American Psychiatric Glossary, 1988)
Dyssomnias (i.e., insomnias or hypersomnias) associated with dysfunction of internal sleep mechanisms or secondary to a sleep-related medical disorder (e.g., sleep apnea, post-traumatic sleep disorders, etc.). (From Thorpy, Sleep Disorders Medicine, 1994, p187)
A medical specialty concerned with the study of the structures, functions, and diseases of the nervous system.
The representation of the phylogenetically oldest part of the corpus striatum called the paleostriatum. It forms the smaller, more medial part of the lentiform nucleus.
Assessment of sensory and motor responses and reflexes that is used to determine impairment of the nervous system.
Categorical classification of MENTAL DISORDERS based on criteria sets with defining features. It is produced by the American Psychiatric Association. (DSM-IV, page xxii)
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
Voluntary or involuntary motion of head that may be relative to or independent of body; includes animals and humans.
Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle.
Impaired ambulation not attributed to sensory impairment or motor weakness. FRONTAL LOBE disorders; BASAL GANGLIA DISEASES (e.g., PARKINSONIAN DISORDERS); DEMENTIA, MULTI-INFARCT; ALZHEIMER DISEASE; and other conditions may be associated with gait apraxia.
Recording of the changes in electric potential of muscle by means of surface or needle electrodes.
The coordination of a sensory or ideational (cognitive) process and a motor activity.
Conditions characterized by disturbances of usual sleep patterns or behaviors. Sleep disorders may be divided into three major categories: DYSSOMNIAS (i.e. disorders characterized by insomnia or hypersomnia), PARASOMNIAS (abnormal sleep behaviors), and sleep disorders secondary to medical or psychiatric disorders. (From Thorpy, Sleep Disorders Medicine, 1994, p187)
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
An antiepileptic agent related to the barbiturates; it is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite. Adverse effects are reported to be more frequent than with PHENOBARBITAL. (From Martindale, The Extra Pharmacopoeia, 30th ed, p309)
Abnormalities of motor function that are associated with organic and non-organic cognitive disorders.
Disorders of the AUTONOMIC NERVOUS SYSTEM occurring as a primary condition. Manifestations can involve any or all body systems but commonly affect the BLOOD PRESSURE and HEART RATE.
The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.
Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
Disorders that feature impairment of eye movements as a primary manifestation of disease. These conditions may be divided into infranuclear, nuclear, and supranuclear disorders. Diseases of the eye muscles or oculomotor cranial nerves (III, IV, and VI) are considered infranuclear. Nuclear disorders are caused by disease of the oculomotor, trochlear, or abducens nuclei in the BRAIN STEM. Supranuclear disorders are produced by dysfunction of higher order sensory and motor systems that control eye movements, including neural networks in the CEREBRAL CORTEX; BASAL GANGLIA; CEREBELLUM; and BRAIN STEM. Ocular torticollis refers to a head tilt that is caused by an ocular misalignment. Opsoclonus refers to rapid, conjugate oscillations of the eyes in multiple directions, which may occur as a parainfectious or paraneoplastic condition (e.g., OPSOCLONUS-MYOCLONUS SYNDROME). (Adams et al., Principles of Neurology, 6th ed, p240)
General or unspecified injuries to the soft tissue or bony portions of the face.
Habitual, repeated, rapid contraction of certain muscles, resulting in stereotyped individualized actions that can be voluntarily suppressed for only brief periods. They often involve the face, vocal cords, neck, and less often the extremities. Examples include repetitive throat clearing, vocalizations, sniffing, pursing the lips, and excessive blinking. Tics tend to be aggravated by emotional stress. When frequent they may interfere with speech and INTERPERSONAL RELATIONS. Conditions which feature frequent and prominent tics as a primary manifestation of disease are referred to as TIC DISORDERS. (From Adams et al., Principles of Neurology, 6th ed, pp109-10)
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders.
Disorders of the centrally located thalamus, which integrates a wide range of cortical and subcortical information. Manifestations include sensory loss, MOVEMENT DISORDERS; ATAXIA, pain syndromes, visual disorders, a variety of neuropsychological conditions, and COMA. Relatively common etiologies include CEREBROVASCULAR DISORDERS; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; BRAIN HYPOXIA; INTRACRANIAL HEMORRHAGES; and infectious processes.
A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep.
Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation.
A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)
A synuclein that is a major component of LEWY BODIES that plays a role in neurodegeneration and neuroprotection.
A well-circumscribed mass composed of tuberculous granulation tissue that may occur in the cerebral hemispheres, cerebellum, brain stem, or perimeningeal spaces. Multiple lesions are quite common. Management of intracranial manifestations vary with lesion site. Intracranial tuberculomas may be associated with SEIZURES, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. Spinal cord tuberculomas may be associated with localized or radicular pain, weakness, sensory loss, and incontinence. Tuberculomas may arise as OPPORTUNISTIC INFECTIONS, but also occur in immunocompetent individuals.
A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or a another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)
Diseases of the facial nerve or nuclei. Pontine disorders may affect the facial nuclei or nerve fascicle. The nerve may be involved intracranially, along its course through the petrous portion of the temporal bone, or along its extracranial course. Clinical manifestations include facial muscle weakness, loss of taste from the anterior tongue, hyperacusis, and decreased lacrimation.
A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)
A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
Viral proteins that facilitate the movement of viruses between plant cells by means of PLASMODESMATA, channels that traverse the plant cell walls.
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)
The distal part of the arm beyond the wrist in humans and primates, that includes the palm, fingers, and thumb.
Lens-shaped structure on the inner aspect of the INTERNAL CAPSULE. The SUBTHALAMIC NUCLEUS and pathways traversing this region are concerned with the integration of somatic motor function.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
Therapy assisted by the use of a horse and/or its movement, including equine-assisted psychotherapy, horseback riding, and hippotherapy.
The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.
Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
Disturbances in mental processes related to learning, thinking, reasoning, and judgment.
Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE.
Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual.
An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
The properties, processes, and behavior of biological systems under the action of mechanical forces.
Physical activity of the FETUS in utero. Gross or fine fetal body movement can be monitored by the mother, PALPATION, or ULTRASONOGRAPHY.
A class of traumatic stress disorders with symptoms that last more than one month. There are various forms of post-traumatic stress disorder, depending on the time of onset and the duration of these stress symptoms. In the acute form, the duration of the symptoms is between 1 to 3 months. In the chronic form, symptoms last more than 3 months. With delayed onset, symptoms develop more than 6 months after the traumatic event.
The physical activity of a human or an animal as a behavioral phenomenon.
A drug formerly used as an antipsychotic and treatment of various movement disorders. Tetrabenazine blocks neurotransmitter uptake into adrenergic storage vesicles and has been used as a high affinity label for the vesicle transport system.
Recording of the average amplitude of the resting potential arising between the cornea and the retina in light and dark adaptation as the eyes turn a standard distance to the right and the left. The increase in potential with light adaptation is used to evaluate the condition of the retinal pigment epithelium.
A characteristic symptom complex.
Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness.
Performance of complex motor acts.
Elements of limited time intervals, contributing to particular results or situations.
Area of the FRONTAL LOBE concerned with primary motor control located in the dorsal PRECENTRAL GYRUS immediately anterior to the central sulcus. It is comprised of three areas: the primary motor cortex located on the anterior paracentral lobule on the medial surface of the brain; the premotor cortex located anterior to the primary motor cortex; and the supplementary motor area located on the midline surface of the hemisphere anterior to the primary motor cortex.
A country in northern Africa, bordering the Mediterranean Sea, between Egypt, Tunisia, and Algeria, having southern border with Chad, Niger, and Sudan. Its capital is Tripoli.
The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.
The study of significant causes and processes in the development of mental illness.
Paired bodies containing mostly GRAY MATTER and forming part of the lateral wall of the THIRD VENTRICLE of the brain.
A long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES.
Simultaneous and continuous monitoring of several parameters during sleep to study normal and abnormal sleep. The study includes monitoring of brain waves, to assess sleep stages, and other physiological variables such as breathing, eye movements, and blood oxygen levels which exhibit a disrupted pattern with sleep disturbances.
The storing or preserving of video signals for television to be played back later via a transmitter or receiver. Recordings may be made on magnetic tape or discs (VIDEODISC RECORDING).
A syndrome characterized by orofacial DYSTONIA; including BLEPHAROSPASM; forceful jaw opening; lip retraction; platysma muscle spasm; and tongue protrusion. It primarily affects older adults, with an incidence peak in the seventh decade of life. (From Adams et al., Principles of Neurology, 6th ed, p108)
Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.
Disorders related to substance abuse.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
A sleep disorder characterized by grinding and clenching of the teeth and forceful lateral or protrusive jaw movements. Sleep bruxism may be associated with TOOTH INJURIES; TEMPOROMANDIBULAR JOINT DISORDERS; sleep disturbances; and other conditions.
Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.
Movement or the ability to move from one place or another. It can refer to humans, vertebrate or invertebrate animals, and microorganisms.
Neural tracts connecting one part of the nervous system with another.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself.
Intracytoplasmic, eosinophilic, round to elongated inclusions found in vacuoles of injured or fragmented neurons. The presence of Lewy bodies is the histological marker of the degenerative changes in LEWY BODY DISEASE and PARKINSON DISEASE but they may be seen in other neurological conditions. They are typically found in the substantia nigra and locus coeruleus but they are also seen in the basal forebrain, hypothalamic nuclei, and neocortex.
Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.
Uncrossed tracts of motor nerves from the brain to the anterior horns of the spinal cord, involved in reflexes, locomotion, complex movements, and postural control.
Surgically placed electric conductors through which ELECTRIC STIMULATION is delivered to or electrical activity is recorded from a specific point inside the body.
An abnormal response to a stimulus applied to the sensory components of the nervous system. This may take the form of increased, decreased, or absent reflexes.
The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis.
Recurrent clonic contraction of facial muscles, restricted to one side. It may occur as a manifestation of compressive lesions involving the seventh cranial nerve (FACIAL NERVE DISEASES), during recovery from BELL PALSY, or in association with other disorders. (From Adams et al., Principles of Neurology, 6th ed, p1378)
An abrupt voluntary shift in ocular fixation from one point to another, as occurs in reading.
The superior part of the upper extremity between the SHOULDER and the ELBOW.
A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury.
The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
Application of electric current in treatment without the generation of perceptible heat. It includes electric stimulation of nerves or muscles, passage of current into the body, or use of interrupted current of low intensity to raise the threshold of the skin to pain.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
Welding is not typically considered a medical term, but rather refers to a process in manufacturing and construction involving the joining of metal components through heat or pressure, which isn't directly related to medicine or healthcare.
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
A repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviors include aggressive conduct that causes or threatens physical harm to other people or animals, nonaggressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18. (From DSM-IV, 1994)
Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain.
Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive.
A family of homologous proteins of low MOLECULAR WEIGHT that are predominately expressed in the BRAIN and that have been implicated in a variety of human diseases. They were originally isolated from CHOLINERGIC FIBERS of TORPEDO.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.
A condition characterized by persistent spasms (SPASM) involving multiple muscles, primarily in the lower limbs and trunk. The illness tends to occur in the fourth to sixth decade of life, presenting with intermittent spasms that become continuous. Minor sensory stimuli, such as noise and light touch, precipitate severe spasms. Spasms do not occur during sleep and only rarely involve cranial muscles. Respiration may become impaired in advanced cases. (Adams et al., Principles of Neurology, 6th ed, p1492; Neurology 1998 Jul;51(1):85-93)
The observable response an animal makes to any situation.
Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
Gait abnormalities that are a manifestation of nervous system dysfunction. These conditions may be caused by a wide variety of disorders which affect motor control, sensory feedback, and muscle strength including: CENTRAL NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or MUSCULAR DISEASES.
Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS.
Dominance of one cerebral hemisphere over the other in cerebral functions.
The muscles that move the eye. Included in this group are the medial rectus, lateral rectus, superior rectus, inferior rectus, inferior oblique, superior oblique, musculus orbitalis, and levator palpebrae superioris.
A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
The positioning and accommodation of eyes that allows the image to be brought into place on the FOVEA CENTRALIS of each eye.
The time from the onset of a stimulus until a response is observed.
A family of cellular proteins that mediate the correct assembly or disassembly of polypeptides and their associated ligands. Although they take part in the assembly process, molecular chaperones are not components of the final structures.
The largest and most lateral of the BASAL GANGLIA lying between the lateral medullary lamina of the GLOBUS PALLIDUS and the EXTERNAL CAPSULE. It is part of the neostriatum and forms part of the LENTIFORM NUCLEUS along with the GLOBUS PALLIDUS.
Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument.
A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)
A subtype of striated muscle, attached by TENDONS to the SKELETON. Skeletal muscles are innervated and their movement can be consciously controlled. They are also called voluntary muscles.
A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV)
A voltage-gated sodium channel subtype found widely expressed in neurons of the central and peripheral nervous systems. Defects in the SCN8A gene which codes for the alpha subunit of this sodium channel are associated with ATAXIA and cognitive deficits.
Methods and procedures for recording EYE MOVEMENTS.
Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS.
A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by a another medical condition, by the direct effects of a substance, or by another mental disorder. The symptoms must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
A family of transmembrane dystrophin-associated proteins that play a role in the membrane association of the DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX.
A POSTURE in which an ideal body mass distribution is achieved. Postural balance provides the body carriage stability and conditions for normal functions in stationary position or in movement, such as sitting, standing, or walking.
Manner or style of walking.
Theoretical representations that simulate the behavior or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment.
'Nerve tissue proteins' are specialized proteins found within the nervous system's biological tissue, including neurofilaments, neuronal cytoskeletal proteins, and neural cell adhesion molecules, which facilitate structural support, intracellular communication, and synaptic connectivity essential for proper neurological function.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures.
Diseases of the parasympathetic or sympathetic divisions of the AUTONOMIC NERVOUS SYSTEM; which has components located in the CENTRAL NERVOUS SYSTEM and PERIPHERAL NERVOUS SYSTEM. Autonomic dysfunction may be associated with HYPOTHALAMIC DISEASES; BRAIN STEM disorders; SPINAL CORD DISEASES; and PERIPHERAL NERVOUS SYSTEM DISEASES. Manifestations include impairments of vegetative functions including the maintenance of BLOOD PRESSURE; HEART RATE; pupil function; SWEATING; REPRODUCTIVE AND URINARY PHYSIOLOGY; and DIGESTION.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Biochemical identification of mutational changes in a nucleotide sequence.
Eye movements that are slow, continuous, and conjugate and occur when a fixed object is moved slowly.
A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25.
I'm sorry for any confusion, but "Ecuador" is a country in South America and not a medical term. The term you might be looking for is "ecdysone," which is a hormone found in arthropods that controls their molting process.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Four or five slender jointed digits in humans and primates, attached to each HAND.
A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.
The part of brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the "little brain" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills.
Neurons whose primary neurotransmitter is DOPAMINE.
Investigative technique commonly used during ELECTROENCEPHALOGRAPHY in which a series of bright light flashes or visual patterns are used to elicit brain activity.
Drugs used to prevent SEIZURES or reduce their severity.
An increased number of contiguous trinucleotide repeats in the DNA sequence from one generation to the next. The presence of these regions is associated with diseases such as FRAGILE X SYNDROME and MYOTONIC DYSTROPHY. Some CHROMOSOME FRAGILE SITES are composed of sequences where trinucleotide repeat expansion occurs.
Drugs that bind to and activate dopamine receptors.
Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS.
An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulchi. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions.
A generic term for any circumscribed mass of foreign (e.g., lead or viruses) or metabolically inactive materials (e.g., ceroid or MALLORY BODIES), within the cytoplasm or nucleus of a cell. Inclusion bodies are in cells infected with certain filtrable viruses, observed especially in nerve, epithelial, or endothelial cells. (Stedman, 25th ed)
Use of electric potential or currents to elicit biological responses.
A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
Acquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language.
Behavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot.
A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli.
Disorders related to or resulting from abuse or mis-use of alcohol.
Therapeutic modalities frequently used in PHYSICAL THERAPY SPECIALTY by PHYSICAL THERAPISTS or physiotherapists to promote, maintain, or restore the physical and physiological well-being of an individual.
Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
The position or attitude of the body.
Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.

Effect of riluzole on the neurological and neuropathological changes in an animal model of cardiac arrest-induced movement disorder. (1/931)

Posthypoxic myoclonus and seizures precipitate as secondary neurological consequences in ischemic/hypoxic insults of the central nervous system. Neuronal hyperexcitation may be due to excessive activation of glutamatergic neurotransmission, an effect that has been shown to follow ischemic/hypoxic events. Therefore, riluzole, an anticonvulsant that inhibits the release of glutamate by stabilizing the inactivated state of activated voltage-sensitive sodium channels, was tested for its antimyoclonic and neuroprotective properties in the cardiac arrest-induced animal model of posthypoxic myoclonus. Riluzole (4-12 mg/kg i.p.) dose-dependently attenuated the audiogenic seizures and action myoclonus seen in this animal model. Histological examination using Nissl staining and the novel Fluoro-Jade histochemistry in cardiac-arrested animals showed an extensive neuronal degeneration in the hippocampus and cerebellum. Riluzole treatment almost completely prevented the neuronal degeneration in these brain areas. The neuroprotective effect was more pronounced in hippocampal pyramidal neurons and cerebellar Purkinje cells. These effects were seen at therapeutically relevant doses of riluzole, and the animals tolerated the treatment well. These findings indicate that the pathogenesis of posthypoxic myoclonus and seizure may involve excessive activation of glutamate neurotransmission, and that riluzole may serve as an effective pharmacological agent with neuroprotective potential for the treatment of neurological conditions associated with cardiac arrest in humans.  (+info)

Effects of constraint-induced movement therapy on patients with chronic motor deficits after stroke: a replication. (2/931)

BACKGROUND AND PURPOSE: Constraint-induced movement therapy (CI therapy) has previously been shown to produce large improvements in actual amount of use of a more affected upper extremity in the "real-world" environment in patients with chronic stroke (ie, >1 year after the event). This work was carried out in an American laboratory. Our aim was to determine whether these results could be replicated in another laboratory located in Germany, operating within the context of a healthcare system in which administration of conventional types of physical therapy is generally more extensive than in the United States. METHODS: Fifteen chronic stroke patients were given CI therapy, involving restriction of movement of the intact upper extremity by placing it in a sling for 90% of waking hours for 12 days and training (by shaping) of the more affected extremity for 7 hours on the 8 weekdays during that period. RESULTS: Patients showed a significant and very large degree of improvement from before to after treatment on a laboratory motor test and on a test assessing amount of use of the affected extremity in activities of daily living in the life setting (effect sizes, 0.9 and 2.2, respectively), with no decrement in performance at 6-month follow-up. During a pretreatment control test-retest interval, there were no significant changes on these tests. CONCLUSIONS: Results replicate in Germany the findings with CI therapy in an American laboratory, suggesting that the intervention has general applicability.  (+info)

An 18-mer peptide fragment of prosaposin ameliorates place navigation disability, cortical infarction, and retrograde thalamic degeneration in rats with focal cerebral ischemia. (3/931)

It was previously reported that prosaposin possesses neurotrophic activity that is ascribed to an 18-mer peptide comprising the hydrophilic sequence of the rat saposin C domain. To evaluate the effect of the 18-mer peptide on ischemic neuronal damage, the peptide was infused in the left lateral ventricle immediately after occlusion of the left middle cerebral artery (MCA) in stroke-prone spontaneously hypertensive (SP-SH) rats. The treatment ameliorated the ischemia-induced space navigation disability and cortical infarction and prevented secondary thalamic degeneration in a dose-dependent manner. In culture experiments, treatment with the 18-mer peptide attenuated free radical-induced neuronal injury at low concentrations (0.002 to 2 pg/mL), and the peptide at higher concentrations (0.2 to 20 ng/mL) protected neurons against hypoxic insult. Furthermore, a saposin C fragment comprising the 18-mer peptide bound to synaptosomal fractions of the cerebral cortex, and this binding decreased at the 1st day after MCA occlusion and recovered to the preischemic level at the 7th day after ischemia. These findings suggest that the 18-mer peptide ameliorates neuronal damage in vivo and in vitro through binding to the functional receptor, although the cDNA encoding prosaposin receptor has not been determined yet.  (+info)

Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study. (4/931)

Unilateral pallidotomy has gained popularity in treating the motor symptoms of Parkinson's disease. We present the results of a 2-year post-pallidotomy follow-up study. Using the Unified Parkinson's Disease Rating Scale (UPDRS), the Goetz dyskinesia scale and the Purdue Pegboard Test (PPBT), we evaluated 20 patients at regular intervals both off and on medications for 2 years post-pallidotomy. There were no significant changes in the dosages of antiparkinsonian medications from 3 months pre-pallidotomy to 2 years post-pallidotomy. On the side contralateral to the operation, the improvements were preserved in 'on'-state dyskinesia (83% reduction from pre-pallidotomy to 2 years post-pallidotomy, P < 0.001) and 'off'-state tremor (90% reduction from pre-pallidotomy to 2 years post-pallidotomy, P = 0.005). There were no statistically significant differences between pre-pallidotomy scores and those at 2 years post-pallidotomy in ipsilateral dyskinesia, axial dyskinesia, 'off'- or 'on'-state PPBT, 'off'-state Activities of Daily Living (ADL) and 'off'-state gait and postural stability. After 2 years, the 'on'-state ADL scores worsened by 75%, compared with pre-pallidotomy (P = 0.005). We conclude that 2 years after pallidotomy, the improvements in dyskinesia and tremor on the side contralateral to pallidotomy are preserved, while the initial improvements in most other deficits disappear, either because of progression of pathology or loss of the early efficacy achieved by surgery.  (+info)

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study. (5/931)

OBJECTIVES: Pramipexole, a non-ergot dopamine D2/D3 receptor agonist, was investigated as an add on drug in advanced parkinsonian patients with motor fluctuations to assess efficacy, safety, and tolerance. METHODS: Seventy eight patients of either sex with advanced Parkinson's disease and treatment complications such as motor fluctuations were enrolled into a double blind, placebo controlled, randomised, multicentre study (phase II) and assigned to add on treatment with pramipexole (n=34) versus placebo (n=44) to a previously stabilised antiparkinsonian medication (7 week dose titration interval, 4 week maintenance period). The primary end point of efficacy was the change from baseline in the total score of the unified Parkinson's disease rating scale (UPDRS) in the on "period" (2 hours after intake of study medication). Safety and tolerability were assessed on the basis of adverse events, vital signs, laboratory measurements, and ECG recordings. RESULTS: There was a significant improvement of the pramipexole group in UPDRS total scores, subscores part II, III (activities of daily living and motor examination), and IV (complications of therapy). Mean UPDRS total score decreased by 37.3% under pramipexole compared with 12.2% under placebo (p<0.001). Patients under pramipexole reported an overall reduction in "off" periods of 12%--resulting in 1.7 more hours "on" time a day--compared with an increase in "off" periods of 2% under placebo. There were no unexpected safety results. The adverse event profile disclosed a high tolerability. The most important adverse events under pramipexole were fatigue, dyskinesia, and vivid dreams. CONCLUSION: Pramipexole administration is an efficacious and well tolerated add on therapy in patients with advanced Parkinson's disease with an improvement in activities of daily living, motor function, and treatment associated complications.  (+info)

Impairment of EEG desynchronisation before and during movement and its relation to bradykinesia in Parkinson's disease. (6/931)

OBJECTIVE: It has been suggested that the basal ganglia act to release cortical elements from idling (alpha) rhythms so that they may become coherent in the gamma range, thereby binding together those distributed activities necessary for the effective selection and execution of a motor act. This hypothesis was tested in 10 patients with idiopathic Parkinson's disease. METHODS: Surface EEG was recorded during self paced squeezing of the hand and elbow flexion performed separately, simultaneously, or sequentially. Recordings were made after overnight withdrawal of medication and, again, 1 hour after levodopa. The medication related improvement in EEG desynchronisation (in the 7.5-12.5 Hz band) over the 1 second before movement and during movement were separately correlated with the improvement in movement time for each electrode site. Correlation coefficients (r) > 0.632 were considered significant (p<0.05). RESULTS: Improvement in premovement desynchronisation correlated with reduction in bradykinesia over the contralateral sensorimotor cortex and supplementary motor area in flexion and squeeze, respectively. However, when both movements were combined either simultaneously or sequentially, this correlation shifted anteriorly, to areas overlying prefrontal cortex. Improvement in EEG desynchronisation during movement only correlated with reduction in bradykinesia in two tasks. Correlation was seen over the supplementary motor area during flexion, and central prefrontal and ipsilateral premotor areas during simultaneous flex and squeeze. CONCLUSIONS: The results are consistent with the idea that the basal ganglia liberate frontal cortex from idling rhythms, and that this effect is focused and specific in so far as it changes with the demands of the task. In particular, the effective selection and execution of more complex tasks is associated with changes over the prefrontal cortex.  (+info)

Movement disorders in encephalitis induced by Rhodococcus aurantiacus infection relieved by the administration of L-dopa and anti-T-cell antibodies. (7/931)

Mice injected with Rhodococcus aurantiacus by the intravenous (i.v.) route show neurological disorders, hemiparesis, vertical headshake and turn-round gait after day 7 postinfection (p.i.). Neurological symptoms caused by i.v. inoculation of R. aurantiacus were relieved by treatment with levodopa (l-dopa). R. aurantiacus was isolated from the brain and was found to be completely eliminated at day 7 p. i. Focal encephalitis was mainly observed in the brain stem, and T cells could be isolated from the brain after day 7 p.i. Administration of both an anti-CD4 monoclonal antibody (mAb) and an anti-CD8 mAb suppressed neurological symptoms. These results suggest that R. aurantiacus induces movement disorders in mice, and that the symptoms are mediated by T cells infiltrating the brain, rather than directly by the bacterium.  (+info)

Bilateral ballism in a patient with overlapping Fisher's and Guillain-Barre syndromes. (8/931)

A 29 year old woman developed diplopia and ataxic gait. Neurological examination showed total ophthalmoplegia, cerebellar ataxia, and areflexia. Moreover, there was muscle weakness in all four limbs. An overlap of Fisher's and Guillain-Barre syndromes was dignosed. On day 5 she suddenly developed involuntary flinging movements that affected the face and four limbs. Surface EMG showed 1.5-2 Hz rhythmic grouping discharges. The involuntary movements were considered ballism. This is the first report of a patient with Guillain-Barre syndrome and a related disorder who showed ballism.  (+info)

Movement disorders are a group of neurological conditions that affect the control and coordination of voluntary movements. These disorders can result from damage to or dysfunction of the cerebellum, basal ganglia, or other parts of the brain that regulate movement. Symptoms may include tremors, rigidity, bradykinesia (slowness of movement), akathisia (restlessness and inability to remain still), dystonia (sustained muscle contractions leading to abnormal postures), chorea (rapid, unpredictable movements), tics, and gait disturbances. Examples of movement disorders include Parkinson's disease, Huntington's disease, Tourette syndrome, and dystonic disorders.

In the context of medicine and healthcare, "movement" refers to the act or process of changing physical location or position. It involves the contraction and relaxation of muscles, which allows for the joints to move and the body to be in motion. Movement can also refer to the ability of a patient to move a specific body part or limb, which is assessed during physical examinations. Additionally, "movement" can describe the progression or spread of a disease within the body.

Dystonia is a neurological movement disorder characterized by involuntary muscle contractions, leading to repetitive or twisting movements. These movements can be painful and may affect one part of the body (focal dystonia) or multiple parts (generalized dystonia). The exact cause of dystonia varies, with some cases being inherited and others resulting from damage to the brain. Treatment options include medications, botulinum toxin injections, and deep brain stimulation surgery.

Chorea is a medical term that describes an involuntary movement disorder characterized by brief, irregular, and abrupt jerky movements. These movements often occur randomly and can affect any part of the body. Chorea can also cause difficulty with coordination and balance, and can sometimes be accompanied by muscle weakness or rigidity.

The term "chorea" comes from the Greek word "χορεία" (khoréia), which means "dance," reflecting the graceful, dance-like movements that are characteristic of this condition. Chorea can occur as a symptom of various underlying medical conditions, including neurological disorders such as Huntington's disease, Sydenham's chorea, and cerebral palsy, as well as metabolic disorders, infections, and certain medications.

Treatment for chorea depends on the underlying cause of the condition and may include medications to help control the involuntary movements, physical therapy to improve coordination and balance, and lifestyle modifications to reduce the risk of injury from falls or other accidents. In some cases, surgery may be recommended as a last resort for severe or refractory chorea.

Dystonic disorders are a group of neurological conditions characterized by sustained or intermittent muscle contractions that result in involuntary, repetitive, and often twisting movements and abnormal postures. These movements can affect any part of the body, including the face, neck, limbs, and trunk. Dystonic disorders can be primary, meaning they are caused by genetic mutations or idiopathic causes, or secondary, resulting from brain injury, infection, or other underlying medical conditions.

The most common form of dystonia is cervical dystonia (spasmodic torticollis), which affects the muscles of the neck and results in abnormal head positioning. Other forms of dystonia include blepharospasm (involuntary eyelid spasms), oromandibular dystonia (affecting the muscles of the jaw, face, and tongue), and generalized dystonia (affecting multiple parts of the body).

Dystonic disorders can significantly impact a person's quality of life, causing pain, discomfort, and social isolation. Treatment options include oral medications, botulinum toxin injections, and deep brain stimulation surgery in severe cases.

Parkinson's disease is a progressive neurodegenerative disorder that affects movement. It is characterized by the death of dopamine-producing cells in the brain, specifically in an area called the substantia nigra. The loss of these cells leads to a decrease in dopamine levels, which results in the motor symptoms associated with Parkinson's disease. These symptoms can include tremors at rest, stiffness or rigidity of the limbs and trunk, bradykinesia (slowness of movement), and postural instability (impaired balance and coordination). In addition to these motor symptoms, non-motor symptoms such as cognitive impairment, depression, anxiety, and sleep disturbances are also common in people with Parkinson's disease. The exact cause of Parkinson's disease is unknown, but it is thought to be a combination of genetic and environmental factors. There is currently no cure for Parkinson's disease, but medications and therapies can help manage the symptoms and improve quality of life.

Essential tremor is a type of involuntary tremor, or shaking, that primarily affects the hands and arms. It can also affect the head, vocal cords, and other parts of the body. Essential tremor is often confused with Parkinson's disease, as they share some similar symptoms, but essential tremor is generally not associated with other neurological conditions.

The tremors associated with essential tremor typically occur when a person is performing voluntary movements, such as writing, eating, or using tools. The shaking may also occur at rest, but this is less common. Essential tremor usually worsens with stress, fatigue, and age.

While the exact cause of essential tremor is not known, it appears to have a genetic component, as it tends to run in families. In some cases, essential tremor may be related to alcohol use or other factors. There is no cure for essential tremor, but medications and lifestyle changes can help manage the symptoms and improve quality of life.

'Dystonia Musculorum Deformans' is a medical term that refers to a rare inherited neurological disorder, which is now more commonly known as "Generalized Dystonia." This condition is characterized by sustained muscle contractions, leading to twisting and repetitive movements or abnormal postures.

The onset of symptoms typically occurs during childhood or adolescence, and they can progress over time, affecting various parts of the body. The exact cause of Generalized Dystonia is not fully understood, but it is believed to involve genetic mutations that affect the functioning of certain proteins in the brain. Treatment options may include medications, botulinum toxin injections, or even deep brain stimulation surgery in severe cases.

Parkinsonian disorders are a group of neurological conditions characterized by motor symptoms such as bradykinesia (slowness of movement), rigidity, resting tremor, and postural instability. These symptoms are caused by the degeneration of dopamine-producing neurons in the brain, particularly in the substantia nigra pars compacta.

The most common Parkinsonian disorder is Parkinson's disease (PD), which is a progressive neurodegenerative disorder. However, there are also several other secondary Parkinsonian disorders, including:

1. Drug-induced parkinsonism: This is caused by the use of certain medications, such as antipsychotics and metoclopramide.
2. Vascular parkinsonism: This is caused by small vessel disease in the brain, which can lead to similar symptoms as PD.
3. Dementia with Lewy bodies (DLB): This is a type of dementia that shares some features with PD, such as the presence of alpha-synuclein protein clumps called Lewy bodies.
4. Progressive supranuclear palsy (PSP): This is a rare brain disorder that affects movement, gait, and eye movements.
5. Multiple system atrophy (MSA): This is a progressive neurodegenerative disorder that affects multiple systems in the body, including the autonomic nervous system, motor system, and cerebellum.
6. Corticobasal degeneration (CBD): This is a rare neurological disorder that affects both movement and cognition.

It's important to note that while these disorders share some symptoms with PD, they have different underlying causes and may require different treatments.

A tremor is an involuntary, rhythmic muscle contraction and relaxation that causes a shaking movement. It's a type of motion disorder that can affect any part of your body, but it most often occurs in your hands. Tremors can be harmless, but they can also be a symptom of a more serious neurological disorder. The cause of tremors isn't always known, but they can be the result of damage to the brain from a stroke, multiple sclerosis, or trauma. Certain medications, alcohol abuse, and drug withdrawal can also cause tremors. In some cases, tremors may be inherited and run in families.

Tremors can be classified based on their cause, appearance, and the situation in which they occur. The two most common types of tremors are:

* Resting tremors, which occur when your muscles are relaxed, such as when your hands are resting on your lap. Parkinson's disease is a common cause of this type of tremor.
* Action tremors, which occur with purposeful movement, such as when you're trying to hold something or when you're using a utensil. Essential tremor, the most common type of tremor, is an action tremor.

Tremors can also be classified based on their frequency (how often they occur) and amplitude (the size of the movement). High-frequency tremors are faster and smaller in amplitude, while low-frequency tremors are slower and larger in amplitude.

In general, tremors are not a life-threatening condition, but they can be embarrassing or make it difficult to perform daily activities. In some cases, tremors may indicate a more serious underlying condition that requires treatment. If you're concerned about tremors or have any questions about your symptoms, it's important to speak with a healthcare provider for an accurate diagnosis and appropriate treatment.

Dyskinesias are a type of movement disorder characterized by involuntary, erratic, and often repetitive muscle movements. These movements can affect any part of the body and can include twisting, writhing, or jerking motions, as well as slow, writhing contortions. Dyskinesias can be caused by a variety of factors, including certain medications (such as those used to treat Parkinson's disease), brain injury, stroke, infection, or exposure to toxins. They can also be a side effect of some medical treatments, such as radiation therapy or chemotherapy.

Dyskinesias can have a significant impact on a person's daily life, making it difficult for them to perform routine tasks and affecting their overall quality of life. Treatment for dyskinesias depends on the underlying cause and may include medication adjustments, surgery, or physical therapy. In some cases, dyskinesias may be managed with the use of assistive devices or by modifying the person's environment to make it easier for them to move around.

Eye movements, also known as ocular motility, refer to the voluntary or involuntary motion of the eyes that allows for visual exploration of our environment. There are several types of eye movements, including:

1. Saccades: rapid, ballistic movements that quickly shift the gaze from one point to another.
2. Pursuits: smooth, slow movements that allow the eyes to follow a moving object.
3. Vergences: coordinated movements of both eyes in opposite directions, usually in response to a three-dimensional stimulus.
4. Vestibulo-ocular reflex (VOR): automatic eye movements that help stabilize the gaze during head movement.
5. Optokinetic nystagmus (OKN): rhythmic eye movements that occur in response to large moving visual patterns, such as when looking out of a moving vehicle.

Abnormalities in eye movements can indicate neurological or ophthalmological disorders and are often assessed during clinical examinations.

Myoclonus is a medical term that describes a quick, involuntary jerking muscle spasm. These spasms can happen once or repeat in a series, and they can range from mild to severe in nature. Myoclonus can affect any muscle in the body and can be caused by several different conditions, including certain neurological disorders, injuries, or diseases. In some cases, myoclonus may occur without an identifiable cause.

There are various types of myoclonus, classified based on their underlying causes, patterns of occurrence, and associated symptoms. Some common forms include:

1. Action myoclonus: Occurs during voluntary muscle movements
2. Stimulus-sensitive myoclonus: Triggered by external or internal stimuli, such as touch, sound, or light
3. Physiological myoclonus: Normal muscle jerks that occur during sleep onset (hypnic jerks) or during sleep (nocturnal myoclonus)
4. Reflex myoclonus: Result of a reflex arc activation due to a peripheral nerve stimulation
5. Epileptic myoclonus: Part of an epilepsy syndrome, often involving the brainstem or cortex
6. Symptomatic myoclonus: Occurs as a result of an underlying medical condition, such as metabolic disorders, infections, or neurodegenerative diseases

Treatment for myoclonus depends on the specific type and underlying cause. Medications, physical therapy, or lifestyle modifications may be recommended to help manage symptoms and improve quality of life.

Nocturnal Myoclonus Syndrome, also known as Periodic Limb Movement Disorder (PLMD), is a condition characterized by recurring involuntary jerking movements of the limbs during sleep, particularly the legs. These movements typically occur every 20-40 seconds and can last for an hour or more throughout the night. They often disrupt normal sleep patterns, causing insomnia or excessive daytime sleepiness.

The movements are usually jerky, rapid, and rhythmic, involving extension of the big toe and flexion of the ankle, knee, or hip. In some cases, these movements can be so forceful that they cause the person to wake up, although often individuals with this condition may not be aware of their nighttime leg movements.

Nocturnal Myoclonus Syndrome is different from another common sleep disorder called Restless Legs Syndrome (RLS), as RLS primarily causes discomfort or an irresistible urge to move the legs while awake and still, whereas Nocturnal Myoclonus Syndrome involves involuntary movements during sleep. However, up to 80% of people with RLS also have PLMD.

The exact cause of Nocturnal Myoclonus Syndrome is not fully understood, but it may be associated with abnormalities in the brain's regulation of muscle activity during sleep. Certain medications, neurological conditions, and iron deficiency anemia have been linked to an increased risk of developing this disorder. Treatment options include medication, lifestyle changes, and addressing any underlying medical conditions that may contribute to the development or worsening of symptoms.

Basal ganglia diseases are a group of neurological disorders that affect the function of the basal ganglia, which are clusters of nerve cells located deep within the brain. The basal ganglia play a crucial role in controlling movement and coordination. When they are damaged or degenerate, it can result in various motor symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and difficulty with balance and walking.

Some examples of basal ganglia diseases include:

1. Parkinson's disease - a progressive disorder that affects movement due to the death of dopamine-producing cells in the basal ganglia.
2. Huntington's disease - an inherited neurodegenerative disorder that causes uncontrolled movements, emotional problems, and cognitive decline.
3. Dystonia - a movement disorder characterized by sustained or intermittent muscle contractions that cause twisting and repetitive movements or abnormal postures.
4. Wilson's disease - a rare genetic disorder that causes excessive copper accumulation in the liver and brain, leading to neurological and psychiatric symptoms.
5. Progressive supranuclear palsy (PSP) - a rare brain disorder that affects movement, gait, and balance, as well as speech and swallowing.
6. Corticobasal degeneration (CBD) - a rare neurological disorder characterized by progressive loss of nerve cells in the cerebral cortex and basal ganglia, leading to stiffness, rigidity, and difficulty with movement and coordination.

Treatment for basal ganglia diseases varies depending on the specific diagnosis and symptoms but may include medication, surgery, physical therapy, or a combination of these approaches.

Anti-dyskinetic agents are a class of medications that are used to treat or manage dyskinesias, which are involuntary movements or abnormal muscle contractions. These medications work by blocking or reducing the activity of dopamine, a neurotransmitter in the brain that is involved in movement control.

Dyskinetic symptoms can occur as a side effect of long-term use of levodopa therapy in patients with Parkinson's disease. Anti-dyskinetic agents such as amantadine, anticholinergics, and dopamine agonists may be used to manage these symptoms.

Amantadine works by increasing the release of dopamine and blocking its reuptake, which can help reduce dyskinesias. Anticholinergic medications such as trihexyphenidyl and benztropine work by blocking the action of acetylcholine, another neurotransmitter that can contribute to dyskinesias. Dopamine agonists such as pramipexole and ropinirole mimic the effects of dopamine in the brain and can help reduce dyskinesias by reducing the dose of levodopa required for symptom control.

It is important to note that anti-dyskinetic agents may have side effects, and their use should be carefully monitored by a healthcare provider.

Athetosis is a medical term that describes a type of involuntary muscle movement. It is characterized by slow, writhing, and continuous movements that can affect the hands, feet, arms, or legs. These movements are not rhythmic and can be interrupted by other voluntary movements. Athetosis is often seen in individuals with certain neurological conditions, such as cerebral palsy or brain injury. It can also be a side effect of some medications. The exact cause of athetosis is not fully understood, but it is believed to result from damage to the basal ganglia, a part of the brain that helps regulate movement. Treatment for athetosis may include physical therapy, medication, or surgery, depending on the underlying cause and severity of the symptoms.

Neuroacanthocytosis is a group of rare, genetic disorders characterized by the presence of abnormal red blood cells called acanthocytes, and various neurological symptoms. The neurological features typically include movement disorders such as chorea (involuntary, dance-like movements), dystonia (sustained muscle contractions causing twisting and repetitive movements or abnormal postures), and parkinsonism (symptoms similar to Parkinson's disease). Neuroacanthocytosis can also cause neuropsychiatric symptoms like personality changes, psychosis, dementia, and seizures.

There are two main types of neuroacanthocytosis: chorea-acanthocytosis (ChAc) and McLeod syndrome (MLS). ChAc is caused by mutations in the VPS13A gene, while MLS is due to mutations in the XK gene. Both conditions are inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the disorder.

Diagnosis of neuroacanthocytosis typically involves blood tests to detect acanthocytes, genetic testing for VPS13A or XK gene mutations, and neurological evaluations to assess movement disorders and other neurological symptoms. Treatment is primarily focused on managing the specific symptoms of the disorder, as there is currently no cure for neuroacanthocytosis.

A mental disorder is a syndrome characterized by clinically significant disturbance in an individual's cognition, emotion regulation, or behavior. It's associated with distress and/or impaired functioning in social, occupational, or other important areas of life, often leading to a decrease in quality of life. These disorders are typically persistent and can be severe and disabling. They may be related to factors such as genetics, early childhood experiences, or trauma. Examples include depression, anxiety disorders, bipolar disorder, schizophrenia, and personality disorders. It's important to note that a diagnosis should be made by a qualified mental health professional.

The basal ganglia are a group of interconnected nuclei, or clusters of neurons, located in the base of the brain. They play a crucial role in regulating motor function, cognition, and emotion. The main components of the basal ganglia include the striatum (made up of the caudate nucleus, putamen, and ventral striatum), globus pallidus (divided into external and internal segments), subthalamic nucleus, and substantia nigra (with its pars compacta and pars reticulata).

The basal ganglia receive input from various regions of the cerebral cortex and other brain areas. They process this information and send output back to the thalamus and cortex, helping to modulate and coordinate movement. The basal ganglia also contribute to higher cognitive functions such as learning, decision-making, and habit formation. Dysfunction in the basal ganglia can lead to neurological disorders like Parkinson's disease, Huntington's disease, and dystonia.

Drug-induced dyskinesia is a movement disorder that is characterized by involuntary muscle movements or abnormal posturing of the body. It is a side effect that can occur from the long-term use or high doses of certain medications, particularly those used to treat Parkinson's disease and psychosis.

The symptoms of drug-induced dyskinesia can vary in severity and may include rapid, involuntary movements of the limbs, face, or tongue; twisting or writhing movements; and abnormal posturing of the arms, legs, or trunk. These symptoms can be distressing and negatively impact a person's quality of life.

The exact mechanism by which certain medications cause dyskinesia is not fully understood, but it is thought to involve changes in the levels of dopamine, a neurotransmitter that plays a key role in regulating movement. In some cases, adjusting the dose or switching to a different medication may help alleviate the symptoms of drug-induced dyskinesia. However, in severe cases, additional treatments such as deep brain stimulation or botulinum toxin injections may be necessary.

Bipolar disorder, also known as manic-depressive illness, is a mental health condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). When you become depressed, you may feel sad or hopeless and lose interest or pleasure in most activities. When your mood shifts to mania or hypomania (a less severe form of mania), you may feel euphoric, full of energy, or unusually irritable. These mood swings can significantly affect your job, school, relationships, and overall quality of life.

Bipolar disorder is typically characterized by the presence of one or more manic or hypomanic episodes, often accompanied by depressive episodes. The episodes may be separated by periods of normal mood, but in some cases, a person may experience rapid cycling between mania and depression.

There are several types of bipolar disorder, including:

* Bipolar I Disorder: This type is characterized by the occurrence of at least one manic episode, which may be preceded or followed by hypomanic or major depressive episodes.
* Bipolar II Disorder: This type involves the presence of at least one major depressive episode and at least one hypomanic episode, but no manic episodes.
* Cyclothymic Disorder: This type is characterized by numerous periods of hypomania and depression that are not severe enough to meet the criteria for a full manic or depressive episode.
* Other Specified and Unspecified Bipolar and Related Disorders: These categories include bipolar disorders that do not fit the criteria for any of the other types.

The exact cause of bipolar disorder is unknown, but it appears to be related to a combination of genetic, environmental, and neurochemical factors. Treatment typically involves a combination of medication, psychotherapy, and lifestyle changes to help manage symptoms and prevent relapses.

Stereotypic Movement Disorder is a neurological condition characterized by the presence of repetitive, often rhythmic and seemingly driven movements that are apparently purposeless. These movements may include body rocking, head banging, hand wringing, or complex whole-body movements. The movements interfere with normal activities and development, and they are not better explained by a neurological condition or another mental disorder. Stereotypic Movement Disorder can occur in individuals of all ages, but it is most commonly diagnosed in children and adolescents. The exact cause of the disorder is unknown, but it may be associated with genetic factors, brain abnormalities, or environmental influences.

Deep brain stimulation (DBS) is a surgical procedure that involves the implantation of a medical device called a neurostimulator, which sends electrical impulses to specific targets in the brain. The impulses help to regulate abnormal brain activity, and can be used to treat a variety of neurological conditions, including Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder.

During the procedure, electrodes are implanted into the brain and connected to the neurostimulator, which is typically implanted in the chest. The neurostimulator can be programmed to deliver electrical impulses at varying frequencies, amplitudes, and pulse widths, depending on the specific needs of the patient.

DBS is generally considered a safe and effective treatment option for many patients with neurological conditions, although it does carry some risks, such as infection, bleeding, and hardware complications. It is typically reserved for patients who have not responded well to other forms of treatment, or who experience significant side effects from medication.

Anxiety disorders are a category of mental health disorders characterized by feelings of excessive and persistent worry, fear, or anxiety that interfere with daily activities. They include several different types of disorders, such as:

1. Generalized Anxiety Disorder (GAD): This is characterized by chronic and exaggerated worry and tension, even when there is little or nothing to provoke it.
2. Panic Disorder: This is characterized by recurring unexpected panic attacks and fear of experiencing more panic attacks.
3. Social Anxiety Disorder (SAD): Also known as social phobia, this is characterized by excessive fear, anxiety, or avoidance of social situations due to feelings of embarrassment, self-consciousness, and concern about being judged or viewed negatively by others.
4. Phobias: These are intense, irrational fears of certain objects, places, or situations. When a person with a phobia encounters the object or situation they fear, they may experience panic attacks or other severe anxiety responses.
5. Agoraphobia: This is a fear of being in places where it may be difficult to escape or get help if one has a panic attack or other embarrassing or incapacitating symptoms.
6. Separation Anxiety Disorder (SAD): This is characterized by excessive anxiety about separation from home or from people to whom the individual has a strong emotional attachment (such as a parent, sibling, or partner).
7. Selective Mutism: This is a disorder where a child becomes mute in certain situations, such as at school, but can speak normally at home or with close family members.

These disorders are treatable with a combination of medication and psychotherapy (cognitive-behavioral therapy, exposure therapy). It's important to seek professional help if you suspect that you or someone you know may have an anxiety disorder.

Torticollis, also known as wry neck, is a condition where the neck muscles contract and cause the head to turn to one side. There are different types of torticollis including congenital (present at birth), acquired (develops after birth), and spasmodic (neurological).

Congenital torticollis can be caused by a tight or shortened sternocleidomastoid muscle in the neck, which can occur due to positioning in the womb or abnormal blood vessels in the muscle. Acquired torticollis can result from injury, infection, or tumors in the neck. Spasmodic torticollis is a neurological disorder that causes involuntary contractions of the neck muscles and can be caused by a variety of factors including genetics, environmental toxins, or head trauma.

Symptoms of torticollis may include difficulty turning the head, tilting the chin upwards or downwards, pain or discomfort in the neck, and a limited range of motion. Treatment for torticollis depends on the underlying cause and can include physical therapy, stretching exercises, medication, or surgery.

Mood disorders are a category of mental health disorders characterized by significant and persistent changes in mood, affect, and emotional state. These disorders can cause disturbances in normal functioning and significantly impair an individual's ability to carry out their daily activities. The two primary types of mood disorders are depressive disorders (such as major depressive disorder or persistent depressive disorder) and bipolar disorders (which include bipolar I disorder, bipolar II disorder, and cyclothymic disorder).

Depressive disorders involve prolonged periods of low mood, sadness, hopelessness, and a lack of interest in activities. Individuals with these disorders may also experience changes in sleep patterns, appetite, energy levels, concentration, and self-esteem. In severe cases, they might have thoughts of death or suicide.

Bipolar disorders involve alternating episodes of mania (or hypomania) and depression. During a manic episode, individuals may feel extremely elated, energetic, or irritable, with racing thoughts, rapid speech, and impulsive behavior. They might engage in risky activities, have decreased sleep needs, and display poor judgment. In contrast, depressive episodes involve the same symptoms as depressive disorders.

Mood disorders can be caused by a combination of genetic, biological, environmental, and psychological factors. Proper diagnosis and treatment, which may include psychotherapy, medication, or a combination of both, are essential for managing these conditions and improving quality of life.

Stereotaxic techniques are minimally invasive surgical procedures used in neuroscience and neurology that allow for precise targeting and manipulation of structures within the brain. These methods use a stereotactic frame, which is attached to the skull and provides a three-dimensional coordinate system to guide the placement of instruments such as electrodes, cannulas, or radiation sources. The main goal is to reach specific brain areas with high precision and accuracy, minimizing damage to surrounding tissues. Stereotaxic techniques are widely used in research, diagnosis, and treatment of various neurological disorders, including movement disorders, pain management, epilepsy, and psychiatric conditions.

Sleep-Wake Transition Disorders are a group of sleep disorders characterized by irregularities in the transition between sleep and wakefulness. These disorders include conditions such as:

1. Narcolepsy: A neurological disorder that affects the control of sleep and wakefulness, causing excessive daytime sleepiness and sudden attacks of sleep.
2. Idiopathic Hypersomnia: A sleep disorder characterized by excessive daytime sleepiness despite adequate or prolonged nighttime sleep.
3. Kleine-Levin Syndrome: A rare sleep disorder characterized by recurring episodes of excessive sleepiness and eating.
4. Insomnia with Non-REM Sleep Disorder: A condition in which a person has difficulty falling asleep or staying asleep, accompanied by abnormal behaviors during non-rapid eye movement (NREM) sleep.
5. Sleepwalking (Somnambulism): A behavior disorder that originates during deep sleep and results in walking or performing other complex behaviors while asleep.
6. Night Terrors (Pavor Nocturnus): A parasomnia characterized by extreme fear, agitation, and arousal during sleep, typically occurring during deep non-REM sleep.
7. Sleep Paralysis: A temporary inability to move or speak while falling asleep or waking up, caused by the failure of the brain to transition properly between sleep and wakefulness.
8. REM Sleep Behavior Disorder (RBD): A disorder characterized by the acting out of dreams during REM sleep, which can result in injury to the sleeper or their bed partner.

These disorders can have significant impacts on a person's quality of life, safety, and overall health. Proper diagnosis and treatment are essential for managing these conditions effectively.

Tic disorders are a group of conditions characterized by the presence of repetitive, involuntary movements or sounds, known as tics. These movements or sounds can vary in complexity and severity, and they may be worsened by stress or strong emotions.

There are several different types of tic disorders, including:

1. Tourette's disorder: This is a neurological condition characterized by the presence of both motor (movement-related) and vocal tics that have been present for at least one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
2. Persistent (chronic) motor or vocal tic disorder: This type of tic disorder is characterized by the presence of either motor or vocal tics (but not both), which have been present for at least one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
3. Provisional tic disorder: This type of tic disorder is characterized by the presence of motor or vocal tics (or both) that have been present for less than one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
4. Tic disorder not otherwise specified: This category is used to describe tic disorders that do not meet the criteria for any of the other types of tic disorders.

Tic disorders are thought to be caused by a combination of genetic and environmental factors, and they often co-occur with other conditions such as attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). Treatment for tic disorders may include behavioral therapy, medication, or a combination of both.

Ataxia is a medical term that refers to a group of disorders affecting coordination, balance, and speech. It is characterized by a lack of muscle control during voluntary movements, causing unsteady or awkward movements, and often accompanied by tremors. Ataxia can affect various parts of the body, such as the limbs, trunk, eyes, and speech muscles. The condition can be congenital or acquired, and it can result from damage to the cerebellum, spinal cord, or sensory nerves. There are several types of ataxia, including hereditary ataxias, degenerative ataxias, cerebellar ataxias, and acquired ataxias, each with its own specific causes, symptoms, and prognosis. Treatment for ataxia typically focuses on managing symptoms and improving quality of life, as there is no cure for most forms of the disorder.

Drug-induced akathisia is a type of movement disorder that is a side effect of certain medications. The term "akathisia" comes from the Greek words "a-," meaning "without," and "kathisia," meaning "sitting." It is characterized by a subjective feeling of restlessness and an uncontrollable urge to be in constant motion, accompanied by objective motor symptoms such as fidgeting, rocking, or pacing.

Drug-induced akathisia is most commonly associated with the use of antipsychotic medications, particularly those that block dopamine receptors in the brain. Other drugs that have been linked to akathisia include certain antidepressants, anti-nausea medications, and some beta blockers used to treat heart conditions.

The symptoms of drug-induced akathisia can range from mild to severe and may include:

* A subjective feeling of inner restlessness or anxiety
* An uncontrollable urge to move, such as fidgeting, rocking, or pacing
* Difficulty sitting still or lying down
* Agitation and irritability
* Sleep disturbances
* Depression or dysphoria
* Suicidal thoughts or behaviors (in severe cases)

The symptoms of drug-induced akathisia can be distressing and may contribute to noncompliance with medication treatment. In some cases, the symptoms may resolve on their own after a period of time, but in other cases, they may persist or worsen, requiring a change in medication or the addition of other medications to manage the symptoms. It is important for individuals who are taking medications that have been associated with akathisia to report any new or worsening symptoms to their healthcare provider as soon as possible.

Psychophysiologic Disorders, also known as psychosomatic disorders, refer to a category of mental health conditions where psychological stress and emotional factors play a significant role in causing physical symptoms. These disorders are characterized by the presence of bodily complaints for which no physiological explanation can be found, or where the severity of the symptoms is far greater than what would be expected from any underlying medical condition.

Examples of psychophysiologic disorders include:

* Conversion disorder: where physical symptoms such as blindness, paralysis, or difficulty swallowing occur in the absence of a clear medical explanation.
* Irritable bowel syndrome (IBS): where abdominal pain, bloating, and changes in bowel habits are thought to be caused or worsened by stress and emotional factors.
* Psychogenic nonepileptic seizures (PNES): where episodes that resemble epileptic seizures occur without any electrical activity in the brain.
* Chronic pain syndromes: where pain persists for months or years beyond the expected healing time, often accompanied by depression and anxiety.

The diagnosis of psychophysiologic disorders typically involves a thorough medical evaluation to rule out other potential causes of the symptoms. Treatment usually includes a combination of psychotherapy, such as cognitive-behavioral therapy (CBT), relaxation techniques, stress management, and sometimes medication for co-occurring mental health conditions.

Sleep disorders, intrinsic, refer to a group of sleep disorders that are caused by underlying medical conditions within an individual's body. These disorders originate from internal physiological or psychological factors and can significantly impact the quality, duration, and timing of sleep. The most common types of intrinsic sleep disorders include insomnia, sleep-related breathing disorders (such as sleep apnea), central hypersomnias (like narcolepsy), circadian rhythm sleep-wake disorders, and parasomnias (including nightmares and sleepwalking).

Intrinsic sleep disorders can lead to various negative consequences, such as excessive daytime sleepiness, impaired cognitive function, reduced quality of life, and increased risk of accidents or injuries. Proper diagnosis and management of these disorders typically involve addressing the underlying medical condition and implementing appropriate treatment strategies, which may include lifestyle modifications, pharmacological interventions, or medical devices.

Neurology is a branch of medicine that deals with the study and treatment of diseases and disorders of the nervous system, which includes the brain, spinal cord, peripheral nerves, muscles, and autonomic nervous system. Neurologists are medical doctors who specialize in this field, diagnosing and treating conditions such as stroke, Alzheimer's disease, epilepsy, Parkinson's disease, multiple sclerosis, and various types of headaches and pain disorders. They use a variety of diagnostic tests, including imaging studies like MRI and CT scans, electrophysiological tests like EEG and EMG, and laboratory tests to evaluate nerve function and identify any underlying conditions or abnormalities. Treatment options may include medication, surgery, rehabilitation, or lifestyle modifications.

The Globus Pallidus is a structure in the brain that is part of the basal ganglia, a group of nuclei associated with movement control and other functions. It has two main subdivisions: the external (GPe) and internal (GPi) segments. The GPe receives input from the striatum and sends inhibitory projections to the subthalamic nucleus, while the GPi sends inhibitory projections to the thalamus, which in turn projects to the cerebral cortex. These connections allow for the regulation of motor activity, with abnormal functioning of the Globus Pallidus being implicated in various movement disorders such as Parkinson's disease and Huntington's disease.

A neurological examination is a series of tests used to evaluate the functioning of the nervous system, including both the central nervous system (the brain and spinal cord) and peripheral nervous system (the nerves that extend from the brain and spinal cord to the rest of the body). It is typically performed by a healthcare professional such as a neurologist or a primary care physician with specialized training in neurology.

During a neurological examination, the healthcare provider will assess various aspects of neurological function, including:

1. Mental status: This involves evaluating a person's level of consciousness, orientation, memory, and cognitive abilities.
2. Cranial nerves: There are 12 cranial nerves that control functions such as vision, hearing, smell, taste, and movement of the face and neck. The healthcare provider will test each of these nerves to ensure they are functioning properly.
3. Motor function: This involves assessing muscle strength, tone, coordination, and reflexes. The healthcare provider may ask the person to perform certain movements or tasks to evaluate these functions.
4. Sensory function: The healthcare provider will test a person's ability to feel different types of sensations, such as touch, pain, temperature, vibration, and proprioception (the sense of where your body is in space).
5. Coordination and balance: The healthcare provider may assess a person's ability to perform coordinated movements, such as touching their finger to their nose or walking heel-to-toe.
6. Reflexes: The healthcare provider will test various reflexes throughout the body using a reflex hammer.

The results of a neurological examination can help healthcare providers diagnose and monitor conditions that affect the nervous system, such as stroke, multiple sclerosis, Parkinson's disease, or peripheral neuropathy.

The Diagnostic and Statistical Manual of Mental Disorders (DSM) is a publication of the American Psychiatric Association (APA) that provides diagnostic criteria for mental disorders. It is widely used by mental health professionals in the United States and around the world to diagnose and classify mental health conditions.

The DSM includes detailed descriptions of symptoms, clinical examples, and specific criteria for each disorder, which are intended to facilitate accurate diagnosis and improve communication among mental health professionals. The manual is regularly updated to reflect current research and clinical practice, with the most recent edition being the DSM-5, published in 2013.

It's important to note that while the DSM is a valuable tool for mental health professionals, it is not without controversy. Some critics argue that the manual medicalizes normal human experiences and that its categories may be too broad or overlapping. Nonetheless, it remains an essential resource for clinicians, researchers, and policymakers in the field of mental health.

The brain is the central organ of the nervous system, responsible for receiving and processing sensory information, regulating vital functions, and controlling behavior, movement, and cognition. It is divided into several distinct regions, each with specific functions:

1. Cerebrum: The largest part of the brain, responsible for higher cognitive functions such as thinking, learning, memory, language, and perception. It is divided into two hemispheres, each controlling the opposite side of the body.
2. Cerebellum: Located at the back of the brain, it is responsible for coordinating muscle movements, maintaining balance, and fine-tuning motor skills.
3. Brainstem: Connects the cerebrum and cerebellum to the spinal cord, controlling vital functions such as breathing, heart rate, and blood pressure. It also serves as a relay center for sensory information and motor commands between the brain and the rest of the body.
4. Diencephalon: A region that includes the thalamus (a major sensory relay station) and hypothalamus (regulates hormones, temperature, hunger, thirst, and sleep).
5. Limbic system: A group of structures involved in emotional processing, memory formation, and motivation, including the hippocampus, amygdala, and cingulate gyrus.

The brain is composed of billions of interconnected neurons that communicate through electrical and chemical signals. It is protected by the skull and surrounded by three layers of membranes called meninges, as well as cerebrospinal fluid that provides cushioning and nutrients.

Head movements refer to the voluntary or involuntary motion of the head in various directions. These movements can occur in different planes, including flexion (moving the head forward), extension (moving the head backward), rotation (turning the head to the side), and lateral bending (leaning the head to one side).

Head movements can be a result of normal physiological processes, such as when nodding in agreement or shaking the head to indicate disagreement. They can also be caused by neurological conditions, such as abnormal head movements in patients with Parkinson's disease or cerebellar disorders. Additionally, head movements may occur in response to sensory stimuli, such as turning the head toward a sound.

In a medical context, an examination of head movements can provide important clues about a person's neurological function and help diagnose various conditions affecting the brain and nervous system.

Blepharospasm is a medical condition characterized by involuntary spasms and contractions of the muscles around the eyelids. These spasms can cause frequent blinkings, eye closure, and even difficulty in keeping the eyes open. In some cases, the spasms may be severe enough to interfere with vision, daily activities, and quality of life.

The exact cause of blepharospasm is not fully understood, but it is believed to involve abnormal functioning of the basal ganglia, a part of the brain that controls movement. It can occur as an isolated condition (known as essential blepharospasm) or as a symptom of other neurological disorders such as Parkinson's disease or dystonia.

Treatment options for blepharospasm may include medication, botulinum toxin injections, surgery, or a combination of these approaches. The goal of treatment is to reduce the frequency and severity of the spasms, improve symptoms, and enhance the patient's quality of life.

Gait apraxia is a neurological disorder that affects an individual's ability to perform coordinated and complex movements required for walking, despite having the physical capability to do so. It is not caused by weakness or sensory loss, but rather by damage to the brain areas responsible for motor planning and execution, particularly in the frontal lobes.

Gait apraxia is characterized by a wide-based, hesitant, and unsteady gait pattern. Individuals with this condition may have difficulty initiating walking, changing direction, or adjusting their stride length and speed. They may also exhibit symptoms such as freezing of gait, where they are unable to move their feet forward despite intending to walk.

This disorder is often associated with various neurological conditions, including cerebrovascular accidents (strokes), degenerative diseases such as Parkinson's disease and multiple sclerosis, traumatic brain injuries, and infections of the central nervous system. Treatment typically involves physical therapy, gait training, and the use of assistive devices to improve mobility and safety.

Electromyography (EMG) is a medical diagnostic procedure that measures the electrical activity of skeletal muscles during contraction and at rest. It involves inserting a thin needle electrode into the muscle to record the electrical signals generated by the muscle fibers. These signals are then displayed on an oscilloscope and may be heard through a speaker.

EMG can help diagnose various neuromuscular disorders, such as muscle weakness, numbness, or pain, and can distinguish between muscle and nerve disorders. It is often used in conjunction with other diagnostic tests, such as nerve conduction studies, to provide a comprehensive evaluation of the nervous system.

EMG is typically performed by a neurologist or a physiatrist, and the procedure may cause some discomfort or pain, although this is usually minimal. The results of an EMG can help guide treatment decisions and monitor the progression of neuromuscular conditions over time.

Psychomotor performance refers to the integration and coordination of mental processes (cognitive functions) with physical movements. It involves the ability to perform complex tasks that require both cognitive skills, such as thinking, remembering, and perceiving, and motor skills, such as gross and fine motor movements. Examples of psychomotor performances include driving a car, playing a musical instrument, or performing surgical procedures.

In a medical context, psychomotor performance is often used to assess an individual's ability to perform activities of daily living (ADLs) and instrumental activities of daily living (IADLs), such as bathing, dressing, cooking, cleaning, and managing medications. Deficits in psychomotor performance can be a sign of neurological or psychiatric disorders, such as dementia, Parkinson's disease, or depression.

Assessment of psychomotor performance may involve tests that measure reaction time, coordination, speed, precision, and accuracy of movements, as well as cognitive functions such as attention, memory, and problem-solving skills. These assessments can help healthcare professionals develop appropriate treatment plans and monitor the progression of diseases or the effectiveness of interventions.

Sleep disorders are a group of conditions that affect the ability to sleep well on a regular basis. They can include problems with falling asleep, staying asleep, or waking up too early in the morning. These disorders can be caused by various factors such as stress, anxiety, depression, medical conditions, or substance abuse.

The American Academy of Sleep Medicine (AASM) recognizes over 80 distinct sleep disorders, which are categorized into the following major groups:

1. Insomnia - difficulty falling asleep or staying asleep.
2. Sleep-related breathing disorders - abnormal breathing during sleep such as obstructive sleep apnea.
3. Central disorders of hypersomnolence - excessive daytime sleepiness, including narcolepsy.
4. Circadian rhythm sleep-wake disorders - disruption of the internal body clock that regulates the sleep-wake cycle.
5. Parasomnias - abnormal behaviors during sleep such as sleepwalking or night terrors.
6. Sleep-related movement disorders - repetitive movements during sleep such as restless legs syndrome.
7. Isolated symptoms and normal variants - brief and occasional symptoms that do not warrant a specific diagnosis.

Sleep disorders can have significant impacts on an individual's quality of life, productivity, and overall health. If you suspect that you may have a sleep disorder, it is recommended to consult with a healthcare professional or a sleep specialist for proper evaluation and treatment.

Antiparkinson agents are a class of medications used to treat the symptoms of Parkinson's disease and related disorders. These agents work by increasing the levels or activity of dopamine, a neurotransmitter in the brain that is responsible for regulating movement and coordination.

There are several types of antiparkinson agents, including:

1. Levodopa: This is the most effective treatment for Parkinson's disease. It is converted to dopamine in the brain and helps to replace the missing dopamine in people with Parkinson's.
2. Dopamine agonists: These medications mimic the effects of dopamine in the brain and can be used alone or in combination with levodopa. Examples include pramipexole, ropinirole, and rotigotine.
3. Monoamine oxidase B (MAO-B) inhibitors: These medications block the breakdown of dopamine in the brain and can help to increase its levels. Examples include selegiline and rasagiline.
4. Catechol-O-methyltransferase (COMT) inhibitors: These medications block the breakdown of levodopa in the body, allowing it to reach the brain in higher concentrations. Examples include entacapone and tolcapone.
5. Anticholinergic agents: These medications block the action of acetylcholine, another neurotransmitter that can contribute to tremors and muscle stiffness in Parkinson's disease. Examples include trihexyphenidyl and benztropine.

It is important to note that antiparkinson agents can have side effects, and their use should be carefully monitored by a healthcare professional. The choice of medication will depend on the individual patient's symptoms, age, overall health, and other factors.

Primidone is an anticonvulsant medication primarily used in the treatment of seizure disorders. It is a barbiturate derivative that has sedative and muscle relaxant properties. Primidone is metabolized in the body into two other anticonvulsants, phenobarbital and phenylethylmalonamide (PEMA). Together, these active metabolites help to reduce the frequency and severity of seizures.

Primidone is used primarily for generalized tonic-clonic seizures and complex partial seizures. It may also be considered for use in absence seizures, although other medications are typically preferred for this type of seizure. The medication works by decreasing abnormal electrical activity in the brain, which helps to prevent or reduce the occurrence of seizures.

Like all anticonvulsant medications, primidone carries a risk of side effects, including dizziness, drowsiness, and unsteady gait. It may also cause rash, nausea, vomiting, and loss of appetite in some individuals. In rare cases, primidone can cause more serious side effects such as blood disorders, liver damage, or suicidal thoughts.

It is important for patients taking primidone to be closely monitored by their healthcare provider to ensure that the medication is working effectively and to monitor for any potential side effects. Dosages of primidone may need to be adjusted over time based on the patient's response to treatment and any adverse reactions that occur.

Psychomotor disorders are conditions that involve abnormalities in cognition, emotion, and behavior associated with impaired voluntary motor or movement functions. These disorders can be characterized by hypoactivity (decreased motor activity) or hyperactivity (increased motor activity). Examples of psychomotor disorders include Parkinson's disease, Huntington's disease, Tourette syndrome, and catatonia. Psychomotor agitation, retardation, and stereotypies are also considered psychomotor disorders. These conditions can significantly impact a person's daily functioning and quality of life.

Primary dysautonomias, also known as primary autonomic disorders or idiopathic dysautonomia, refer to a group of conditions that affect the autonomic nervous system (ANS) without an identifiable underlying cause. The ANS is responsible for regulating many automatic bodily functions such as heart rate, blood pressure, digestion, and body temperature.

In primary dysautonomias, the ANS fails to function properly, leading to a variety of symptoms that can affect different organ systems. These symptoms may include orthostatic intolerance (lightheadedness or fainting upon standing), irregular heart rate, excessive sweating, heat or cold intolerance, difficulty with digestion, and pupillary abnormalities.

Examples of primary dysautonomias include pure autonomic failure, multiple system atrophy, and familial dysautonomia. These conditions are typically progressive, meaning that symptoms tend to worsen over time. Treatment for primary dysautonomias is focused on managing symptoms and improving quality of life.

Levodopa, also known as L-dopa, is a medication used primarily in the treatment of Parkinson's disease. It is a direct precursor to the neurotransmitter dopamine and works by being converted into dopamine in the brain, helping to restore the balance between dopamine and other neurotransmitters. This helps alleviate symptoms such as stiffness, tremors, spasms, and poor muscle control. Levodopa is often combined with carbidopa (a peripheral decarboxylase inhibitor) to prevent the conversion of levodopa to dopamine outside of the brain, reducing side effects like nausea and vomiting.

Psychotic disorders are a group of severe mental health conditions characterized by distorted perceptions, thoughts, and emotions that lead to an inability to recognize reality. The two most common symptoms of psychotic disorders are hallucinations and delusions. Hallucinations are when a person sees, hears, or feels things that aren't there, while delusions are fixed, false beliefs that are not based on reality.

Other symptoms may include disorganized speech, disorganized behavior, catatonic behavior, and negative symptoms such as apathy and lack of emotional expression. Schizophrenia is the most well-known psychotic disorder, but other types include schizoaffective disorder, delusional disorder, brief psychotic disorder, shared psychotic disorder, and substance-induced psychotic disorder.

Psychotic disorders can be caused by a variety of factors, including genetics, brain chemistry imbalances, trauma, and substance abuse. Treatment typically involves a combination of medication, therapy, and support services to help manage symptoms and improve quality of life.

Ocular motility disorders refer to a group of conditions that affect the movement of the eyes. These disorders can result from nerve damage, muscle dysfunction, or brain injuries. They can cause abnormal eye alignment, limited range of motion, and difficulty coordinating eye movements. Common symptoms include double vision, blurry vision, strabismus (crossed eyes), nystagmus (involuntary eye movement), and difficulty tracking moving objects. Ocular motility disorders can be congenital or acquired and may require medical intervention to correct or manage the condition.

Facial injuries refer to any damage or trauma caused to the face, which may include the bones of the skull that form the face, teeth, salivary glands, muscles, nerves, and skin. Facial injuries can range from minor cuts and bruises to severe fractures and disfigurement. They can be caused by a variety of factors such as accidents, falls, sports-related injuries, physical assaults, or animal attacks.

Facial injuries can affect one or more areas of the face, including the forehead, eyes, nose, cheeks, ears, mouth, and jaw. Common types of facial injuries include lacerations (cuts), contusions (bruises), abrasions (scrapes), fractures (broken bones), and burns.

Facial injuries can have significant psychological and emotional impacts on individuals, in addition to physical effects. Treatment for facial injuries may involve simple first aid, suturing of wounds, splinting or wiring of broken bones, reconstructive surgery, or other medical interventions. It is essential to seek prompt medical attention for any facial injury to ensure proper healing and minimize the risk of complications.

A tic is a sudden, repetitive, involuntary movement or vocalization that occurs frequently. Tics can be simple, involving only one muscle group, or complex, involving several muscle groups or coordinated patterns of movements. Common motor tics include eye blinking, facial grimacing, and shoulder shrugging, while common vocal tics include throat clearing, sniffing, and grunting.

Tics can vary in severity and frequency over time, and they may be exacerbated by stress, anxiety, or fatigue. In some cases, tics may be suppressible for brief periods of time, but this can lead to a buildup of tension that eventually results in an explosive release of the tic.

Tourette syndrome is a neurological disorder characterized by the presence of both motor and vocal tics that persist for more than one year. However, tics can also occur as a symptom of other medical conditions, such as Huntington's disease, Wilson's disease, or certain infections. In some cases, tics may be caused by medication side effects or substance abuse.

Antipsychotic agents are a class of medications used to manage and treat psychosis, which includes symptoms such as delusions, hallucinations, paranoia, disordered thought processes, and agitated behavior. These drugs work by blocking the action of dopamine, a neurotransmitter in the brain that is believed to play a role in the development of psychotic symptoms. Antipsychotics can be broadly divided into two categories: first-generation antipsychotics (also known as typical antipsychotics) and second-generation antipsychotics (also known as atypical antipsychotics).

First-generation antipsychotics, such as chlorpromazine, haloperidol, and fluphenazine, were developed in the 1950s and have been widely used for several decades. They are generally effective in reducing positive symptoms of psychosis (such as hallucinations and delusions) but can cause significant side effects, including extrapyramidal symptoms (EPS), such as rigidity, tremors, and involuntary movements, as well as weight gain, sedation, and orthostatic hypotension.

Second-generation antipsychotics, such as clozapine, risperidone, olanzapine, quetiapine, and aripiprazole, were developed more recently and are considered to have a more favorable side effect profile than first-generation antipsychotics. They are generally effective in reducing both positive and negative symptoms of psychosis (such as apathy, anhedonia, and social withdrawal) and cause fewer EPS. However, they can still cause significant weight gain, metabolic disturbances, and sedation.

Antipsychotic agents are used to treat various psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder with psychotic features, delusional disorder, and other conditions that involve psychosis or agitation. They can be administered orally, intramuscularly, or via long-acting injectable formulations. The choice of antipsychotic agent depends on the individual patient's needs, preferences, and response to treatment, as well as the potential for side effects. Regular monitoring of patients taking antipsychotics is essential to ensure their safety and effectiveness.

Hyperkinesis is not considered a formal medical diagnosis. However, the term is often used informally to refer to a state of excessive or involuntary muscle movements. It is sometimes used as a synonym for hyperkinetic movement disorders, which are a group of neurological conditions characterized by an excess of involuntary movements. Examples of hyperkinetic movement disorders include chorea, dystonia, tics, myoclonus, and stereotypies.

It is important to note that the term "hyperkinesis" is not used in the current diagnostic classifications such as the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) or the International Classification of Diseases (ICD-10). Instead, specific movement disorders are diagnosed and classified based on their underlying causes and symptoms.

Thalamic diseases refer to conditions that affect the thalamus, which is a part of the brain that acts as a relay station for sensory and motor signals to the cerebral cortex. The thalamus plays a crucial role in regulating consciousness, sleep, and alertness. Thalamic diseases can cause a variety of symptoms depending on the specific area of the thalamus that is affected. These symptoms may include sensory disturbances, motor impairment, cognitive changes, and altered levels of consciousness. Examples of thalamic diseases include stroke, tumors, multiple sclerosis, infections, and degenerative disorders such as dementia and Parkinson's disease. Treatment for thalamic diseases depends on the underlying cause and may include medications, surgery, or rehabilitation therapy.

Restless Legs Syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move one's body to stop uncomfortable or odd sensations. It most commonly affects the legs. The condition worsens during periods of rest, particularly when lying or sitting.

The symptoms typically include:

1. An uncontrollable need or urge to move the legs to relieve uncomfortable sensations such as crawling, creeping, tingling, pulling, or painful feelings.
2. Symptoms begin or intensify during rest or inactivity.
3. Symptoms are partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues.
4. Symptoms are worse in the evening or night, often leading to disturbed sleep.

The exact cause of RLS is unknown, but it may be related to abnormalities in the brain's dopamine pathways that control muscle movements. It can also be associated with certain medical conditions like iron deficiency, kidney disease, diabetes, and pregnancy. Treatment often involves addressing any underlying conditions and using medications to manage symptoms.

Secondary Parkinson's disease, also known as acquired or symptomatic Parkinsonism, is a clinical syndrome characterized by the signs and symptoms of classic Parkinson's disease (tremor at rest, rigidity, bradykinesia, and postural instability) but caused by a known secondary cause. These causes can include various conditions such as brain injuries, infections, drugs or toxins, metabolic disorders, and vascular damage. The underlying pathology of secondary Parkinson's disease is different from that of classic Parkinson's disease, which is primarily due to the degeneration of dopamine-producing neurons in a specific area of the brain called the substantia nigra pars compacta.

Major Depressive Disorder (MDD), also simply referred to as depression, is a serious mental health condition characterized by the presence of one or more major depressive episodes. A major depressive episode is a period of at least two weeks during which an individual experiences a severely depressed mood and/or loss of interest or pleasure in nearly all activities, accompanied by at least four additional symptoms such as significant changes in appetite or weight, sleep disturbances, psychomotor agitation or retardation, fatigue or loss of energy, feelings of worthlessness or excessive guilt, difficulty thinking, concentrating, or making decisions, and recurrent thoughts of death or suicide.

MDD can significantly impair an individual's ability to function in daily life, and it is associated with increased risks of suicide, substance abuse, and other mental health disorders. The exact cause of MDD is not fully understood, but it is believed to result from a complex interplay of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of psychotherapy (such as cognitive-behavioral therapy) and medication (such as selective serotonin reuptake inhibitors or tricyclic antidepressants).

Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder that affects multiple systems in the body. It is characterized by a combination of symptoms including Parkinsonism (such as stiffness, slowness of movement, and tremors), cerebellar ataxia (lack of muscle coordination), autonomic dysfunction (problems with the autonomic nervous system which controls involuntary actions like heart rate, blood pressure, sweating, and digestion), and pyramidal signs (abnormalities in the corticospinal tracts that control voluntary movements).

The disorder is caused by the degeneration of nerve cells in various parts of the brain and spinal cord, leading to a loss of function in these areas. The exact cause of MSA is unknown, but it is thought to involve a combination of genetic and environmental factors. There is currently no cure for MSA, and treatment is focused on managing symptoms and improving quality of life.

Alpha-synuclein is a protein that is primarily found in neurons (nerve cells) in the brain. It is encoded by the SNCA gene and is abundantly expressed in presynaptic terminals, where it is believed to play a role in the regulation of neurotransmitter release.

In certain neurological disorders, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, alpha-synuclein can form aggregates known as Lewy bodies and Lewy neurites. These aggregates are a pathological hallmark of these diseases and are believed to contribute to the death of nerve cells, leading to the symptoms associated with these disorders.

The precise function of alpha-synuclein is not fully understood, but it is thought to be involved in various cellular processes such as maintaining the structure of the presynaptic terminal, regulating synaptic vesicle trafficking and neurotransmitter release, and protecting neurons from stress.

A tuberculoma is a specific type of granulomatous lesion that occurs in the brain due to infection with the Mycobacterium tuberculosis bacterium. This condition is relatively rare in developed countries but is still common in developing nations where tuberculosis (TB) is prevalent.

Intracranial tuberculomas are formed when M. tuberculosis bacteria spread through the bloodstream from a primary focus, usually in the lungs, and lodge in the brain tissue. The bacteria then multiply within the brain, leading to an inflammatory response characterized by the formation of granulomas. These granulomas consist of central caseous necrosis (cheese-like material) surrounded by a layer of epithelioid histiocytes, lymphocytes, and multinucleated giant cells.

Tuberculomas can vary in size from a few millimeters to several centimeters in diameter. They may be solitary or multiple and are often found near the surface of the brain, particularly in the cerebral cortex or meninges (the protective membranes surrounding the brain). The presence of intracranial tuberculomas can lead to various neurological symptoms, such as headaches, seizures, focal deficits, and cognitive impairment.

Diagnosis of intracranial tuberculomas typically involves a combination of imaging techniques (such as CT or MRI scans) and laboratory tests (such as cerebrospinal fluid analysis and PCR for M. tuberculosis). Treatment usually consists of a prolonged course of anti-tuberculous medications, which can help to reduce the size of the lesions and alleviate symptoms. In some cases, surgical intervention may be necessary to remove or decompress large or symptomatic tuberculomas.

Tourette Syndrome (TS) is a neurological disorder characterized by the presence of multiple motor tics and at least one vocal (phonic) tic. These tics are sudden, repetitive, rapid, involuntary movements or sounds that occur for more than a year and are not due to substance use or other medical conditions. The symptoms typically start before the age of 18, with the average onset around 6-7 years old.

The severity, frequency, and types of tics can vary greatly among individuals with TS and may change over time. Common motor tics include eye blinking, facial grimacing, shoulder shrugging, and head or limb jerking. Vocal tics can range from simple sounds like throat clearing, coughing, or barking to more complex phrases or words.

In some cases, TS may be accompanied by co-occurring conditions such as attention deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), anxiety, and depression. These associated symptoms can sometimes have a greater impact on daily functioning than the tics themselves.

The exact cause of Tourette Syndrome remains unclear, but it is believed to involve genetic factors and abnormalities in certain brain regions involved in movement control and inhibition. There is currently no cure for TS, but various treatments, including behavioral therapy and medications, can help manage the symptoms and improve quality of life.

Facial nerve diseases refer to a group of medical conditions that affect the function of the facial nerve, also known as the seventh cranial nerve. This nerve is responsible for controlling the muscles of facial expression, and it also carries sensory information from the taste buds in the front two-thirds of the tongue, and regulates saliva flow and tear production.

Facial nerve diseases can cause a variety of symptoms, depending on the specific location and extent of the nerve damage. Common symptoms include:

* Facial weakness or paralysis on one or both sides of the face
* Drooping of the eyelid and corner of the mouth
* Difficulty closing the eye or keeping it closed
* Changes in taste sensation or dryness of the mouth and eyes
* Abnormal sensitivity to sound (hyperacusis)
* Twitching or spasms of the facial muscles

Facial nerve diseases can be caused by a variety of factors, including:

* Infections such as Bell's palsy, Ramsay Hunt syndrome, and Lyme disease
* Trauma or injury to the face or skull
* Tumors that compress or invade the facial nerve
* Neurological conditions such as multiple sclerosis or Guillain-Barre syndrome
* Genetic disorders such as Moebius syndrome or hemifacial microsomia

Treatment for facial nerve diseases depends on the underlying cause and severity of the symptoms. In some cases, medication, physical therapy, or surgery may be necessary to restore function and relieve symptoms.

Attention Deficit Hyperactivity Disorder (ADHD) with hyperactivity is a neurodevelopmental disorder that affects both children and adults. The condition is characterized by symptoms including:

1. Difficulty paying attention or staying focused on a single task
2. Impulsivity, or acting without thinking
3. Hyperactivity, or excessive fidgeting, restlessness, or talking

In order to be diagnosed with ADHD with hyperactivity, an individual must exhibit these symptoms to a degree that is developmentally inappropriate and interferes with their daily functioning. Additionally, the symptoms must have been present for at least six months and be present in multiple settings (e.g., at home, school, work).

It's important to note that ADHD can manifest differently in different people, and some individuals may experience predominantly inattentive or impulsive symptoms rather than hyperactive ones. However, when the hyperactive component is prominent, it is referred to as ADHD with hyperactivity.

Effective treatments for ADHD with hyperactivity include a combination of medication (such as stimulants) and behavioral therapy. With appropriate treatment, individuals with ADHD can learn to manage their symptoms and lead successful, fulfilling lives.

Progressive Supranuclear Palsy (PSP) is a rare neurological disorder characterized by the progressive degeneration of brain cells that regulate movement, thoughts, behavior, and eye movements. The term "supranuclear" refers to the location of the damage in the brain, specifically above the level of the "nuclei" which are clusters of nerve cells that control voluntary movements.

The most common early symptom of PSP is a loss of balance and difficulty coordinating eye movements, particularly vertical gaze. Other symptoms may include stiffness or rigidity of muscles, slowness of movement, difficulty swallowing, changes in speech and writing, and cognitive decline leading to dementia.

PSP typically affects people over the age of 60, and its progression can vary from person to person. Currently, there is no cure for PSP, and treatment is focused on managing symptoms and maintaining quality of life.

Plant viral movement proteins (MPs) are specialized proteins encoded by plant viruses that play a crucial role in the infection process. These proteins are responsible for the cell-to-cell movement of the virus, allowing it to spread throughout the infected plant. MPs facilitate the transport of viral genetic material from infected cells to neighboring uninfected cells, often through plasmodesmata, which are specialized channels that connect the cytoplasm of adjacent plant cells.

Movement proteins can increase the size exclusion limit (SEL) of plasmodesmata, creating a larger pore through which viral RNA or DNA can pass. They also form complexes with viral nucleic acids and other MPs to create movement protein-viral RNA/DNA complexes that are transported between cells. The precise mechanisms by which MPs function vary among different virus families, but their role in facilitating the spread of plant viruses is well established.

It's important to note that understanding the structure and function of plant viral movement proteins can provide valuable insights into plant-virus interactions and contribute to the development of novel strategies for controlling plant virus diseases.

Medical Definition:

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a strong magnetic field and radio waves to create detailed cross-sectional or three-dimensional images of the internal structures of the body. The patient lies within a large, cylindrical magnet, and the scanner detects changes in the direction of the magnetic field caused by protons in the body. These changes are then converted into detailed images that help medical professionals to diagnose and monitor various medical conditions, such as tumors, injuries, or diseases affecting the brain, spinal cord, heart, blood vessels, joints, and other internal organs. MRI does not use radiation like computed tomography (CT) scans.

Huntington Disease (HD) is a genetic neurodegenerative disorder that affects both cognitive and motor functions. It is characterized by the progressive loss of neurons in various areas of the brain, particularly in the striatum and cortex. The disease is caused by an autosomal dominant mutation in the HTT gene, which codes for the huntingtin protein. The most common mutation is a CAG repeat expansion in this gene, leading to the production of an abnormal form of the huntingtin protein that is toxic to nerve cells.

The symptoms of HD typically appear between the ages of 30 and 50, but they can start earlier or later in life. The early signs of HD may include subtle changes in mood, cognition, and coordination. As the disease progresses, individuals with HD experience uncontrolled movements (chorea), emotional disturbances, cognitive decline, and difficulties with communication and swallowing. Eventually, they become dependent on others for their daily needs and lose their ability to walk, talk, and care for themselves.

There is currently no cure for HD, but medications and therapies can help manage the symptoms of the disease and improve quality of life. Genetic testing is available to confirm the diagnosis and provide information about the risk of passing the disease on to future generations.

In medical terms, a hand is the part of the human body that is attached to the forearm and consists of the carpus (wrist), metacarpus, and phalanges. It is made up of 27 bones, along with muscles, tendons, ligaments, and other soft tissues. The hand is a highly specialized organ that is capable of performing a wide range of complex movements and functions, including grasping, holding, manipulating objects, and communicating through gestures. It is also richly innervated with sensory receptors that provide information about touch, temperature, pain, and proprioception (the sense of the position and movement of body parts).

The subthalamic nucleus (STN) is a small, lens-shaped structure located in the basal ganglia of the brain. It plays a crucial role in motor control and has been identified as a key target for deep brain stimulation surgery in the treatment of Parkinson's disease and other movement disorders.

The STN is involved in the regulation of movement, balance, and posture, and helps to filter and coordinate signals that are sent from the cerebral cortex to the thalamus and then on to the motor neurons in the brainstem and spinal cord. In Parkinson's disease, abnormal activity in the STN can contribute to symptoms such as tremors, rigidity, and difficulty initiating movements.

Deep brain stimulation of the STN involves implanting electrodes into the nucleus and delivering electrical impulses that help to regulate its activity. This can lead to significant improvements in motor function and quality of life for some people with Parkinson's disease.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

A depressive disorder is a mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest or pleasure in activities. It can also include changes in sleep, appetite, energy levels, concentration, and self-esteem, as well as thoughts of death or suicide. Depressive disorders can vary in severity and duration, with some people experiencing mild and occasional symptoms, while others may have severe and chronic symptoms that interfere with their ability to function in daily life.

There are several types of depressive disorders, including major depressive disorder (MDD), persistent depressive disorder (PDD), and postpartum depression. MDD is characterized by symptoms that interfere significantly with a person's ability to function and last for at least two weeks, while PDD involves chronic low-grade depression that lasts for two years or more. Postpartum depression occurs in women after childbirth and can range from mild to severe.

Depressive disorders are thought to be caused by a combination of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of medication, psychotherapy (talk therapy), and lifestyle changes.

Equine-assisted therapy (EAT) is a form of experiential psychotherapy that involves interactions between patients and horses. It is facilitated by a licensed therapist, equine specialist, and sometimes a horse handler. The goal of EAT is to help patients achieve specific physical, occupational, and emotional health goals.

The therapy can include various activities such as grooming, feeding, leading, and riding horses. These activities are designed to improve the patient's physical, cognitive, emotional, and social skills. For example, patients with physical disabilities may work on balance and coordination while riding a horse, while those with mental health disorders may work on building self-esteem and confidence through caring for and interacting with the horse.

Equine-assisted therapy has been shown to be effective in treating a variety of conditions, including but not limited to:

* Mental health disorders such as depression, anxiety, post-traumatic stress disorder (PTSD), and substance abuse disorders
* Physical disabilities such as cerebral palsy, muscular dystrophy, and spinal cord injuries
* Developmental disorders such as autism spectrum disorder and intellectual disabilities
* Neurological conditions such as multiple sclerosis, stroke, and traumatic brain injury.

It is important to note that EAT should only be facilitated by trained professionals who adhere to the standards set forth by professional organizations such as the Equine Assisted Growth and Learning Association (EAGALA) or the Professional Association of Therapeutic Horsemanship International (PATH Intl.).

Neurons, also known as nerve cells or neurocytes, are specialized cells that constitute the basic unit of the nervous system. They are responsible for receiving, processing, and transmitting information and signals within the body. Neurons have three main parts: the dendrites, the cell body (soma), and the axon. The dendrites receive signals from other neurons or sensory receptors, while the axon transmits these signals to other neurons, muscles, or glands. The junction between two neurons is called a synapse, where neurotransmitters are released to transmit the signal across the gap (synaptic cleft) to the next neuron. Neurons vary in size, shape, and structure depending on their function and location within the nervous system.

Phenothiazines are a class of heterocyclic organic compounds that contain a phenothiazine nucleus, which consists of a pair of benzene rings fused to a thiazine ring. They have been widely used in medicine as antipsychotic drugs for the treatment of various mental disorders such as schizophrenia and bipolar disorder.

Phenothiazines work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis such as hallucinations, delusions, and disordered thinking. They also have sedative and antiemetic (anti-nausea) effects. However, they can cause a range of side effects including extrapyramidal symptoms (involuntary muscle movements), tardive dyskinesia (irreversible movement disorder), and neuroleptic malignant syndrome (a rare but potentially fatal reaction to antipsychotic drugs).

Examples of phenothiazine drugs include chlorpromazine, thioridazine, and promethazine. While they have been largely replaced by newer atypical antipsychotics, phenothiazines are still used in some cases due to their lower cost and effectiveness in treating certain symptoms.

Cognitive disorders are a category of mental health disorders that primarily affect cognitive abilities including learning, memory, perception, and problem-solving. These disorders can be caused by various factors such as brain injury, degenerative diseases, infection, substance abuse, or developmental disabilities. Examples of cognitive disorders include dementia, amnesia, delirium, and intellectual disability. It's important to note that the specific definition and diagnostic criteria for cognitive disorders may vary depending on the medical source or classification system being used.

The corpus striatum is a part of the brain that plays a crucial role in movement, learning, and cognition. It consists of two structures called the caudate nucleus and the putamen, which are surrounded by the external and internal segments of the globus pallidus. Together, these structures form the basal ganglia, a group of interconnected neurons that help regulate voluntary movement.

The corpus striatum receives input from various parts of the brain, including the cerebral cortex, thalamus, and other brainstem nuclei. It processes this information and sends output to the globus pallidus and substantia nigra, which then project to the thalamus and back to the cerebral cortex. This feedback loop helps coordinate and fine-tune movements, allowing for smooth and coordinated actions.

Damage to the corpus striatum can result in movement disorders such as Parkinson's disease, Huntington's disease, and dystonia. These conditions are characterized by abnormal involuntary movements, muscle stiffness, and difficulty initiating or controlling voluntary movements.

Nervous system diseases, also known as neurological disorders, refer to a group of conditions that affect the nervous system, which includes the brain, spinal cord, nerves, and muscles. These diseases can affect various functions of the body, such as movement, sensation, cognition, and behavior. They can be caused by genetics, infections, injuries, degeneration, or tumors. Examples of nervous system diseases include Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, migraine, stroke, and neuroinfections like meningitis and encephalitis. The symptoms and severity of these disorders can vary widely, ranging from mild to severe and debilitating.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

The "age of onset" is a medical term that refers to the age at which an individual first develops or displays symptoms of a particular disease, disorder, or condition. It can be used to describe various medical conditions, including both physical and mental health disorders. The age of onset can have implications for prognosis, treatment approaches, and potential causes of the condition. In some cases, early onset may indicate a more severe or progressive course of the disease, while late-onset symptoms might be associated with different underlying factors or etiologies. It is essential to provide accurate and precise information regarding the age of onset when discussing a patient's medical history and treatment plan.

Obsessive-Compulsive Disorder (OCD) is a mental health disorder characterized by the presence of obsessions and compulsions. Obsessions are recurrent and persistent thoughts, urges, or images that are intrusive, unwanted, and often distressing. Compulsions are repetitive behaviors or mental acts that an individual feels driven to perform in response to an obsession or according to rigid rules, and which are aimed at preventing or reducing anxiety or distress, or preventing some dreaded event or situation. These obsessions and/or compulsions cause significant distress, take up a lot of time (an hour or more a day), and interfere with the individual's daily life, including social activities, relationships, and work or school performance. OCD is considered a type of anxiety disorder and can also co-occur with other mental health conditions.

Autistic Disorder, also known as Autism or Classic Autism, is a neurodevelopmental disorder that affects communication and behavior. It is characterized by:

1. Persistent deficits in social communication and social interaction across multiple contexts, including:
* Deficits in social-emotional reciprocity;
* Deficits in nonverbal communicative behaviors used for social interaction;
* Deficits in developing, maintaining, and understanding relationships.
2. Restricted, repetitive patterns of behavior, interests, or activities, as manifested by at least two of the following:
* Stereotyped or repetitive motor movements, use of objects, or speech;
* Insistence on sameness, inflexible adherence to routines, or ritualized patterns of verbal or nonverbal behavior;
* Highly restricted, fixated interests that are abnormal in intensity or focus;
* Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment.
3. Symptoms must be present in the early developmental period (but may not become fully manifest until social demands exceed limited capacities) and limit or impair everyday functioning.
4. Symptoms do not occur exclusively during the course of a schizophrenia spectrum disorder or other psychotic disorders.

Autistic Disorder is part of the autism spectrum disorders (ASDs), which also include Asperger's Syndrome and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS). The current diagnostic term for this category of conditions, according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), is Autism Spectrum Disorder.

Biomechanics is the application of mechanical laws to living structures and systems, particularly in the field of medicine and healthcare. A biomechanical phenomenon refers to a observable event or occurrence that involves the interaction of biological tissues or systems with mechanical forces. These phenomena can be studied at various levels, from the molecular and cellular level to the tissue, organ, and whole-body level.

Examples of biomechanical phenomena include:

1. The way that bones and muscles work together to produce movement (known as joint kinematics).
2. The mechanical behavior of biological tissues such as bone, cartilage, tendons, and ligaments under various loads and stresses.
3. The response of cells and tissues to mechanical stimuli, such as the way that bone tissue adapts to changes in loading conditions (known as Wolff's law).
4. The biomechanics of injury and disease processes, such as the mechanisms of joint injury or the development of osteoarthritis.
5. The use of mechanical devices and interventions to treat medical conditions, such as orthopedic implants or assistive devices for mobility impairments.

Understanding biomechanical phenomena is essential for developing effective treatments and prevention strategies for a wide range of medical conditions, from musculoskeletal injuries to neurological disorders.

Fetal movement, also known as quickening, refers to the first perceived movements of the fetus in the uterus during pregnancy. These movements are often described as a fluttering sensation in the lower abdomen and are usually felt by pregnant individuals between 18 and 25 weeks of gestation, although they may occur earlier or later depending on various factors such as the position of the placenta and whether it is a first-time pregnancy.

Fetal movements are an important sign of fetal well-being, and pregnant individuals are typically advised to monitor them regularly starting from around 28 weeks of gestation. A decrease in fetal movement or the absence of fetal movement for an extended period may indicate a problem and should be reported to a healthcare provider immediately.

Fetal movements can be described as kicks, rolls, jabs, or turns, and they become stronger and more frequent as the pregnancy progresses. By 32 weeks of gestation, most fetuses move around 10 times per hour, and by 37 weeks, they typically move around 30 times per day. However, it is important to note that every fetus has its own pattern of movements, and what is normal for one may not be normal for another.

Post-traumatic stress disorder (PTSD) is a psychiatric condition that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, serious accident, war combat, rape, or violent personal assault. According to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), PTSD is characterized by the following symptoms, which must last for more than one month:

1. Intrusion symptoms: These include distressing memories, nightmares, flashbacks, or intense psychological distress or reactivity to internal or external cues that symbolize or resemble an aspect of the traumatic event.
2. Avoidance symptoms: Persistent avoidance of stimuli associated with the traumatic event, including thoughts, feelings, conversations, activities, places, or people.
3. Negative alterations in cognitions and mood: This includes negative beliefs about oneself, others, or the world; distorted blame of self or others for causing the trauma; persistent negative emotional state; decreased interest in significant activities; and feelings of detachment or estrangement from others.
4. Alterations in arousal and reactivity: This includes irritable behavior and angry outbursts, reckless or self-destructive behavior, hypervigilance, exaggerated startle response, problems with concentration, and sleep disturbance.
5. Duration of symptoms: The symptoms must last for more than one month.
6. Functional significance: The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.

It is essential to note that PTSD can occur at any age and can be accompanied by various physical and mental health problems, such as depression, substance abuse, memory problems, and other difficulties in cognition. Appropriate treatment, which may include psychotherapy, medication, or a combination of both, can significantly improve the symptoms and overall quality of life for individuals with PTSD.

"Motor activity" is a general term used in the field of medicine and neuroscience to refer to any kind of physical movement or action that is generated by the body's motor system. The motor system includes the brain, spinal cord, nerves, and muscles that work together to produce movements such as walking, talking, reaching for an object, or even subtle actions like moving your eyes.

Motor activity can be voluntary, meaning it is initiated intentionally by the individual, or involuntary, meaning it is triggered automatically by the nervous system without conscious control. Examples of voluntary motor activity include deliberately lifting your arm or kicking a ball, while examples of involuntary motor activity include heartbeat, digestion, and reflex actions like jerking your hand away from a hot stove.

Abnormalities in motor activity can be a sign of neurological or muscular disorders, such as Parkinson's disease, cerebral palsy, or multiple sclerosis. Assessment of motor activity is often used in the diagnosis and treatment of these conditions.

Tetrabenazine is a prescription medication used to treat conditions associated with abnormal involuntary movements, such as chorea in Huntington's disease. It works by depleting the neurotransmitter dopamine in the brain, which helps to reduce the severity and frequency of these movements.

Here is the medical definition:

Tetrabenazine is a selective monoamine-depleting agent, with preferential uptake by dopamine neurons. It is used in the treatment of chorea associated with Huntington's disease. Tetrabenazine inhibits vesicular monoamine transporter 2 (VMAT2), leading to depletion of presynaptic dopamine and subsequent reduction in post-synaptic dopamine receptor activation. This mechanism of action is thought to underlie its therapeutic effect in reducing chorea severity and frequency.

(Definitions provided by Stedman's Medical Dictionary and American Society of Health-System Pharmacists)

Electrooculography (EOG) is a technique for measuring the resting potential of the eye and the changes in this potential that occur with eye movements. It involves placing electrodes near the eyes to detect the small electric fields generated by the movement of the eyeball within the surrounding socket. This technique is used in research and clinical settings to study eye movements and their control, as well as in certain diagnostic applications such as assessing the function of the oculomotor system in patients with neurological disorders.

A syndrome, in medical terms, is a set of symptoms that collectively indicate or characterize a disease, disorder, or underlying pathological process. It's essentially a collection of signs and/or symptoms that frequently occur together and can suggest a particular cause or condition, even though the exact physiological mechanisms might not be fully understood.

For example, Down syndrome is characterized by specific physical features, cognitive delays, and other developmental issues resulting from an extra copy of chromosome 21. Similarly, metabolic syndromes like diabetes mellitus type 2 involve a group of risk factors such as obesity, high blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels that collectively increase the risk of heart disease, stroke, and diabetes.

It's important to note that a syndrome is not a specific diagnosis; rather, it's a pattern of symptoms that can help guide further diagnostic evaluation and management.

Psychiatric Status Rating Scales are standardized assessment tools used by mental health professionals to evaluate and rate the severity of a person's psychiatric symptoms and functioning. These scales provide a systematic and structured approach to measuring various aspects of an individual's mental health, such as mood, anxiety, psychosis, behavior, and cognitive abilities.

The purpose of using Psychiatric Status Rating Scales is to:

1. Assess the severity and improvement of psychiatric symptoms over time.
2. Aid in diagnostic decision-making and treatment planning.
3. Monitor treatment response and adjust interventions accordingly.
4. Facilitate communication among mental health professionals about a patient's status.
5. Provide an objective basis for research and epidemiological studies.

Examples of Psychiatric Status Rating Scales include:

1. Clinical Global Impression (CGI): A brief, subjective rating scale that measures overall illness severity, treatment response, and improvement.
2. Positive and Negative Syndrome Scale (PANSS): A comprehensive scale used to assess the symptoms of psychosis, including positive, negative, and general psychopathology domains.
3. Hamilton Rating Scale for Depression (HRSD) or Montgomery-Åsberg Depression Rating Scale (MADRS): Scales used to evaluate the severity of depressive symptoms.
4. Young Mania Rating Scale (YMRS): A scale used to assess the severity of manic or hypomanic symptoms.
5. Brief Psychiatric Rating Scale (BPRS) or Symptom Checklist-90 Revised (SCL-90-R): Scales that measure a broad range of psychiatric symptoms and psychopathology.
6. Global Assessment of Functioning (GAF): A scale used to rate an individual's overall psychological, social, and occupational functioning on a hypothetical continuum of mental health-illness.

It is important to note that Psychiatric Status Rating Scales should be administered by trained mental health professionals to ensure accurate and reliable results.

Motor skills are defined as the abilities required to plan, control and execute physical movements. They involve a complex interplay between the brain, nerves, muscles, and the environment. Motor skills can be broadly categorized into two types: fine motor skills, which involve small, precise movements (such as writing or picking up small objects), and gross motor skills, which involve larger movements using the arms, legs, and torso (such as crawling, walking, or running).

Motor skills development is an essential aspect of child growth and development, and it continues to evolve throughout adulthood. Difficulties with motor skills can impact a person's ability to perform daily activities and can be associated with various neurological and musculoskeletal conditions.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

The motor cortex is a region in the frontal lobe of the brain that is responsible for controlling voluntary movements. It is involved in planning, initiating, and executing movements of the limbs, body, and face. The motor cortex contains neurons called Betz cells, which have large cell bodies and are responsible for transmitting signals to the spinal cord to activate muscles. Damage to the motor cortex can result in various movement disorders such as hemiplegia or paralysis on one side of the body.

I'm sorry for any confusion, but "Libya" is not a medical term. It is a country located in North Africa, known officially as the "State of Libya." If you have any questions about medical terms or concepts, I would be happy to help answer those for you!

Cell movement, also known as cell motility, refers to the ability of cells to move independently and change their location within tissue or inside the body. This process is essential for various biological functions, including embryonic development, wound healing, immune responses, and cancer metastasis.

There are several types of cell movement, including:

1. **Crawling or mesenchymal migration:** Cells move by extending and retracting protrusions called pseudopodia or filopodia, which contain actin filaments. This type of movement is common in fibroblasts, immune cells, and cancer cells during tissue invasion and metastasis.
2. **Amoeboid migration:** Cells move by changing their shape and squeezing through tight spaces without forming protrusions. This type of movement is often observed in white blood cells (leukocytes) as they migrate through the body to fight infections.
3. **Pseudopodial extension:** Cells extend pseudopodia, which are temporary cytoplasmic projections containing actin filaments. These protrusions help the cell explore its environment and move forward.
4. **Bacterial flagellar motion:** Bacteria use a whip-like structure called a flagellum to propel themselves through their environment. The rotation of the flagellum is driven by a molecular motor in the bacterial cell membrane.
5. **Ciliary and ependymal movement:** Ciliated cells, such as those lining the respiratory tract and fallopian tubes, have hair-like structures called cilia that beat in coordinated waves to move fluids or mucus across the cell surface.

Cell movement is regulated by a complex interplay of signaling pathways, cytoskeletal rearrangements, and adhesion molecules, which enable cells to respond to environmental cues and navigate through tissues.

Psychopathology is a branch of psychology and medicine that involves the study and classification of mental disorders, including their causes, symptoms, and treatment. It is an interdisciplinary field that draws on various methods and perspectives from psychology, neuroscience, genetics, sociology, and other related disciplines to understand and explain abnormal behavior and mental processes.

The term "psychopathology" can also refer specifically to the presence of a mental disorder or to the symptoms and features of a particular mental disorder. For example, one might say that someone has a psychopathology or that they exhibit certain psychopathological symptoms.

Psychopathology is often contrasted with normal psychology, which focuses on understanding and explaining typical behavior and mental processes. However, it is important to note that the boundary between normal and abnormal behavior is not always clear-cut, and many psychological phenomena exist on a continuum rather than falling neatly into one category or the other.

The thalamus is a large, paired structure in the brain that serves as a relay station for sensory and motor signals to the cerebral cortex. It is located in the dorsal part of the diencephalon and is made up of two symmetrical halves, each connected to the corresponding cerebral hemisphere.

The thalamus receives inputs from almost all senses, except for the olfactory system, and processes them before sending them to specific areas in the cortex. It also plays a role in regulating consciousness, sleep, and alertness. Additionally, the thalamus is involved in motor control by relaying information between the cerebellum and the motor cortex.

The thalamus is divided into several nuclei, each with distinct connections and functions. Some of these nuclei are involved in sensory processing, while others are involved in motor function or regulation of emotions and cognition. Overall, the thalamus plays a critical role in integrating information from various brain regions and modulating cognitive and emotional processes.

Pergolide is a medication that belongs to a class of drugs called ergoline derivatives. It is primarily used in the management of Parkinson's disease, a neurological disorder characterized by symptoms such as muscle stiffness, tremors, spasms, and poor muscle control. Pergolide works by mimicking the action of dopamine, a neurotransmitter that regulates movement, in the brain.

Specifically, pergolide acts as an agonist at dopamine receptors, particularly D2 and D3 receptors, which helps to reduce the symptoms of Parkinson's disease. It is often used as an adjunct therapy with levodopa, another medication commonly used in the treatment of Parkinson's disease.

However, it is important to note that pergolide has been associated with serious side effects, including heart valve damage and lung scarring, and its use has been significantly restricted or withdrawn in many countries. Therefore, it should only be prescribed and used under the close supervision of a healthcare professional.

Polysomnography (PSG) is a comprehensive sleep study that monitors various body functions during sleep, including brain activity, eye movement, muscle tone, heart rate, respirations, and oxygen levels. It is typically conducted in a sleep laboratory under the supervision of a trained technologist. The data collected during PSG is used to diagnose and manage various sleep disorders such as sleep-related breathing disorders (e.g., sleep apnea), movement disorders (e.g., periodic limb movement disorder), parasomnias, and narcolepsy.

The study usually involves the attachment of electrodes to different parts of the body, such as the scalp, face, chest, and legs, to record electrical signals from the brain, eye movements, muscle activity, and heartbeats. Additionally, sensors may be placed on or near the nose and mouth to measure airflow, and a belt may be worn around the chest and abdomen to monitor breathing efforts. Oxygen levels are also monitored through a sensor attached to the finger or ear.

Polysomnography is often recommended when a sleep disorder is suspected based on symptoms or medical history, and other diagnostic tests have been inconclusive. The results of the study can help guide treatment decisions and improve overall sleep health.

I apologize, but "video recording" is not a term that has a specific medical definition. It generally refers to the process of capturing and storing moving visual images on electronic media, which is used in various medical fields for different purposes such as surgical training, telemedicine consultations, or monitoring patient conditions. However, there is no unique medical meaning associated with this term.

Meige Syndrome, also known as Brueghel's syndrome or Hemifacial spasm-blepharospasm syndrome, is a rare neurological disorder characterized by the simultaneous contraction of muscles in the face, neck, and sometimes other parts of the body. It is a form of dystonia, which is a movement disorder that causes involuntary muscle contractions and abnormal postures.

Meige Syndrome is typically divided into two types:

1. Ocular Meige Syndrome: This type primarily affects the muscles around the eyes, causing involuntary spasms, blinks, and eyelid closure.
2. Cranio-cervical Dystonia or Brueghel's syndrome: This type involves both the cranial (head) and cervical (neck) regions, leading to abnormal head postures, neck pain, and involuntary movements of the facial muscles.

The exact cause of Meige Syndrome is not fully understood, but it is believed to be related to abnormal functioning in the basal ganglia, a part of the brain responsible for controlling movement. In some cases, it may be associated with structural lesions or vascular abnormalities in the brain.

Treatment options for Meige Syndrome include medications such as botulinum toxin (Botox) injections, which help to relax the overactive muscles and reduce spasms. In severe cases, surgical interventions may be considered.

Neurodegenerative diseases are a group of disorders characterized by progressive and persistent loss of neuronal structure and function, often leading to cognitive decline, functional impairment, and ultimately death. These conditions are associated with the accumulation of abnormal protein aggregates, mitochondrial dysfunction, oxidative stress, chronic inflammation, and genetic mutations in the brain. Examples of neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis (ALS), and Spinal Muscular Atrophy (SMA). The underlying causes and mechanisms of these diseases are not fully understood, and there is currently no cure for most neurodegenerative disorders. Treatment typically focuses on managing symptoms and slowing disease progression.

Schizophrenia is a severe mental disorder characterized by disturbances in thought, perception, emotion, and behavior. It often includes hallucinations (usually hearing voices), delusions, paranoia, and disorganized speech and behavior. The onset of symptoms typically occurs in late adolescence or early adulthood. Schizophrenia is a complex, chronic condition that requires ongoing treatment and management. It significantly impairs social and occupational functioning, and it's often associated with reduced life expectancy due to comorbid medical conditions. The exact causes of schizophrenia are not fully understood, but research suggests that genetic, environmental, and neurodevelopmental factors play a role in its development.

A phobic disorder is a type of anxiety disorder characterized by an excessive and irrational fear or avoidance of specific objects, situations, or activities. This fear can cause significant distress and interfere with a person's daily life. Phobic disorders are typically classified into three main categories: specific phobias (such as fear of heights, spiders, or needles), social phobia (or social anxiety disorder), and agoraphobia (fear of open spaces or situations where escape might be difficult).

People with phobic disorders often recognize that their fear is excessive or unreasonable, but they are unable to control it. When exposed to the feared object or situation, they may experience symptoms such as rapid heartbeat, sweating, trembling, and difficulty breathing. These symptoms can be so distressing that individuals with phobic disorders go to great lengths to avoid the feared situation, which can have a significant impact on their quality of life.

Treatment for phobic disorders typically involves cognitive-behavioral therapy (CBT), which helps individuals identify and challenge their irrational thoughts and fears, as well as exposure therapy, which gradually exposes them to the feared object or situation in a safe and controlled environment. In some cases, medication may also be recommended to help manage symptoms of anxiety.

Pervasive developmental disorders (PDD) are a group of conditions that affect the development and functioning of the brain, leading to delays in many areas of development. The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) has replaced the term "pervasive developmental disorders" with "autism spectrum disorder" and "other neurodevelopmental disorders."

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction across multiple contexts, as well as restricted, repetitive patterns of behavior, interests, or activities. The symptoms of ASD can range from mild to severe, and the condition affects approximately 1 in 54 children in the United States.

Other neurodevelopmental disorders that were previously classified as PDDs include:

1. Intellectual disability (ID): a condition characterized by significant limitations in intellectual functioning and adaptive behavior, which covers many everyday social and practical skills. This disorder used to be referred to as "mental retardation."
2. Communication disorders: these are disorders that affect an individual's ability to communicate, including language disorders, speech sound disorders, and stuttering.
3. Attention-deficit/hyperactivity disorder (ADHD): a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity.
4. Specific learning disorder: a neurodevelopmental disorder that affects an individual's ability to learn and use specific academic skills, such as reading, writing, or mathematics.
5. Motor disorders: these are disorders that affect an individual's movement and coordination, including developmental coordination disorder, stereotypic movement disorder, and tic disorders.

The medical definition of 'Child Development Disorders, Pervasive' has been replaced with more specific diagnoses in the DSM-5 to better reflect the diverse nature of these conditions and improve diagnostic accuracy and treatment planning.

I must clarify that the term "pedigree" is not typically used in medical definitions. Instead, it is often employed in genetics and breeding, where it refers to the recorded ancestry of an individual or a family, tracing the inheritance of specific traits or diseases. In human genetics, a pedigree can help illustrate the pattern of genetic inheritance in families over multiple generations. However, it is not a medical term with a specific clinical definition.

Dopamine is a type of neurotransmitter, which is a chemical messenger that transmits signals in the brain and nervous system. It plays several important roles in the body, including:

* Regulation of movement and coordination
* Modulation of mood and motivation
* Control of the reward and pleasure centers of the brain
* Regulation of muscle tone
* Involvement in memory and attention

Dopamine is produced in several areas of the brain, including the substantia nigra and the ventral tegmental area. It is released by neurons (nerve cells) and binds to specific receptors on other neurons, where it can either excite or inhibit their activity.

Abnormalities in dopamine signaling have been implicated in several neurological and psychiatric conditions, including Parkinson's disease, schizophrenia, and addiction.

Substance-related disorders, as defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), refer to a group of conditions caused by the use of substances such as alcohol, drugs, or medicines. These disorders are characterized by a problematic pattern of using a substance that leads to clinically significant impairment or distress. They can be divided into two main categories: substance use disorders and substance-induced disorders. Substance use disorders involve a pattern of compulsive use despite negative consequences, while substance-induced disorders include conditions such as intoxication, withdrawal, and substance/medication-induced mental disorders. The specific diagnosis depends on the type of substance involved, the patterns of use, and the presence or absence of physiological dependence.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Sleep bruxism is a sleep-related movement disorder characterized by the involuntary clenching or grinding of teeth and jaw muscle activity during sleep, which can lead to tooth wear, jaw pain, headaches, and other oral health issues. It is typically considered a parasomnia, which is a type of abnormal behavior that occurs during sleep. The exact causes of sleep bruxism are not fully understood, but it may be associated with stress, certain medications, alcohol and drug use, and other factors. Treatment options can include stress management techniques, dental guards to protect the teeth, and in some cases, medication.

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a type of autoimmune encephalitis, which is a inflammation of the brain. It occurs when the body's immune system produces antibodies against NMDA receptors, which are proteins found on the surface of certain brain cells (neurons). These antibodies can bind to and disrupt the function of the NMDA receptors, leading to a range of neurological symptoms.

The symptoms of anti-NMDA receptor encephalitis typically develop over several weeks or months and can include:

* Behavioral changes, such as anxiety, agitation, or paranoia
* Memory loss
* Seizures
* Movement disorders, such as involuntary jerking or twitching of muscles
* Speech difficulties
* Loss of consciousness
* Autonomic instability (problems regulating heart rate, blood pressure, breathing and temperature)

The diagnosis is confirmed by detecting the anti-NMDA receptor antibodies in the cerebrospinal fluid (CSF) or serum. Treatment typically involves a combination of immunotherapy (such as corticosteroids, intravenous immunoglobulin, and plasma exchange) and tumor removal if a tumor is present.

It's important to note that this disorder can affect both children and adults, and it can be associated with ovarian teratoma in women of childbearing age.

Locomotion, in a medical context, refers to the ability to move independently and change location. It involves the coordinated movement of the muscles, bones, and nervous system that enables an individual to move from one place to another. This can include walking, running, jumping, or using assistive devices such as wheelchairs or crutches. Locomotion is a fundamental aspect of human mobility and is often assessed in medical evaluations to determine overall health and functioning.

Neural pathways, also known as nerve tracts or fasciculi, refer to the highly organized and specialized routes through which nerve impulses travel within the nervous system. These pathways are formed by groups of neurons (nerve cells) that are connected in a series, creating a continuous communication network for electrical signals to transmit information between different regions of the brain, spinal cord, and peripheral nerves.

Neural pathways can be classified into two main types: sensory (afferent) and motor (efferent). Sensory neural pathways carry sensory information from various receptors in the body (such as those for touch, temperature, pain, and vision) to the brain for processing. Motor neural pathways, on the other hand, transmit signals from the brain to the muscles and glands, controlling movements and other effector functions.

The formation of these neural pathways is crucial for normal nervous system function, as it enables efficient communication between different parts of the body and allows for complex behaviors, cognitive processes, and adaptive responses to internal and external stimuli.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

Carbidopa is a peripheral decarboxylase inhibitor used in the treatment of Parkinson's disease. It works by preventing the conversion of levodopa to dopamine outside of the brain, allowing more levodopa to reach the brain and reduce the symptoms of Parkinson's disease. Carbidopa is often combined with levodopa in medication formulations and is available under various brand names, such as Sinemet.

Here are some key points about carbidopa:

* It is a peripheral decarboxylase inhibitor that prevents the conversion of levodopa to dopamine outside of the brain.
* Carbidopa is often combined with levodopa in medication formulations for the treatment of Parkinson's disease.
* By preventing the conversion of levodopa to dopamine outside of the brain, more levodopa can reach the brain and reduce the symptoms of Parkinson's disease.
* Common side effects of carbidopa include nausea, vomiting, and orthostatic hypotension.
* Carbidopa should be used under the guidance of a healthcare professional and dosed appropriately to minimize side effects and maximize therapeutic benefit.

Lewy bodies are abnormal aggregates of alpha-synuclein protein that develop in nerve cells (neurons) in the brain. They are named after Frederick Lewy, a German-American neurologist who discovered them while working with Dr. Alois Alzheimer. The presence of Lewy bodies is a hallmark feature of Lewy body dementia, which includes both Parkinson's disease dementia and dementia with Lewy bodies.

Lewy bodies can lead to the dysfunction and death of neurons in areas of the brain that control movement, cognition, and behavior. This can result in a range of symptoms, including motor impairments, cognitive decline, visual hallucinations, and mood changes. The exact role of Lewy bodies in the development and progression of these disorders is not fully understood, but they are believed to contribute to the neurodegenerative process that underlies these conditions.

Cerebellar diseases refer to a group of medical conditions that affect the cerebellum, which is the part of the brain located at the back of the head, below the occipital lobe and above the brainstem. The cerebellum plays a crucial role in motor control, coordination, balance, and some cognitive functions.

Cerebellar diseases can be caused by various factors, including genetics, infections, tumors, stroke, trauma, or degenerative processes. These conditions can result in a wide range of symptoms, such as:

1. Ataxia: Loss of coordination and unsteady gait
2. Dysmetria: Inability to judge distance and force while performing movements
3. Intention tremors: Shaking or trembling that worsens during purposeful movements
4. Nystagmus: Rapid, involuntary eye movement
5. Dysarthria: Speech difficulty due to muscle weakness or incoordination
6. Hypotonia: Decreased muscle tone
7. Titubation: Rhythmic, involuntary oscillations of the head and neck
8. Cognitive impairment: Problems with memory, attention, and executive functions

Some examples of cerebellar diseases include:

1. Ataxia-telangiectasia
2. Friedrich's ataxia
3. Multiple system atrophy (MSA)
4. Spinocerebellar ataxias (SCAs)
5. Cerebellar tumors, such as medulloblastomas or astrocytomas
6. Infarctions or hemorrhages in the cerebellum due to stroke or trauma
7. Infections, such as viral encephalitis or bacterial meningitis
8. Autoimmune disorders, like multiple sclerosis (MS) or paraneoplastic syndromes
9. Metabolic disorders, such as Wilson's disease or phenylketonuria (PKU)
10. Chronic alcoholism and withdrawal

Treatment for cerebellar diseases depends on the underlying cause and may involve medications, physical therapy, surgery, or supportive care to manage symptoms and improve quality of life.

Extrapyramidal tracts are a part of the motor system that lies outside of the pyramidal tracts, which are responsible for controlling voluntary movements. These extrapyramidal tracts consist of several different pathways in the brain and spinal cord that work together to regulate and coordinate involuntary movements, muscle tone, and posture.

The extrapyramidal system includes structures such as the basal ganglia, cerebellum, and brainstem, and it helps to modulate and fine-tune motor activity. Disorders of the extrapyramidal tracts can result in a variety of symptoms, including rigidity, tremors, involuntary movements, and difficulty with coordination and balance.

Some common conditions that affect the extrapyramidal system include Parkinson's disease, Huntington's disease, and drug-induced movement disorders. Treatment for these conditions may involve medications that target specific components of the extrapyramidal system to help alleviate symptoms and improve function.

Implanted electrodes are medical devices that are surgically placed inside the body to interface directly with nerves, neurons, or other electrically excitable tissue for various therapeutic purposes. These electrodes can be used to stimulate or record electrical activity from specific areas of the body, depending on their design and application.

There are several types of implanted electrodes, including:

1. Deep Brain Stimulation (DBS) electrodes: These are placed deep within the brain to treat movement disorders such as Parkinson's disease, essential tremor, and dystonia. DBS electrodes deliver electrical impulses that modulate abnormal neural activity in targeted brain regions.
2. Spinal Cord Stimulation (SCS) electrodes: These are implanted along the spinal cord to treat chronic pain syndromes. SCS electrodes emit low-level electrical pulses that interfere with pain signals traveling to the brain, providing relief for patients.
3. Cochlear Implant electrodes: These are surgically inserted into the cochlea of the inner ear to restore hearing in individuals with severe to profound hearing loss. The electrodes stimulate the auditory nerve directly, bypassing damaged hair cells within the cochlea.
4. Retinal Implant electrodes: These are implanted in the retina to treat certain forms of blindness caused by degenerative eye diseases like retinitis pigmentosa. The electrodes convert visual information from a camera into electrical signals, which stimulate remaining retinal cells and transmit the information to the brain via the optic nerve.
5. Sacral Nerve Stimulation (SNS) electrodes: These are placed near the sacral nerves in the lower back to treat urinary or fecal incontinence and overactive bladder syndrome. SNS electrodes deliver electrical impulses that regulate the function of the affected muscles and nerves.
6. Vagus Nerve Stimulation (VNS) electrodes: These are wrapped around the vagus nerve in the neck to treat epilepsy and depression. VNS electrodes provide intermittent electrical stimulation to the vagus nerve, which has connections to various regions of the brain involved in these conditions.

Overall, implanted electrodes serve as a crucial component in many neuromodulation therapies, offering an effective treatment option for numerous neurological and sensory disorders.

An abnormal reflex in a medical context refers to an involuntary and exaggerated response or lack of response to a stimulus that is not expected in the normal physiological range. These responses can be indicative of underlying neurological disorders or damage to the nervous system. Examples include hyperreflexia (overactive reflexes) and hyporeflexia (underactive reflexes). The assessment of reflexes is an important part of a physical examination, as it can provide valuable information about the functioning of the nervous system.

The Substantia Nigra is a region in the midbrain that plays a crucial role in movement control and reward processing. It is composed of two parts: the pars compacta and the pars reticulata. The pars compacta contains dopamine-producing neurons, whose loss or degeneration is associated with Parkinson's disease, leading to motor symptoms such as tremors, rigidity, and bradykinesia.

In summary, Substantia Nigra is a brain structure that contains dopamine-producing cells and is involved in movement control and reward processing. Its dysfunction or degeneration can lead to neurological disorders like Parkinson's disease.

Hemifacial spasm is a neuromuscular disorder characterized by involuntary, irregular contractions or twitching of the muscles on one side of the face. These spasms typically begin around the eye and may progress to involve the muscles of the lower face, including those around the mouth.

The primary cause of hemifacial spasm is pressure on or irritation of the facial nerve (cranial nerve VII) as it exits the brainstem, often due to a blood vessel or tumor. This pressure can lead to abnormal electrical signals in the facial nerve, resulting in uncontrolled muscle contractions.

In some cases, hemifacial spasm may be associated with other conditions such as multiple sclerosis or Bell's palsy. Treatment options for hemifacial spasm include medications to help relax the muscles, botulinum toxin (Botox) injections to paralyze the affected muscles temporarily, and, in rare cases, surgical intervention to relieve pressure on the facial nerve.

A saccade is a quick, rapid, and ballistic conjugate eye movement that shifts the point of fixation from one target to another. It helps in rapidly repositioning the fovea (the central part of the retina with the highest visual acuity) to focus on different targets of interest in the visual scene. Saccades are essential for efficient scanning and exploration of our environment, allowing us to direct our high-resolution vision towards various points of interest. They typically take only about 20-200 milliseconds to complete and can reach peak velocities of up to 500 degrees per second or more, depending on the amplitude of the movement. Saccades are a critical component of normal visual function and are often studied in fields such as ophthalmology, neurology, and neuroscience.

In medical terms, the arm refers to the upper limb of the human body, extending from the shoulder to the wrist. It is composed of three major bones: the humerus in the upper arm, and the radius and ulna in the lower arm. The arm contains several joints, including the shoulder joint, elbow joint, and wrist joint, which allow for a wide range of motion. The arm also contains muscles, blood vessels, nerves, and other soft tissues that are essential for normal function.

Analysis of Variance (ANOVA) is a statistical technique used to compare the means of two or more groups and determine whether there are any significant differences between them. It is a way to analyze the variance in a dataset to determine whether the variability between groups is greater than the variability within groups, which can indicate that the groups are significantly different from one another.

ANOVA is based on the concept of partitioning the total variance in a dataset into two components: variance due to differences between group means (also known as "between-group variance") and variance due to differences within each group (also known as "within-group variance"). By comparing these two sources of variance, ANOVA can help researchers determine whether any observed differences between groups are statistically significant, or whether they could have occurred by chance.

ANOVA is a widely used technique in many areas of research, including biology, psychology, engineering, and business. It is often used to compare the means of two or more experimental groups, such as a treatment group and a control group, to determine whether the treatment had a significant effect. ANOVA can also be used to compare the means of different populations or subgroups within a population, to identify any differences that may exist between them.

Neuropsychological tests are a type of psychological assessment that measures cognitive functions, such as attention, memory, language, problem-solving, and perception. These tests are used to help diagnose and understand the cognitive impact of neurological conditions, including dementia, traumatic brain injury, stroke, Parkinson's disease, and other disorders that affect the brain.

The tests are typically administered by a trained neuropsychologist and can take several hours to complete. They may involve paper-and-pencil tasks, computerized tasks, or interactive activities. The results of the tests are compared to normative data to help identify any areas of cognitive weakness or strength.

Neuropsychological testing can provide valuable information for treatment planning, rehabilitation, and assessing response to treatment. It can also be used in research to better understand the neural basis of cognition and the impact of neurological conditions on cognitive function.

Comorbidity is the presence of one or more additional health conditions or diseases alongside a primary illness or condition. These co-occurring health issues can have an impact on the treatment plan, prognosis, and overall healthcare management of an individual. Comorbidities often interact with each other and the primary condition, leading to more complex clinical situations and increased healthcare needs. It is essential for healthcare professionals to consider and address comorbidities to provide comprehensive care and improve patient outcomes.

Electric stimulation therapy, also known as neuromuscular electrical stimulation (NMES) or electromyostimulation, is a therapeutic treatment that uses electrical impulses to stimulate muscles and nerves. The electrical signals are delivered through electrodes placed on the skin near the target muscle group or nerve.

The therapy can be used for various purposes, including:

1. Pain management: Electric stimulation can help reduce pain by stimulating the release of endorphins, which are natural painkillers produced by the body. It can also help block the transmission of pain signals to the brain.
2. Muscle rehabilitation: NMES can be used to prevent muscle atrophy and maintain muscle tone in individuals who are unable to move their muscles due to injury or illness, such as spinal cord injuries or stroke.
3. Improving circulation: Electric stimulation can help improve blood flow and reduce swelling by contracting the muscles and promoting the movement of fluids in the body.
4. Wound healing: NMES can be used to promote wound healing by increasing blood flow, reducing swelling, and improving muscle function around the wound site.
5. Muscle strengthening: Electric stimulation can be used to strengthen muscles by causing them to contract and relax repeatedly, which can help improve muscle strength and endurance.

It is important to note that electric stimulation therapy should only be administered under the guidance of a trained healthcare professional, as improper use can cause harm or discomfort.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

I must apologize, but "welding" is not a term that is typically used in medical definitions. Welding is a process that is commonly used in manufacturing and construction to join two pieces of metal together by melting them and adding a filler material to form a pool of molten metal (the weld puddle) that cools to become a strong joint.

If you have any questions related to medical terminology or health-related topics, I would be happy to help answer them for you.

Reproducibility of results in a medical context refers to the ability to obtain consistent and comparable findings when a particular experiment or study is repeated, either by the same researcher or by different researchers, following the same experimental protocol. It is an essential principle in scientific research that helps to ensure the validity and reliability of research findings.

In medical research, reproducibility of results is crucial for establishing the effectiveness and safety of new treatments, interventions, or diagnostic tools. It involves conducting well-designed studies with adequate sample sizes, appropriate statistical analyses, and transparent reporting of methods and findings to allow other researchers to replicate the study and confirm or refute the results.

The lack of reproducibility in medical research has become a significant concern in recent years, as several high-profile studies have failed to produce consistent findings when replicated by other researchers. This has led to increased scrutiny of research practices and a call for greater transparency, rigor, and standardization in the conduct and reporting of medical research.

Conduct Disorder is a mental health disorder that typically begins in childhood or adolescence and is characterized by a repetitive pattern of behavior that violates the rights of others or major age-appropriate societal norms and rules. The behaviors fall into four main categories: aggression to people and animals, destruction of property, deceitfulness or theft, and serious violation of rules.

The specific symptoms of Conduct Disorder can vary widely among individuals, but they generally include:

1. Aggression to people and animals: This may include physical fights, bullying, threatening others, cruelty to animals, and use of weapons.
2. Destruction of property: This may include deliberate destruction of others' property, arson, and vandalism.
3. Deceitfulness or theft: This may include lying, shoplifting, stealing, and breaking into homes, buildings, or cars.
4. Serious violation of rules: This may include running away from home, truancy, staying out late without permission, and frequent violations of school rules.

Conduct Disorder can have serious consequences for individuals who suffer from it, including academic failure, substance abuse, depression, anxiety, and difficulties in interpersonal relationships. It is important to note that Conduct Disorder should be diagnosed by a qualified mental health professional based on a comprehensive evaluation.

Electroencephalography (EEG) is a medical procedure that records electrical activity in the brain. It uses small, metal discs called electrodes, which are attached to the scalp with paste or a specialized cap. These electrodes detect tiny electrical charges that result from the activity of brain cells, and the EEG machine then amplifies and records these signals.

EEG is used to diagnose various conditions related to the brain, such as seizures, sleep disorders, head injuries, infections, and degenerative diseases like Alzheimer's or Parkinson's. It can also be used during surgery to monitor brain activity and ensure that surgical procedures do not interfere with vital functions.

EEG is a safe and non-invasive procedure that typically takes about 30 minutes to an hour to complete, although longer recordings may be necessary in some cases. Patients are usually asked to relax and remain still during the test, as movement can affect the quality of the recording.

Stereotyped behavior, in the context of medicine and psychology, refers to repetitive, rigid, and invariant patterns of behavior or movements that are purposeless and often non-functional. These behaviors are not goal-directed or spontaneous and typically do not change in response to environmental changes or social interactions.

Stereotypies can include a wide range of motor behaviors such as hand flapping, rocking, head banging, body spinning, self-biting, or complex sequences of movements. They are often seen in individuals with developmental disabilities, intellectual disabilities, autism spectrum disorder, and some mental health conditions.

Stereotyped behaviors can also be a result of substance abuse, neurological disorders, or brain injuries. In some cases, these behaviors may serve as a self-soothing mechanism or a way to cope with stress, anxiety, or boredom. However, they can also interfere with daily functioning and social interactions, and in severe cases, may cause physical harm to the individual.

Synucleins are a family of small, heat-stable, water-soluble proteins that are primarily expressed in neurons. They are involved in various cellular processes such as modulating synaptic plasticity, vesicle trafficking, and neurotransmitter release. The most well-known members of this family are alpha-synuclein, beta-synuclein, and gamma-synuclein.

Abnormal accumulation and aggregation of alpha-synuclein into insoluble fibrils called Lewy bodies and Lewy neurites are hallmark features of several neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. These conditions are collectively referred to as synucleinopathies. The dysfunction and aggregation of alpha-synuclein are thought to contribute to the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, a region of the brain involved in motor control, leading to the characteristic symptoms observed in these disorders.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Dopamine agents are medications that act on dopamine receptors in the brain. Dopamine is a neurotransmitter, a chemical messenger that transmits signals in the brain and other areas of the body. It plays important roles in many functions, including movement, motivation, emotion, and cognition.

Dopamine agents can be classified into several categories based on their mechanism of action:

1. Dopamine agonists: These medications bind to dopamine receptors and mimic the effects of dopamine. They are used to treat conditions such as Parkinson's disease, restless legs syndrome, and certain types of dopamine-responsive dystonia. Examples include pramipexole, ropinirole, and rotigotine.
2. Dopamine precursors: These medications provide the building blocks for the body to produce dopamine. Levodopa is a commonly used dopamine precursor that is converted to dopamine in the brain. It is often used in combination with carbidopa, which helps to prevent levodopa from being broken down before it reaches the brain.
3. Dopamine antagonists: These medications block the action of dopamine at its receptors. They are used to treat conditions such as schizophrenia and certain types of nausea and vomiting. Examples include haloperidol, risperidone, and metoclopramide.
4. Dopamine reuptake inhibitors: These medications increase the amount of dopamine available in the synapse (the space between two neurons) by preventing its reuptake into the presynaptic neuron. They are used to treat conditions such as attention deficit hyperactivity disorder (ADHD) and depression. Examples include bupropion and nomifensine.
5. Dopamine release inhibitors: These medications prevent the release of dopamine from presynaptic neurons. They are used to treat conditions such as Tourette's syndrome and certain types of chronic pain. Examples include tetrabenazine and deutetrabenazine.

It is important to note that dopamine agents can have significant side effects, including addiction, movement disorders, and psychiatric symptoms. Therefore, they should be used under the close supervision of a healthcare provider.

Stiff-Person Syndrome (SPS) is a rare neurological disorder characterized by fluctuating muscle rigidity in the trunk and limbs and a heightened sensitivity to stimuli such as touch, sound, and emotional distress, which can trigger muscle spasms. The symptoms can significantly affect a person's ability to perform daily activities and can lead to frequent falls and injuries. SPS is often associated with antibodies against glutamic acid decarboxylase (GAD), an enzyme involved in the production of a neurotransmitter called gamma-aminobutyric acid (GABA) that helps regulate muscle movement. The exact cause of SPS remains unknown, but it is thought to involve both autoimmune and genetic factors.

'Animal behavior' refers to the actions or responses of animals to various stimuli, including their interactions with the environment and other individuals. It is the study of the actions of animals, whether they are instinctual, learned, or a combination of both. Animal behavior includes communication, mating, foraging, predator avoidance, and social organization, among other things. The scientific study of animal behavior is called ethology. This field seeks to understand the evolutionary basis for behaviors as well as their physiological and psychological mechanisms.

Nerve degeneration, also known as neurodegeneration, is the progressive loss of structure and function of neurons, which can lead to cognitive decline, motor impairment, and various other symptoms. This process occurs due to a variety of factors, including genetics, environmental influences, and aging. It is a key feature in several neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis. The degeneration can affect any part of the nervous system, leading to different symptoms depending on the location and extent of the damage.

A gait disorder is a disturbance in the ability to walk that can't be attributed to physical disabilities such as weakness or paralysis. Neurologic gait disorders are those specifically caused by underlying neurological conditions. These disorders can result from damage to the brain, spinal cord, or peripheral nerves that disrupts communication between the muscles and the brain.

Neurologic gait disorders can present in various ways, including:

1. **Spastic Gait:** This is a stiff, foot-dragging walk caused by increased muscle tone (hypertonia) and stiffness (spasticity). It's often seen in conditions like cerebral palsy or multiple sclerosis.

2. **Ataxic Gait:** This is a broad-based, unsteady, and irregular walk caused by damage to the cerebellum, which affects balance and coordination. Conditions such as cerebellar atrophy or stroke can cause this type of gait disorder.

3. **Parkinsonian Gait:** This is a shuffling walk with small steps, flexed knees, and difficulty turning. It's often seen in Parkinson's disease.

4. **Neuropathic Gait:** This is a high-stepping walk caused by foot drop (difficulty lifting the front part of the foot), which results from damage to the peripheral nerves. Conditions such as diabetic neuropathy or Guillain-Barre syndrome can cause this type of gait disorder.

5. **Choreic Gait:** This is an irregular, dance-like walk caused by involuntary movements (chorea) seen in conditions like Huntington's disease.

6. **Mixed Gait:** Sometimes, a person may exhibit elements of more than one type of gait disorder.

The specific type of gait disorder can provide important clues about the underlying neurological condition and help guide diagnosis and treatment.

Botulinum toxins are neurotoxic proteins produced by the bacterium Clostridium botulinum and related species. They are the most potent naturally occurring toxins, and are responsible for the paralytic illness known as botulism. There are seven distinct botulinum toxin serotypes (A-G), each of which targets specific proteins in the nervous system, leading to inhibition of neurotransmitter release and subsequent muscle paralysis.

In clinical settings, botulinum toxins have been used for therapeutic purposes due to their ability to cause temporary muscle relaxation. Botulinum toxin type A (Botox) is the most commonly used serotype in medical treatments, including management of dystonias, spasticity, migraines, and certain neurological disorders. Additionally, botulinum toxins are widely employed in aesthetic medicine for reducing wrinkles and fine lines by temporarily paralyzing facial muscles.

It is important to note that while botulinum toxins have therapeutic benefits when used appropriately, they can also pose significant health risks if misused or improperly handled. Proper medical training and supervision are essential for safe and effective utilization of these powerful toxins.

Cerebral dominance is a concept in neuropsychology that refers to the specialization of one hemisphere of the brain over the other for certain cognitive functions. In most people, the left hemisphere is dominant for language functions such as speaking and understanding spoken or written language, while the right hemisphere is dominant for non-verbal functions such as spatial ability, face recognition, and artistic ability.

Cerebral dominance does not mean that the non-dominant hemisphere is incapable of performing the functions of the dominant hemisphere, but rather that it is less efficient or specialized in those areas. The concept of cerebral dominance has been used to explain individual differences in cognitive abilities and learning styles, as well as the laterality of brain damage and its effects on cognition and behavior.

It's important to note that cerebral dominance is a complex phenomenon that can vary between individuals and can be influenced by various factors such as genetics, environment, and experience. Additionally, recent research has challenged the strict lateralization of functions and suggested that there is more functional overlap and interaction between the two hemispheres than previously thought.

The oculomotor muscles are a group of extraocular muscles that control the movements of the eye. They include:

1. Superior rectus: This muscle is responsible for elevating the eye and helping with inward rotation (intorsion) when looking downwards.
2. Inferior rectus: It depresses the eye and helps with outward rotation (extorsion) when looking upwards.
3. Medial rectus: This muscle adducts, or moves, the eye towards the midline of the face.
4. Inferior oblique: The inferior oblique muscle intorts and elevates the eye.
5. Superior oblique: It extorts and depresses the eye.

These muscles work together to allow for smooth and precise movements of the eyes, enabling tasks such as tracking moving objects, reading, and maintaining visual fixation on a single point in space.

Cerebral palsy (CP) is a group of disorders that affect a person's ability to move and maintain balance and posture. According to the Mayo Clinic, CP is caused by abnormal brain development or damage to the developing brain that affects a child's ability to control movement.

The symptoms of cerebral palsy can vary in severity and may include:

* Spasticity (stiff or tight muscles)
* Rigidity (resistance to passive movement)
* Poor coordination and balance
* Weakness or paralysis
* Tremors or involuntary movements
* Abnormal gait or difficulty walking
* Difficulty with fine motor skills, such as writing or using utensils
* Speech and language difficulties
* Vision, hearing, or swallowing problems

It's important to note that cerebral palsy is not a progressive condition, meaning that it does not worsen over time. However, the symptoms may change over time, and some individuals with CP may experience additional medical conditions as they age.

Cerebral palsy is usually caused by brain damage that occurs before or during birth, but it can also be caused by brain injuries that occur in the first few years of life. Some possible causes of cerebral palsy include:

* Infections during pregnancy
* Lack of oxygen to the brain during delivery
* Traumatic head injury during birth
* Brain bleeding or stroke in the newborn period
* Genetic disorders
* Maternal illness or infection during pregnancy

There is no cure for cerebral palsy, but early intervention and treatment can help improve outcomes and quality of life. Treatment may include physical therapy, occupational therapy, speech therapy, medications to manage symptoms, surgery, and assistive devices such as braces or wheelchairs.

Ocular fixation is a term used in ophthalmology and optometry to refer to the ability of the eyes to maintain steady gaze or visual focus on an object. It involves the coordinated movement of the extraocular muscles that control eye movements, allowing for clear and stable vision.

In medical terminology, fixation specifically refers to the state in which the eyes are aligned and focused on a single point in space. This is important for maintaining visual perception and preventing blurring or double vision. Ocular fixation can be affected by various factors such as muscle weakness, nerve damage, or visual processing disorders.

Assessment of ocular fixation is often used in eye examinations to evaluate visual acuity, eye alignment, and muscle function. Abnormalities in fixation may indicate the presence of underlying eye conditions or developmental delays that require further investigation and treatment.

Reaction time, in the context of medicine and physiology, refers to the time period between the presentation of a stimulus and the subsequent initiation of a response. This complex process involves the central nervous system, particularly the brain, which perceives the stimulus, processes it, and then sends signals to the appropriate muscles or glands to react.

There are different types of reaction times, including simple reaction time (responding to a single, expected stimulus) and choice reaction time (choosing an appropriate response from multiple possibilities). These measures can be used in clinical settings to assess various aspects of neurological function, such as cognitive processing speed, motor control, and alertness.

However, it is important to note that reaction times can be influenced by several factors, including age, fatigue, attention, and the use of certain medications or substances.

Molecular chaperones are a group of proteins that assist in the proper folding and assembly of other protein molecules, helping them achieve their native conformation. They play a crucial role in preventing protein misfolding and aggregation, which can lead to the formation of toxic species associated with various neurodegenerative diseases. Molecular chaperones are also involved in protein transport across membranes, degradation of misfolded proteins, and protection of cells under stress conditions. Their function is generally non-catalytic and ATP-dependent, and they often interact with their client proteins in a transient manner.

The putamen is a round, egg-shaped structure that is a part of the basal ganglia, located in the forebrain. It is situated laterally to the globus pallidus and medially to the internal capsule. The putamen plays a crucial role in regulating movement and is involved in various functions such as learning, motivation, and habit formation.

It receives input from the cerebral cortex via the corticostriatal pathway and sends output to the globus pallidus and substantia nigra pars reticulata, which are also part of the basal ganglia circuitry. The putamen is heavily innervated by dopaminergic neurons from the substantia nigra pars compacta, and degeneration of these neurons in Parkinson's disease leads to a significant reduction in dopamine levels in the putamen, resulting in motor dysfunction.

Dopamine receptors are a type of G protein-coupled receptor that bind to and respond to the neurotransmitter dopamine. There are five subtypes of dopamine receptors (D1-D5), which are classified into two families based on their structure and function: D1-like (D1 and D5) and D2-like (D2, D3, and D4).

Dopamine receptors play a crucial role in various physiological processes, including movement, motivation, reward, cognition, emotion, and neuroendocrine regulation. They are widely distributed throughout the central nervous system, with high concentrations found in the basal ganglia, limbic system, and cortex.

Dysfunction of dopamine receptors has been implicated in several neurological and psychiatric disorders, such as Parkinson's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD), drug addiction, and depression. Therefore, drugs targeting dopamine receptors have been developed for the treatment of these conditions.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

A questionnaire in the medical context is a standardized, systematic, and structured tool used to gather information from individuals regarding their symptoms, medical history, lifestyle, or other health-related factors. It typically consists of a series of written questions that can be either self-administered or administered by an interviewer. Questionnaires are widely used in various areas of healthcare, including clinical research, epidemiological studies, patient care, and health services evaluation to collect data that can inform diagnosis, treatment planning, and population health management. They provide a consistent and organized method for obtaining information from large groups or individual patients, helping to ensure accurate and comprehensive data collection while minimizing bias and variability in the information gathered.

Lewy body disease, also known as dementia with Lewy bodies, is a type of progressive degenerative dementia that affects thinking, behavior, and movement. It's named after Dr. Friedrich Lewy, the scientist who discovered the abnormal protein deposits, called Lewy bodies, that are characteristic of this disease.

Lewy bodies are made up of a protein called alpha-synuclein and are found in the brain cells of individuals with Lewy body disease. These abnormal protein deposits are also found in people with Parkinson's disease, but they are more widespread in Lewy body disease, affecting multiple areas of the brain.

The symptoms of Lewy body disease can vary from person to person, but they often include:

* Cognitive decline, such as memory loss, confusion, and difficulty with problem-solving
* Visual hallucinations and delusions
* Parkinsonian symptoms, such as stiffness, tremors, and difficulty walking or moving
* Fluctuations in alertness and attention
* REM sleep behavior disorder, where a person acts out their dreams during sleep

Lewy body disease is a progressive condition, which means that the symptoms get worse over time. Currently, there is no cure for Lewy body disease, but medications can help manage some of the symptoms.

Skeletal muscle, also known as striated or voluntary muscle, is a type of muscle that is attached to bones by tendons or aponeuroses and functions to produce movements and support the posture of the body. It is composed of long, multinucleated fibers that are arranged in parallel bundles and are characterized by alternating light and dark bands, giving them a striped appearance under a microscope. Skeletal muscle is under voluntary control, meaning that it is consciously activated through signals from the nervous system. It is responsible for activities such as walking, running, jumping, and lifting objects.

Borderline Personality Disorder (BPD) is a mental health disorder characterized by a pervasive pattern of instability in interpersonal relationships, self-image, affect, and mood, as well as marked impulsivity that begins by early adulthood and is present in various contexts.

Individuals with BPD often experience intense and fluctuating emotions, ranging from profound sadness, anxiety, and anger to feelings of happiness or calm. They may have difficulty managing these emotions, leading to impulsive behavior, self-harm, or suicidal ideation.

People with BPD also tend to have an unstable sense of self, which can lead to rapid changes in their goals, values, and career choices. They often struggle with feelings of emptiness and boredom, and may engage in risky behaviors such as substance abuse, reckless driving, or binge eating to alleviate these feelings.

Interpersonal relationships are often strained due to the individual's fear of abandonment, intense emotional reactions, and difficulty regulating their emotions. They may experience idealization and devaluation of others, leading to rapid shifts in how they view and treat people close to them.

Diagnosis of BPD is typically made by a mental health professional using criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), which is published by the American Psychiatric Association. Treatment for BPD may include psychotherapy, medication, and support groups to help individuals manage their symptoms and improve their quality of life.

NAV1.6, also known as SCN8A, is a gene that encodes for the α subunit of a voltage-gated sodium channel, specifically Nav1.6. This channel plays a crucial role in the initiation and propagation of action potentials in neurons. It has a predominant expression in the central and peripheral nervous system, including the nodes of Ranvier in myelinated axons.

Nav1.6 voltage-gated sodium channels are responsible for the rapid upstroke of the action potential and contribute to the generation of repetitive firing in some neuronal populations. Mutations in the SCN8A gene have been associated with various neurological disorders, such as epilepsy, intellectual disability, and movement disorders.

In summary, NAV1.6 voltage-gated sodium channels are essential for normal neuronal excitability and function, and their dysfunction can lead to a range of neurological symptoms.

Eye movement measurements, also known as oculometry, refer to the measurement and analysis of eye movements. This can include assessing the direction, speed, range, and patterns of eye movement. These measurements are often used in research and clinical settings to understand various aspects of vision, perception, and cognition. They can be used to diagnose and monitor conditions that affect eye movement, such as strabismus (crossed eyes), amblyopia (lazy eye), or neurological disorders. Additionally, eye movement measurements are also used in areas such as human-computer interaction, marketing research, and virtual reality to understand how individuals interact with their environment.

Neuromuscular agents are drugs or substances that affect the function of the neuromuscular junction, which is the site where nerve impulses are transmitted to muscles. These agents can either enhance or inhibit the transmission of signals across the neuromuscular junction, leading to a variety of effects on muscle tone and activity.

Neuromuscular blocking agents (NMBAs) are a type of neuromuscular agent that is commonly used in anesthesia and critical care settings to induce paralysis during intubation or mechanical ventilation. NMBAs can be classified into two main categories: depolarizing and non-depolarizing agents.

Depolarizing NMBAs, such as succinylcholine, work by activating the nicotinic acetylcholine receptors at the neuromuscular junction, causing muscle contraction followed by paralysis. Non-depolarizing NMBAs, such as rocuronium and vecuronium, block the activation of these receptors, preventing muscle contraction and leading to paralysis.

Other types of neuromuscular agents include cholinesterase inhibitors, which increase the levels of acetylcholine at the neuromuscular junction and can be used to reverse the effects of NMBAs, and botulinum toxin, which is a potent neurotoxin that inhibits the release of acetylcholine from nerve terminals and is used in the treatment of various neurological disorders.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a chemical compound that can cause permanent parkinsonian symptoms. It is not a medication or a treatment, but rather a toxin that can damage the dopamine-producing neurons in the brain, leading to symptoms similar to those seen in Parkinson's disease.

MPTP itself is not harmful, but it is metabolized in the body into a toxic compound called MPP+, which accumulates in and damages dopaminergic neurons. MPTP was discovered in the 1980s when a group of drug users in California developed parkinsonian symptoms after injecting a heroin-like substance contaminated with MPTP.

Since then, MPTP has been used as a research tool to study Parkinson's disease and develop new treatments. However, it is not used clinically and should be handled with caution due to its toxicity.

Somatoform disorders are a group of psychological disorders characterized by the presence of physical symptoms that cannot be fully explained by a medical condition or substance abuse. These symptoms cause significant distress and impairment in social, occupational, or other important areas of functioning. The individual's belief about the symptoms is not consistent with the medical evaluation and often leads to excessive or repeated medical evaluations.

Examples of somatoform disorders include:

1. Somatization disorder: characterized by multiple physical symptoms that cannot be explained medically, affecting several parts of the body.
2. Conversion disorder: characterized by the presence of one or more neurological symptoms (such as blindness, paralysis, or difficulty swallowing) that cannot be explained medically and appear to have a psychological origin.
3. Pain disorder: characterized by chronic pain that is not fully explained by a medical condition.
4. Hypochondriasis: characterized by an excessive preoccupation with having a serious illness, despite reassurance from medical professionals.
5. Body dysmorphic disorder: characterized by the obsessive idea that some aspect of one's own body part or appearance is severely flawed and warrants exceptional measures to hide or fix it.

It's important to note that these disorders are not caused by intentional deceit or malingering, but rather reflect a genuine belief in the presence of physical symptoms and distress related to them.

Sarcoglycans are a group of proteins that are part of the dystrophin-glycoprotein complex in muscle cells. This complex helps to maintain the structural integrity of the muscle fiber by forming a link between the cytoskeleton and the extracellular matrix. Sarcoglycans are located on the surface of the muscle fiber and play a critical role in protecting the muscle from damage during contraction.

There are four main sarcoglycans, known as alpha, beta, gamma, and delta-sarcoglycan. Mutations in any one of these proteins can lead to a group of genetic disorders known as the sarcoglycanopathies, which are characterized by progressive muscle weakness and wasting. The most severe form of this disorder is called limb-girdle muscular dystrophy type 2C (LGMD2C), which is caused by mutations in the gamma-sarcoglycan gene.

In addition to their role in muscle cells, sarcoglycans have also been found to be expressed in other tissues, including the brain and the lungs, suggesting that they may have additional functions beyond their structural role in muscle.

Postural balance is the ability to maintain, achieve, or restore a state of equilibrium during any posture or activity. It involves the integration of sensory information (visual, vestibular, and proprioceptive) to control and adjust body position in space, thereby maintaining the center of gravity within the base of support. This is crucial for performing daily activities and preventing falls, especially in older adults and individuals with neurological or orthopedic conditions.

Gait is a medical term used to describe the pattern of movement of the limbs during walking or running. It includes the manner or style of walking, including factors such as rhythm, speed, and step length. A person's gait can provide important clues about their physical health and neurological function, and abnormalities in gait may indicate the presence of underlying medical conditions, such as neuromuscular disorders, orthopedic problems, or injuries.

A typical human gait cycle involves two main phases: the stance phase, during which the foot is in contact with the ground, and the swing phase, during which the foot is lifted and moved forward in preparation for the next step. The gait cycle can be further broken down into several sub-phases, including heel strike, foot flat, midstance, heel off, and toe off.

Gait analysis is a specialized field of study that involves observing and measuring a person's gait pattern using various techniques, such as video recordings, force plates, and motion capture systems. This information can be used to diagnose and treat gait abnormalities, improve mobility and function, and prevent injuries.

Neurological models are simplified representations or simulations of various aspects of the nervous system, including its structure, function, and processes. These models can be theoretical, computational, or physical and are used to understand, explain, and predict neurological phenomena. They may focus on specific neurological diseases, disorders, or functions, such as memory, learning, or movement. The goal of these models is to provide insights into the complex workings of the nervous system that cannot be easily observed or understood through direct examination alone.

Nerve tissue proteins are specialized proteins found in the nervous system that provide structural and functional support to nerve cells, also known as neurons. These proteins include:

1. Neurofilaments: These are type IV intermediate filaments that provide structural support to neurons and help maintain their shape and size. They are composed of three subunits - NFL (light), NFM (medium), and NFH (heavy).

2. Neuronal Cytoskeletal Proteins: These include tubulins, actins, and spectrins that provide structural support to the neuronal cytoskeleton and help maintain its integrity.

3. Neurotransmitter Receptors: These are specialized proteins located on the postsynaptic membrane of neurons that bind neurotransmitters released by presynaptic neurons, triggering a response in the target cell.

4. Ion Channels: These are transmembrane proteins that regulate the flow of ions across the neuronal membrane and play a crucial role in generating and transmitting electrical signals in neurons.

5. Signaling Proteins: These include enzymes, receptors, and adaptor proteins that mediate intracellular signaling pathways involved in neuronal development, differentiation, survival, and death.

6. Adhesion Proteins: These are cell surface proteins that mediate cell-cell and cell-matrix interactions, playing a crucial role in the formation and maintenance of neural circuits.

7. Extracellular Matrix Proteins: These include proteoglycans, laminins, and collagens that provide structural support to nerve tissue and regulate neuronal migration, differentiation, and survival.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Brain mapping is a broad term that refers to the techniques used to understand the structure and function of the brain. It involves creating maps of the various cognitive, emotional, and behavioral processes in the brain by correlating these processes with physical locations or activities within the nervous system. Brain mapping can be accomplished through a variety of methods, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET) scans, electroencephalography (EEG), and others. These techniques allow researchers to observe which areas of the brain are active during different tasks or thoughts, helping to shed light on how the brain processes information and contributes to our experiences and behaviors. Brain mapping is an important area of research in neuroscience, with potential applications in the diagnosis and treatment of neurological and psychiatric disorders.

The Autonomic Nervous System (ANS) is a part of the nervous system that controls involuntary actions, such as heart rate, digestion, respiratory rate, pupillary response, urination, and sexual arousal. It consists of two subdivisions: the sympathetic and parasympathetic nervous systems, which generally have opposing effects and maintain homeostasis in the body.

Autonomic Nervous System Diseases (also known as Autonomic Disorders or Autonomic Neuropathies) refer to a group of conditions that affect the functioning of the autonomic nervous system. These diseases can cause damage to the nerves that control automatic functions, leading to various symptoms and complications.

Autonomic Nervous System Diseases can be classified into two main categories:

1. Primary Autonomic Nervous System Disorders: These are conditions that primarily affect the autonomic nervous system without any underlying cause. Examples include:
* Pure Autonomic Failure (PAF): A rare disorder characterized by progressive loss of autonomic nerve function, leading to symptoms such as orthostatic hypotension, urinary retention, and constipation.
* Multiple System Atrophy (MSA): A degenerative neurological disorder that affects both the autonomic nervous system and movement coordination. Symptoms may include orthostatic hypotension, urinary incontinence, sexual dysfunction, and Parkinsonian features like stiffness and slowness of movements.
* Autonomic Neuropathy associated with Parkinson's Disease: Some individuals with Parkinson's disease develop autonomic symptoms such as orthostatic hypotension, constipation, and urinary dysfunction due to the degeneration of autonomic nerves.
2. Secondary Autonomic Nervous System Disorders: These are conditions that affect the autonomic nervous system as a result of an underlying cause or disease. Examples include:
* Diabetic Autonomic Neuropathy: A complication of diabetes mellitus that affects the autonomic nerves, leading to symptoms such as orthostatic hypotension, gastroparesis (delayed gastric emptying), and sexual dysfunction.
* Autoimmune-mediated Autonomic Neuropathies: Conditions like Guillain-Barré syndrome or autoimmune autonomic ganglionopathy can cause autonomic symptoms due to the immune system attacking the autonomic nerves.
* Infectious Autonomic Neuropathies: Certain infections, such as HIV or Lyme disease, can lead to autonomic dysfunction as a result of nerve damage.
* Toxin-induced Autonomic Neuropathy: Exposure to certain toxins, like heavy metals or organophosphate pesticides, can cause autonomic neuropathy.

Autonomic nervous system disorders can significantly impact a person's quality of life and daily functioning. Proper diagnosis and management are crucial for improving symptoms and preventing complications. Treatment options may include lifestyle modifications, medications, and in some cases, devices or surgical interventions.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

DNA Mutational Analysis is a laboratory test used to identify genetic variations or changes (mutations) in the DNA sequence of a gene. This type of analysis can be used to diagnose genetic disorders, predict the risk of developing certain diseases, determine the most effective treatment for cancer, or assess the likelihood of passing on an inherited condition to offspring.

The test involves extracting DNA from a patient's sample (such as blood, saliva, or tissue), amplifying specific regions of interest using polymerase chain reaction (PCR), and then sequencing those regions to determine the precise order of nucleotide bases in the DNA molecule. The resulting sequence is then compared to reference sequences to identify any variations or mutations that may be present.

DNA Mutational Analysis can detect a wide range of genetic changes, including single-nucleotide polymorphisms (SNPs), insertions, deletions, duplications, and rearrangements. The test is often used in conjunction with other diagnostic tests and clinical evaluations to provide a comprehensive assessment of a patient's genetic profile.

It is important to note that not all mutations are pathogenic or associated with disease, and the interpretation of DNA Mutational Analysis results requires careful consideration of the patient's medical history, family history, and other relevant factors.

In the context of medical terminology, I believe you may be referring to "pursuit" as it relates to neurological tests. A smooth pursuit is a type of eye movement in which the eyes smoothly and slowly follow a moving object. It requires coordination between the extraocular muscles, vestibular system, and visual system. If there are issues with any of these systems, smooth pursuit can be affected, leading to abnormalities such as jerky or saccadic movements.

Therefore, "smooth pursuit" is a medical term used to describe the normal, coordinated movement of the eyes that allows for the tracking of moving objects in a smooth and continuous manner.

Botulinum toxins type A are neurotoxins produced by the bacterium Clostridium botulinum and related species. These toxins act by blocking the release of acetylcholine at the neuromuscular junction, leading to muscle paralysis. Botulinum toxin type A is used in medical treatments for various conditions characterized by muscle spasticity or excessive muscle activity, such as cervical dystonia, blepharospasm, strabismus, and chronic migraine. It is also used cosmetically to reduce the appearance of wrinkles by temporarily paralyzing the muscles that cause them. The commercial forms of botulinum toxin type A include Botox, Dysport, and Xeomin.

I apologize for any confusion, but "Ecuador" is not a medical term or concept. It is the name of a country located in South America, officially known as the "República del Ecuador." If you have any questions related to medicine or health, I would be happy to try and help answer those for you!

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

In medical terms, fingers are not specifically defined as they are common anatomical structures. However, I can provide you with a general anatomy definition:

Fingers are the terminal parts of the upper limb in primates, including humans, consisting of four digits (thumb, index, middle, and ring fingers) and one opposable thumb. They contain bones called phalanges, connected by joints that allow for movement and flexibility. Each finger has a nail, nerve endings for sensation, and blood vessels to supply nutrients and oxygen. Fingers are crucial for various activities such as grasping, manipulating objects, and tactile exploration of the environment.

Genetic predisposition to disease refers to an increased susceptibility or vulnerability to develop a particular illness or condition due to inheriting specific genetic variations or mutations from one's parents. These genetic factors can make it more likely for an individual to develop a certain disease, but it does not guarantee that the person will definitely get the disease. Environmental factors, lifestyle choices, and interactions between genes also play crucial roles in determining if a genetically predisposed person will actually develop the disease. It is essential to understand that having a genetic predisposition only implies a higher risk, not an inevitable outcome.

The cerebellum is a part of the brain that lies behind the brainstem and is involved in the regulation of motor movements, balance, and coordination. It contains two hemispheres and a central portion called the vermis. The cerebellum receives input from sensory systems and other areas of the brain and spinal cord and sends output to motor areas of the brain. Damage to the cerebellum can result in problems with movement, balance, and coordination.

Dopaminergic neurons are a type of specialized brain cells that produce, synthesize, and release the neurotransmitter dopamine. These neurons play crucial roles in various brain functions, including motivation, reward processing, motor control, and cognition. They are primarily located in several regions of the midbrain, such as the substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA).

Dopaminergic neurons have a unique physiology characterized by their ability to generate slow, irregular electrical signals called pacemaker activity. This distinctive firing pattern allows dopamine to be released in a controlled manner, which is essential for proper brain function.

The degeneration and loss of dopaminergic neurons in the SNc are associated with Parkinson's disease, a neurodegenerative disorder characterized by motor impairments such as tremors, rigidity, and bradykinesia (slowness of movement). The reduction in dopamine levels caused by this degeneration leads to an imbalance in the brain's neural circuitry, resulting in the characteristic symptoms of Parkinson's disease.

Photic stimulation is a medical term that refers to the exposure of the eyes to light, specifically repetitive pulses of light, which is used as a method in various research and clinical settings. In neuroscience, it's often used in studies related to vision, circadian rhythms, and brain function.

In a clinical context, photic stimulation is sometimes used in the diagnosis of certain medical conditions such as seizure disorders (like epilepsy). By observing the response of the brain to this light stimulus, doctors can gain valuable insights into the functioning of the brain and the presence of any neurological disorders.

However, it's important to note that photic stimulation should be conducted under the supervision of a trained healthcare professional, as improper use can potentially trigger seizures in individuals who are susceptible to them.

Anticonvulsants are a class of drugs used primarily to treat seizure disorders, also known as epilepsy. These medications work by reducing the abnormal electrical activity in the brain that leads to seizures. In addition to their use in treating epilepsy, anticonvulsants are sometimes also prescribed for other conditions, such as neuropathic pain, bipolar disorder, and migraine headaches.

Anticonvulsants can work in different ways to reduce seizure activity. Some medications, such as phenytoin and carbamazepine, work by blocking sodium channels in the brain, which helps to stabilize nerve cell membranes and prevent excessive electrical activity. Other medications, such as valproic acid and gabapentin, increase the levels of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain, which has a calming effect on nerve cells and helps to reduce seizure activity.

While anticonvulsants are generally effective at reducing seizure frequency and severity, they can also have side effects, such as dizziness, drowsiness, and gastrointestinal symptoms. In some cases, these side effects may be managed by adjusting the dosage or switching to a different medication. It is important for individuals taking anticonvulsants to work closely with their healthcare provider to monitor their response to the medication and make any necessary adjustments.

Trinucleotide Repeat Expansion is a genetic mutation where a sequence of three DNA nucleotides is repeated more frequently than what is typically found in the general population. In this type of mutation, the number of repeats can expand or increase from one generation to the next, leading to an increased risk of developing certain genetic disorders.

These disorders are often neurological and include conditions such as Huntington's disease, myotonic dystrophy, fragile X syndrome, and Friedreich's ataxia. The severity of these diseases can be related to the number of repeats present in the affected gene, with a higher number of repeats leading to more severe symptoms or an earlier age of onset.

It is important to note that not all trinucleotide repeat expansions will result in disease, and some people may carry these mutations without ever developing any symptoms. However, if the number of repeats crosses a certain threshold, it can lead to genetic instability and an increased risk of disease development.

Dopamine agonists are a class of medications that mimic the action of dopamine, a neurotransmitter in the brain that regulates movement, emotion, motivation, and reinforcement of rewarding behaviors. These medications bind to dopamine receptors in the brain and activate them, leading to an increase in dopaminergic activity.

Dopamine agonists are used primarily to treat Parkinson's disease, a neurological disorder characterized by motor symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and postural instability. By increasing dopaminergic activity in the brain, dopamine agonists can help alleviate some of these symptoms.

Examples of dopamine agonists include:

1. Pramipexole (Mirapex)
2. Ropinirole (Requip)
3. Rotigotine (Neupro)
4. Apomorphine (Apokyn)

Dopamine agonists may also be used off-label to treat other conditions, such as restless legs syndrome or certain types of dopamine-responsive dystonia. However, these medications can have significant side effects, including nausea, dizziness, orthostatic hypotension, compulsive behaviors (such as gambling, shopping, or sexual addiction), and hallucinations. Therefore, they should be used with caution and under the close supervision of a healthcare provider.

Dopamine plasma membrane transport proteins, also known as dopamine transporters (DAT), are a type of protein found in the cell membrane that play a crucial role in the regulation of dopamine neurotransmission. They are responsible for the reuptake of dopamine from the synaptic cleft back into the presynaptic neuron, thereby terminating the signal transduction of dopamine and regulating the amount of dopamine available for further release.

Dopamine transporters belong to the family of sodium-dependent neurotransmitter transporters and are encoded by the SLC6A3 gene in humans. Abnormalities in dopamine transporter function have been implicated in several neurological and psychiatric disorders, including Parkinson's disease, attention deficit hyperactivity disorder (ADHD), and substance use disorders.

In summary, dopamine plasma membrane transport proteins are essential for the regulation of dopamine neurotransmission by mediating the reuptake of dopamine from the synaptic cleft back into the presynaptic neuron.

Dementia is a broad term that describes a decline in cognitive functioning, including memory, language, problem-solving, and judgment, severe enough to interfere with daily life. It is not a specific disease but rather a group of symptoms that may be caused by various underlying diseases or conditions. Alzheimer's disease is the most common cause of dementia, accounting for 60-80% of cases. Other causes include vascular dementia, Lewy body dementia, frontotemporal dementia, and Huntington's disease.

The symptoms of dementia can vary widely depending on the cause and the specific areas of the brain that are affected. However, common early signs of dementia may include:

* Memory loss that affects daily life
* Difficulty with familiar tasks
* Problems with language or communication
* Difficulty with visual and spatial abilities
* Misplacing things and unable to retrace steps
* Decreased or poor judgment
* Withdrawal from work or social activities
* Changes in mood or behavior

Dementia is a progressive condition, meaning that symptoms will gradually worsen over time. While there is currently no cure for dementia, early diagnosis and treatment can help slow the progression of the disease and improve quality of life for those affected.

Lymphoproliferative disorders (LPDs) are a group of diseases characterized by the excessive proliferation of lymphoid cells, which are crucial components of the immune system. These disorders can arise from both B-cells and T-cells, leading to various clinical manifestations ranging from benign to malignant conditions.

LPDs can be broadly classified into reactive and neoplastic categories:

1. Reactive Lymphoproliferative Disorders: These are typically triggered by infections, autoimmune diseases, or immunodeficiency states. They involve an exaggerated response of the immune system leading to the excessive proliferation of lymphoid cells. Examples include:
* Infectious mononucleosis (IM) caused by Epstein-Barr virus (EBV)
* Lymph node enlargement due to various infections or autoimmune disorders
* Post-transplant lymphoproliferative disorder (PTLD), which occurs in the context of immunosuppression following organ transplantation
2. Neoplastic Lymphoproliferative Disorders: These are malignant conditions characterized by uncontrolled growth and accumulation of abnormal lymphoid cells, leading to the formation of tumors. They can be further classified into Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Examples include:
* Hodgkin lymphoma (HL): Classical HL and nodular lymphocyte-predominant HL
* Non-Hodgkin lymphoma (NHL): Various subtypes, such as diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Burkitt lymphoma

It is important to note that the distinction between reactive and neoplastic LPDs can sometimes be challenging, requiring careful clinical, histopathological, immunophenotypic, and molecular evaluations. Proper diagnosis and classification of LPDs are crucial for determining appropriate treatment strategies and predicting patient outcomes.

The cerebral cortex is the outermost layer of the brain, characterized by its intricate folded structure and wrinkled appearance. It is a region of great importance as it plays a key role in higher cognitive functions such as perception, consciousness, thought, memory, language, and attention. The cerebral cortex is divided into two hemispheres, each containing four lobes: the frontal, parietal, temporal, and occipital lobes. These areas are responsible for different functions, with some regions specializing in sensory processing while others are involved in motor control or associative functions. The cerebral cortex is composed of gray matter, which contains neuronal cell bodies, and is covered by a layer of white matter that consists mainly of myelinated nerve fibers.

Inclusion bodies are abnormal, intracellular accumulations or aggregations of various misfolded proteins, protein complexes, or other materials within the cells of an organism. They can be found in various tissues and cell types and are often associated with several pathological conditions, including infectious diseases, neurodegenerative disorders, and genetic diseases.

Inclusion bodies can vary in size, shape, and location depending on the specific disease or condition. Some inclusion bodies have a characteristic appearance under the microscope, such as eosinophilic (pink) staining with hematoxylin and eosin (H&E) histological stain, while others may require specialized stains or immunohistochemical techniques to identify the specific misfolded proteins involved.

Examples of diseases associated with inclusion bodies include:

1. Infectious diseases: Some viral infections, such as HIV, hepatitis B and C, and herpes simplex virus, can lead to the formation of inclusion bodies within infected cells.
2. Neurodegenerative disorders: Several neurodegenerative diseases are characterized by the presence of inclusion bodies, including Alzheimer's disease (amyloid-beta plaques and tau tangles), Parkinson's disease (Lewy bodies), Huntington's disease (Huntingtin aggregates), and amyotrophic lateral sclerosis (TDP-43 and SOD1 inclusions).
3. Genetic diseases: Certain genetic disorders, such as Danon disease, neuronal intranuclear inclusion disease, and some lysosomal storage disorders, can also present with inclusion bodies due to the accumulation of abnormal proteins or metabolic products within cells.

The exact role of inclusion bodies in disease pathogenesis remains unclear; however, they are often associated with cellular dysfunction, oxidative stress, and increased inflammation, which can contribute to disease progression and neurodegeneration.

Electric stimulation, also known as electrical nerve stimulation or neuromuscular electrical stimulation, is a therapeutic treatment that uses low-voltage electrical currents to stimulate nerves and muscles. It is often used to help manage pain, promote healing, and improve muscle strength and mobility. The electrical impulses can be delivered through electrodes placed on the skin or directly implanted into the body.

In a medical context, electric stimulation may be used for various purposes such as:

1. Pain management: Electric stimulation can help to block pain signals from reaching the brain and promote the release of endorphins, which are natural painkillers produced by the body.
2. Muscle rehabilitation: Electric stimulation can help to strengthen muscles that have become weak due to injury, illness, or surgery. It can also help to prevent muscle atrophy and improve range of motion.
3. Wound healing: Electric stimulation can promote tissue growth and help to speed up the healing process in wounds, ulcers, and other types of injuries.
4. Urinary incontinence: Electric stimulation can be used to strengthen the muscles that control urination and reduce symptoms of urinary incontinence.
5. Migraine prevention: Electric stimulation can be used as a preventive treatment for migraines by applying electrical impulses to specific nerves in the head and neck.

It is important to note that electric stimulation should only be administered under the guidance of a qualified healthcare professional, as improper use can cause harm or discomfort.

Dihydroxyphenylalanine is not a medical term per se, but it is a chemical compound that is often referred to in the context of biochemistry and neuroscience. It is also known as levodopa or L-DOPA for short.

L-DOPA is a precursor to dopamine, a neurotransmitter that plays a critical role in regulating movement, emotion, and cognition. In the brain, L-DOPA is converted into dopamine through the action of an enzyme called tyrosine hydroxylase.

L-DOPA is used medically to treat Parkinson's disease, a neurological disorder characterized by motor symptoms such as tremors, rigidity, and bradykinesia (slowness of movement). In Parkinson's disease, the dopamine-producing neurons in the brain gradually degenerate, leading to a deficiency of dopamine. By providing L-DOPA as a replacement therapy, doctors can help alleviate some of the symptoms of the disease.

It is important to note that L-DOPA has potential side effects and risks, including nausea, dizziness, and behavioral changes. Long-term use of L-DOPA can also lead to motor complications such as dyskinesias (involuntary movements) and fluctuations in response to the medication. Therefore, it is typically used in combination with other medications and under the close supervision of a healthcare provider.

Biological models, also known as physiological models or organismal models, are simplified representations of biological systems, processes, or mechanisms that are used to understand and explain the underlying principles and relationships. These models can be theoretical (conceptual or mathematical) or physical (such as anatomical models, cell cultures, or animal models). They are widely used in biomedical research to study various phenomena, including disease pathophysiology, drug action, and therapeutic interventions.

Examples of biological models include:

1. Mathematical models: These use mathematical equations and formulas to describe complex biological systems or processes, such as population dynamics, metabolic pathways, or gene regulation networks. They can help predict the behavior of these systems under different conditions and test hypotheses about their underlying mechanisms.
2. Cell cultures: These are collections of cells grown in a controlled environment, typically in a laboratory dish or flask. They can be used to study cellular processes, such as signal transduction, gene expression, or metabolism, and to test the effects of drugs or other treatments on these processes.
3. Animal models: These are living organisms, usually vertebrates like mice, rats, or non-human primates, that are used to study various aspects of human biology and disease. They can provide valuable insights into the pathophysiology of diseases, the mechanisms of drug action, and the safety and efficacy of new therapies.
4. Anatomical models: These are physical representations of biological structures or systems, such as plastic models of organs or tissues, that can be used for educational purposes or to plan surgical procedures. They can also serve as a basis for developing more sophisticated models, such as computer simulations or 3D-printed replicas.

Overall, biological models play a crucial role in advancing our understanding of biology and medicine, helping to identify new targets for therapeutic intervention, develop novel drugs and treatments, and improve human health.

Speech disorders refer to a group of conditions in which a person has difficulty producing or articulating sounds, words, or sentences in a way that is understandable to others. These disorders can be caused by various factors such as developmental delays, neurological conditions, hearing loss, structural abnormalities, or emotional issues.

Speech disorders may include difficulties with:

* Articulation: the ability to produce sounds correctly and clearly.
* Phonology: the sound system of language, including the rules that govern how sounds are combined and used in words.
* Fluency: the smoothness and flow of speech, including issues such as stuttering or cluttering.
* Voice: the quality, pitch, and volume of the spoken voice.
* Resonance: the way sound is produced and carried through the vocal tract, which can affect the clarity and quality of speech.

Speech disorders can impact a person's ability to communicate effectively, leading to difficulties in social situations, academic performance, and even employment opportunities. Speech-language pathologists are trained to evaluate and treat speech disorders using various evidence-based techniques and interventions.

Functional laterality, in a medical context, refers to the preferential use or performance of one side of the body over the other for specific functions. This is often demonstrated in hand dominance, where an individual may be right-handed or left-handed, meaning they primarily use their right or left hand for tasks such as writing, eating, or throwing.

However, functional laterality can also apply to other bodily functions and structures, including the eyes (ocular dominance), ears (auditory dominance), or legs. It's important to note that functional laterality is not a strict binary concept; some individuals may exhibit mixed dominance or no strong preference for one side over the other.

In clinical settings, assessing functional laterality can be useful in diagnosing and treating various neurological conditions, such as stroke or traumatic brain injury, where understanding any resulting lateralized impairments can inform rehabilitation strategies.

Epilepsy is a chronic neurological disorder characterized by recurrent, unprovoked seizures. These seizures are caused by abnormal electrical activity in the brain, which can result in a wide range of symptoms, including convulsions, loss of consciousness, and altered sensations or behaviors. Epilepsy can have many different causes, including genetic factors, brain injury, infection, or stroke. In some cases, the cause may be unknown.

There are many different types of seizures that can occur in people with epilepsy, and the specific type of seizure will depend on the location and extent of the abnormal electrical activity in the brain. Some people may experience only one type of seizure, while others may have several different types. Seizures can vary in frequency, from a few per year to dozens or even hundreds per day.

Epilepsy is typically diagnosed based on the patient's history of recurrent seizures and the results of an electroencephalogram (EEG), which measures the electrical activity in the brain. Imaging tests such as MRI or CT scans may also be used to help identify any structural abnormalities in the brain that may be contributing to the seizures.

While there is no cure for epilepsy, it can often be effectively managed with medication. In some cases, surgery may be recommended to remove the area of the brain responsible for the seizures. With proper treatment and management, many people with epilepsy are able to lead normal, productive lives.

An action potential is a brief electrical signal that travels along the membrane of a nerve cell (neuron) or muscle cell. It is initiated by a rapid, localized change in the permeability of the cell membrane to specific ions, such as sodium and potassium, resulting in a rapid influx of sodium ions and a subsequent efflux of potassium ions. This ion movement causes a brief reversal of the electrical potential across the membrane, which is known as depolarization. The action potential then propagates along the cell membrane as a wave, allowing the electrical signal to be transmitted over long distances within the body. Action potentials play a crucial role in the communication and functioning of the nervous system and muscle tissue.

According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), alcohol-related disorders are a category of mental disorders defined by a problematic pattern of alcohol use that leads to clinically significant impairment or distress. The disorders include:

1. Alcohol Use Disorder (AUD): A chronic relapsing brain disorder characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. AUD can be mild, moderate, or severe, and recovery is possible regardless of severity. The symptoms include problems controlling intake of alcohol, continued use despite problems resulting from drinking, development of a tolerance, drinking that leads to risky situations, or withdrawal symptoms when not drinking.
2. Alcohol Intoxication: A state of acute impairment in mental and motor function caused by the recent consumption of alcohol. The symptoms include slurred speech, unsteady gait, nystagmus, impaired attention or memory, stupor, or coma. In severe cases, it can lead to respiratory depression, hypothermia, or even death.
3. Alcohol Withdrawal: A syndrome that occurs when alcohol use is heavily reduced or stopped after prolonged and heavy use. The symptoms include autonomic hyperactivity, increased hand tremor, insomnia, nausea or vomiting, transient visual, tactile, or auditory hallucinations or illusions, psychomotor agitation, anxiety, and grand mal seizures.
4. Other Alcohol-Induced Disorders: These include alcohol-induced sleep disorder, alcohol-induced sexual dysfunction, and alcohol-induced major neurocognitive disorder.

It is important to note that alcohol use disorders are complex conditions that can be influenced by a variety of factors, including genetics, environment, and personal behavior. If you or someone you know is struggling with alcohol use, it is recommended to seek professional help.

Physical therapy modalities refer to the various forms of treatment that physical therapists use to help reduce pain, promote healing, and restore function to the body. These modalities can include:

1. Heat therapy: This includes the use of hot packs, paraffin baths, and infrared heat to increase blood flow, relax muscles, and relieve pain.
2. Cold therapy: Also known as cryotherapy, this involves the use of ice packs, cold compresses, or cooling gels to reduce inflammation, numb the area, and relieve pain.
3. Electrical stimulation: This uses electrical currents to stimulate nerves and muscles, which can help to reduce pain, promote healing, and improve muscle strength and function.
4. Ultrasound: This uses high-frequency sound waves to penetrate deep into tissues, increasing blood flow, reducing inflammation, and promoting healing.
5. Manual therapy: This includes techniques such as massage, joint mobilization, and stretching, which are used to improve range of motion, reduce pain, and promote relaxation.
6. Traction: This is a technique that uses gentle pulling on the spine or other joints to help relieve pressure and improve alignment.
7. Light therapy: Also known as phototherapy, this involves the use of low-level lasers or light-emitting diodes (LEDs) to promote healing and reduce pain and inflammation.
8. Therapeutic exercise: This includes a range of exercises that are designed to improve strength, flexibility, balance, and coordination, and help patients recover from injury or illness.

Physical therapy modalities are often used in combination with other treatments, such as manual therapy and therapeutic exercise, to provide a comprehensive approach to rehabilitation and pain management.

Brain diseases, also known as neurological disorders, refer to a wide range of conditions that affect the brain and nervous system. These diseases can be caused by various factors such as genetics, infections, injuries, degeneration, or structural abnormalities. They can affect different parts of the brain, leading to a variety of symptoms and complications.

Some examples of brain diseases include:

1. Alzheimer's disease - a progressive degenerative disorder that affects memory and cognitive function.
2. Parkinson's disease - a movement disorder characterized by tremors, stiffness, and difficulty with coordination and balance.
3. Multiple sclerosis - a chronic autoimmune disease that affects the nervous system and can cause a range of symptoms such as vision loss, muscle weakness, and cognitive impairment.
4. Epilepsy - a neurological disorder characterized by recurrent seizures.
5. Brain tumors - abnormal growths in the brain that can be benign or malignant.
6. Stroke - a sudden interruption of blood flow to the brain, which can cause paralysis, speech difficulties, and other neurological symptoms.
7. Meningitis - an infection of the membranes surrounding the brain and spinal cord.
8. Encephalitis - an inflammation of the brain that can be caused by viruses, bacteria, or autoimmune disorders.
9. Huntington's disease - a genetic disorder that affects muscle coordination, cognitive function, and mental health.
10. Migraine - a neurological condition characterized by severe headaches, often accompanied by nausea, vomiting, and sensitivity to light and sound.

Brain diseases can range from mild to severe and may be treatable or incurable. They can affect people of all ages and backgrounds, and early diagnosis and treatment are essential for improving outcomes and quality of life.

Posture is the position or alignment of body parts supported by the muscles, especially the spine and head in relation to the vertebral column. It can be described as static (related to a stationary position) or dynamic (related to movement). Good posture involves training your body to stand, walk, sit, and lie in positions where the least strain is placed on supporting muscles and ligaments during movement or weight-bearing activities. Poor posture can lead to various health issues such as back pain, neck pain, headaches, and respiratory problems.

A cross-sectional study is a type of observational research design that examines the relationship between variables at one point in time. It provides a snapshot or a "cross-section" of the population at a particular moment, allowing researchers to estimate the prevalence of a disease or condition and identify potential risk factors or associations.

In a cross-sectional study, data is collected from a sample of participants at a single time point, and the variables of interest are measured simultaneously. This design can be used to investigate the association between exposure and outcome, but it cannot establish causality because it does not follow changes over time.

Cross-sectional studies can be conducted using various data collection methods, such as surveys, interviews, or medical examinations. They are often used in epidemiology to estimate the prevalence of a disease or condition in a population and to identify potential risk factors that may contribute to its development. However, because cross-sectional studies only provide a snapshot of the population at one point in time, they cannot account for changes over time or determine whether exposure preceded the outcome.

Therefore, while cross-sectional studies can be useful for generating hypotheses and identifying potential associations between variables, further research using other study designs, such as cohort or case-control studies, is necessary to establish causality and confirm any findings.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Genetic testing is a type of medical test that identifies changes in chromosomes, genes, or proteins. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder. Genetic tests are performed on a sample of blood, hair, skin, amniotic fluid (the fluid that surrounds a fetus during pregnancy), or other tissue. For example, a physician may recommend genetic testing to help diagnose a genetic condition, confirm the presence of a gene mutation known to increase the risk of developing certain cancers, or determine the chance for a couple to have a child with a genetic disorder.

There are several types of genetic tests, including:

* Diagnostic testing: This type of test is used to identify or confirm a suspected genetic condition in an individual. It may be performed before birth (prenatal testing) or at any time during a person's life.
* Predictive testing: This type of test is used to determine the likelihood that a person will develop a genetic disorder. It is typically offered to individuals who have a family history of a genetic condition but do not show any symptoms themselves.
* Carrier testing: This type of test is used to determine whether a person carries a gene mutation for a genetic disorder. It is often offered to couples who are planning to have children and have a family history of a genetic condition or belong to a population that has an increased risk of certain genetic disorders.
* Preimplantation genetic testing: This type of test is used in conjunction with in vitro fertilization (IVF) to identify genetic changes in embryos before they are implanted in the uterus. It can help couples who have a family history of a genetic disorder or who are at risk of having a child with a genetic condition to conceive a child who is free of the genetic change in question.
* Pharmacogenetic testing: This type of test is used to determine how an individual's genes may affect their response to certain medications. It can help healthcare providers choose the most effective medication and dosage for a patient, reducing the risk of adverse drug reactions.

It is important to note that genetic testing should be performed under the guidance of a qualified healthcare professional who can interpret the results and provide appropriate counseling and support.

Combat disorders are a category of mental health conditions that can occur in military personnel as a result of their experiences during combat. These disorders can include post-traumatic stress disorder (PTSD), acute stress disorder, and adjustment disorders, among others. Combat disorders may be caused by exposure to traumatic events, such as experiencing or witnessing combat, the threat of death or serious injury, or the loss of fellow soldiers. Symptoms can include flashbacks, nightmares, avoidance of reminders of the trauma, difficulty sleeping, irritability, and feelings of detachment or numbness. Treatment for combat disorders typically involves a combination of medication and therapy.

Attention Deficit and Disruptive Behavior Disorders (ADDBDs) are a group of childhood-onset disorders characterized by persistent patterns of behavior that are difficult for the individual to control. These disorders include Attention Deficit Hyperactivity Disorder (ADHD), Oppositional Defiant Disorder (ODD), and Conduct Disorder (CD).

Attention Deficit Hyperactivity Disorder (ADHD) is characterized by symptoms of inattention, hyperactivity, and impulsivity that interfere with daily functioning. These symptoms must be present for at least six months and occur in multiple settings, such as school, home, and social situations.

Oppositional Defiant Disorder (ODD) is characterized by a pattern of negative, hostile, and defiant behavior towards authority figures, which includes arguing with adults, losing temper, actively defying rules, and deliberately annoying others. These symptoms must be present for at least six months and occur more frequently than in other children of the same age and developmental level.

Conduct Disorder (CD) is characterized by a repetitive and persistent pattern of behavior that violates the rights of others or major age-appropriate societal norms and rules. These behaviors include aggression towards people and animals, destruction of property, deceitfulness or theft, and serious violation of rules.

It's important to note that these disorders can co-occur with other mental health conditions, such as mood disorders, anxiety disorders, and learning disabilities. Proper diagnosis and treatment are essential for managing the symptoms and improving the individual's quality of life.

In the context of medicine, particularly in anatomy and physiology, "rotation" refers to the movement of a body part around its own axis or the long axis of another structure. This type of motion is three-dimensional and can occur in various planes. A common example of rotation is the movement of the forearm bones (radius and ulna) around each other during pronation and supination, which allows the hand to be turned palm up or down. Another example is the rotation of the head during mastication (chewing), where the mandible moves in a circular motion around the temporomandibular joint.

Impulse Control Disorders (ICDs) are a group of psychiatric conditions characterized by the failure to resist an impulse, drive, or temptation to perform an act that is harmful to oneself or others. This leads to negative consequences such as distress, anxiety, or disruption in social, occupational, or other important areas of functioning.

The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) recognizes several specific ICDs, including:

1. Kleptomania - the recurrent failure to resist impulses to steal items, even though they are not needed for personal use or financial gain.
2. Pyromania - the deliberate and purposeful fire-setting on more than one occasion.
3. Intermittent Explosive Disorder - recurrent behavioral outbursts representing a failure to control aggressive impulses, resulting in serious assaultive acts or destruction of property.
4. Pathological Gambling - persistent and recurrent maladaptive gambling behavior that disrupts personal, family, or vocational pursuits.
5. Internet Gaming Disorder - the excessive and prolonged use of the internet for gaming, which leads to clinically significant impairment or distress.

These disorders are typically associated with a range of emotional, cognitive, and behavioral symptoms that can vary depending on the specific disorder and individual presentation. Treatment often involves a combination of psychotherapy, medication, and self-help strategies to manage symptoms and improve overall functioning.

Disability Evaluation is the process of determining the nature and extent of a person's functional limitations or impairments, and assessing their ability to perform various tasks and activities in order to determine eligibility for disability benefits or accommodations. This process typically involves a medical examination and assessment by a licensed healthcare professional, such as a physician or psychologist, who evaluates the individual's symptoms, medical history, laboratory test results, and functional abilities. The evaluation may also involve input from other professionals, such as vocational experts, occupational therapists, or speech-language pathologists, who can provide additional information about the person's ability to perform specific tasks and activities in a work or daily living context. Based on this information, a determination is made about whether the individual meets the criteria for disability as defined by the relevant governing authority, such as the Social Security Administration or the Americans with Disabilities Act.

Encephalitis is defined as inflammation of the brain parenchyma, which is often caused by viral infections but can also be due to bacterial, fungal, or parasitic infections, autoimmune disorders, or exposure to toxins. The infection or inflammation can cause various symptoms such as headache, fever, confusion, seizures, and altered consciousness, ranging from mild symptoms to severe cases that can lead to brain damage, long-term disabilities, or even death.

The diagnosis of encephalitis typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT scans), and laboratory tests (such as cerebrospinal fluid analysis). Treatment may include antiviral medications, corticosteroids, immunoglobulins, and supportive care to manage symptoms and prevent complications.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

REM sleep, or Rapid Eye Movement sleep, is a stage of sleep characterized by rapid eye movements, low muscle tone, and active brain activity. It is one of the two main types of sleep along with non-REM sleep and is marked by vivid dreaming, increased brain metabolism, and altered brain wave patterns. REM sleep is often referred to as "paradoxical sleep" because of the seemingly contradictory nature of its characteristics - an active brain in a state of relaxation. It is thought to play a role in memory consolidation, learning, and mood regulation. A typical night's sleep cycle includes several episodes of REM sleep, with each episode becoming longer as the night progresses.

The mesencephalon, also known as the midbrain, is the middle portion of the brainstem that connects the hindbrain (rhombencephalon) and the forebrain (prosencephalon). It plays a crucial role in several important functions including motor control, vision, hearing, and the regulation of consciousness and sleep-wake cycles. The mesencephalon contains several important structures such as the cerebral aqueduct, tectum, tegmentum, cerebral peduncles, and several cranial nerve nuclei (III and IV).

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

Oxidopamine is not a recognized medical term or a medication commonly used in clinical practice. However, it is a chemical compound that is often used in scientific research, particularly in the field of neuroscience.

Oxidopamine is a synthetic catecholamine that can be selectively taken up by dopaminergic neurons and subsequently undergo oxidation, leading to the production of reactive oxygen species. This property makes it a useful tool for studying the effects of oxidative stress on dopaminergic neurons in models of Parkinson's disease and other neurological disorders.

In summary, while not a medical definition per se, oxidopamine is a chemical compound used in research to study the effects of oxidative stress on dopaminergic neurons.

Transgenic mice are genetically modified rodents that have incorporated foreign DNA (exogenous DNA) into their own genome. This is typically done through the use of recombinant DNA technology, where a specific gene or genetic sequence of interest is isolated and then introduced into the mouse embryo. The resulting transgenic mice can then express the protein encoded by the foreign gene, allowing researchers to study its function in a living organism.

The process of creating transgenic mice usually involves microinjecting the exogenous DNA into the pronucleus of a fertilized egg, which is then implanted into a surrogate mother. The offspring that result from this procedure are screened for the presence of the foreign DNA, and those that carry the desired genetic modification are used to establish a transgenic mouse line.

Transgenic mice have been widely used in biomedical research to model human diseases, study gene function, and test new therapies. They provide a valuable tool for understanding complex biological processes and developing new treatments for a variety of medical conditions.

Temporomandibular Joint Disorders (TMD) refer to a group of conditions that cause pain and dysfunction in the temporomandibular joint (TMJ) and the muscles that control jaw movement. The TMJ is the hinge joint that connects the lower jaw (mandible) to the skull (temporal bone) in front of the ear. It allows for movements required for activities such as eating, speaking, and yawning.

TMD can result from various causes, including:

1. Muscle tension or spasm due to clenching or grinding teeth (bruxism), stress, or jaw misalignment
2. Dislocation or injury of the TMJ disc, which is a small piece of cartilage that acts as a cushion between the bones in the joint
3. Arthritis or other degenerative conditions affecting the TMJ
4. Bite problems (malocclusion) leading to abnormal stress on the TMJ and its surrounding muscles
5. Stress, which can exacerbate existing TMD symptoms by causing muscle tension

Symptoms of Temporomandibular Joint Disorders may include:
- Pain or tenderness in the jaw, face, neck, or shoulders
- Limited jaw movement or locking of the jaw
- Clicking, popping, or grating sounds when moving the jaw
- Headaches, earaches, or dizziness
- Difficulty chewing or biting
- Swelling on the side of the face

Treatment for TMD varies depending on the severity and cause of the condition. It may include self-care measures (like eating soft foods, avoiding extreme jaw movements, and applying heat or cold packs), physical therapy, medications (such as muscle relaxants, pain relievers, or anti-inflammatory drugs), dental work (including bite adjustments or orthodontic treatment), or even surgery in severe cases.

Proprioception is the unconscious perception of movement and spatial orientation arising from stimuli within the body itself. It is sometimes described as the "sixth sense" and it's all about knowing where your body parts are, how they are moving, and the effort being used to move them. This information is crucial for motor control, balance, and coordination.

The proprioceptive system includes sensory receptors called proprioreceptors located in muscles, tendons, and joints that send messages to the brain through nerves regarding body position and movement. These messages are then integrated with information from other senses, such as vision and vestibular sense (related to balance), to create a complete understanding of the body's position and motion in space.

Deficits in proprioception can lead to problems with coordination, balance, and fine motor skills.

"Macaca mulatta" is the scientific name for the Rhesus macaque, a species of monkey that is native to South, Central, and Southeast Asia. They are often used in biomedical research due to their genetic similarity to humans.

Chromosome mapping, also known as physical mapping, is the process of determining the location and order of specific genes or genetic markers on a chromosome. This is typically done by using various laboratory techniques to identify landmarks along the chromosome, such as restriction enzyme cutting sites or patterns of DNA sequence repeats. The resulting map provides important information about the organization and structure of the genome, and can be used for a variety of purposes, including identifying the location of genes associated with genetic diseases, studying evolutionary relationships between organisms, and developing genetic markers for use in breeding or forensic applications.

Antisocial Personality Disorder (ASPD) is a mental health condition characterized by a pervasive pattern of disregard for the rights of others, lack of empathy, and manipulative behaviors. It is defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), as follows:

A. A consistent pattern of behavior that violates the basic rights of others and major age-appropriate societal norms and rules, as indicated by the presence of at least three of the following:

1. Failure to conform to social norms and laws, indicated by repeatedly performing acts that are grounds for arrest.
2. Deceitfulness, as indicated by repeated lying, use of aliases, or conning others for personal profit or pleasure.
3. Impulsivity or failure to plan ahead; indication of this symptom may include promiscuity.
4. Irritability and aggressiveness, as indicated by repeated physical fights or assaults.
5. Reckless disregard for safety of self or others.
6. Consistent irresponsibility, as indicated by repeated failure to sustain consistent work behavior or honor financial obligations.
7. Lack of remorse, as indicated by being indifferent to or rationalizing having hurt, mistreated, or stolen from another.

B. The individual is at least 18 years of age.

C. There is evidence of conduct disorder with onset before the age of 15 years.

D. The occurrence of antisocial behavior is not exclusively during the course of schizophrenia or bipolar disorder.

E. The individual's criminal behavior has not been better explained by a conduct disorder diagnosis or antisocial behavior that began before the age of 15 years.

It's important to note that ASPD can be challenging to diagnose, and it often requires a comprehensive evaluation from a mental health professional with experience in personality disorders.

Atrophy is a medical term that refers to the decrease in size and wasting of an organ or tissue due to the disappearance of cells, shrinkage of cells, or decreased number of cells. This process can be caused by various factors such as disuse, aging, degeneration, injury, or disease.

For example, if a muscle is immobilized for an extended period, it may undergo atrophy due to lack of use. Similarly, certain medical conditions like diabetes, cancer, and heart failure can lead to the wasting away of various tissues and organs in the body.

Atrophy can also occur as a result of natural aging processes, leading to decreased muscle mass and strength in older adults. In general, atrophy is characterized by a decrease in the volume or weight of an organ or tissue, which can have significant impacts on its function and overall health.

Astrocytoma is a type of brain tumor that arises from astrocytes, which are star-shaped glial cells in the brain. These tumors can occur in various parts of the brain and can have different grades of malignancy, ranging from low-grade (I or II) to high-grade (III or IV). Low-grade astrocytomas tend to grow slowly and may not cause any symptoms for a long time, while high-grade astrocytomas are more aggressive and can grow quickly, causing neurological problems.

Symptoms of astrocytoma depend on the location and size of the tumor but may include headaches, seizures, weakness or numbness in the limbs, difficulty speaking or swallowing, changes in vision or behavior, and memory loss. Treatment options for astrocytomas include surgery, radiation therapy, chemotherapy, or a combination of these approaches. The prognosis for astrocytoma varies widely depending on the grade and location of the tumor, as well as the age and overall health of the patient.

Emission-Computed Tomography, Single-Photon (SPECT) is a type of nuclear medicine imaging procedure that generates detailed, three-dimensional images of the distribution of radioactive pharmaceuticals within the body. It uses gamma rays emitted by a radiopharmaceutical that is introduced into the patient's body, and a specialized gamma camera to detect these gamma rays and create tomographic images. The data obtained from the SPECT imaging can be used to diagnose various medical conditions, evaluate organ function, and guide treatment decisions. It is commonly used to image the heart, brain, and bones, among other organs and systems.

Motion perception is the ability to interpret and understand the movement of objects in our environment. It is a complex process that involves multiple areas of the brain and the visual system. In medical terms, motion perception refers to the specific function of the visual system to detect and analyze the movement of visual stimuli. This allows us to perceive and respond to moving objects in our environment, which is crucial for activities such as driving, sports, and even maintaining balance. Disorders in motion perception can lead to conditions like motion sickness or difficulty with depth perception.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Binge-Eating Disorder (BED) is a type of eating disorder characterized by recurrent episodes of consuming large amounts of food in a short period of time, often to the point of discomfort or pain. These episodes are accompanied by a loss of control over eating and are not followed by compensatory behaviors such as purging or excessive exercise.

To be diagnosed with BED, an individual must experience these binge-eating episodes at least once a week for three months or more, along with feelings of distress, shame, or guilt about their eating habits. Additionally, the binge eating must occur on average at least once a week for three months.

BED is different from overeating and can cause significant emotional and physical problems, including depression, anxiety, obesity, and other health issues related to weight gain. It is important to seek professional help if you suspect that you or someone you know may have BED.

X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.

The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.

CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.

In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.

CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.

In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.

Dysthymic disorder, also known as persistent depressive disorder, is a chronic type of depression where a person's moods are regularly low. It is characterized by depressed mood that occurs for most of the day, for at least two years, and is accompanied by at least two other symptoms such as appetite or sleep changes, low energy, low self-esteem, difficulty making decisions, or feelings of hopelessness.

To meet the diagnostic criteria, the symptoms cannot be explained by substance abuse or a medical condition, and they must cause significant distress or impairment in social, occupational, or other important areas of functioning. Dysthymic disorder typically has a chronic course, but it may respond to treatment, including psychotherapy and medication.

Conversion disorder is a mental health condition that is characterized by the presence of neurological symptoms, such as blindness, paralysis, or difficulty swallowing, that cannot be explained by a medical condition. These symptoms are thought to be caused by psychological factors, such as stress or trauma, and may be a way for the individual to express emotional distress or avoid certain situations.

The symptoms of conversion disorder are typically dramatic and can interfere significantly with a person's daily life. They may include:

* Loss of or alteration in physical senses (such as blindness, deafness, or loss of touch)
* Weakness or paralysis in a part or all of the body
* Difficulty swallowing or speaking
* Seizures or convulsions
* Inability to move certain parts of the body
* Tremors or shaking
* Loss of consciousness

It is important to note that conversion disorder is not a fake or intentional condition. Rather, it is a genuine medical condition that requires treatment. Treatment typically involves addressing any underlying psychological issues and helping the individual develop more effective ways of coping with stress and emotional distress.

Myeloproliferative disorders (MPDs) are a group of rare, chronic blood cancers that originate from the abnormal proliferation or growth of one or more types of blood-forming cells in the bone marrow. These disorders result in an overproduction of mature but dysfunctional blood cells, which can lead to serious complications such as blood clots, bleeding, and organ damage.

There are several subtypes of MPDs, including:

1. Chronic Myeloid Leukemia (CML): A disorder characterized by the overproduction of mature granulocytes (a type of white blood cell) in the bone marrow, leading to an increased number of these cells in the blood. CML is caused by a genetic mutation that results in the formation of the BCR-ABL fusion protein, which drives uncontrolled cell growth and division.
2. Polycythemia Vera (PV): A disorder characterized by the overproduction of all three types of blood cells - red blood cells, white blood cells, and platelets - in the bone marrow. This can lead to an increased risk of blood clots, bleeding, and enlargement of the spleen.
3. Essential Thrombocythemia (ET): A disorder characterized by the overproduction of platelets in the bone marrow, leading to an increased risk of blood clots and bleeding.
4. Primary Myelofibrosis (PMF): A disorder characterized by the replacement of normal bone marrow tissue with scar tissue, leading to impaired blood cell production and anemia, enlargement of the spleen, and increased risk of infections and bleeding.
5. Chronic Neutrophilic Leukemia (CNL): A rare disorder characterized by the overproduction of neutrophils (a type of white blood cell) in the bone marrow, leading to an increased number of these cells in the blood. CNL can lead to an increased risk of infections and organ damage.

MPDs are typically treated with a combination of therapies, including chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation. The choice of treatment depends on several factors, including the subtype of MPD, the patient's age and overall health, and the presence of any comorbidities.

Neuroprotective agents are substances that protect neurons or nerve cells from damage, degeneration, or death caused by various factors such as trauma, inflammation, oxidative stress, or excitotoxicity. These agents work through different mechanisms, including reducing the production of free radicals, inhibiting the release of glutamate (a neurotransmitter that can cause cell damage in high concentrations), promoting the growth and survival of neurons, and preventing apoptosis (programmed cell death). Neuroprotective agents have been studied for their potential to treat various neurological disorders, including stroke, traumatic brain injury, Parkinson's disease, Alzheimer's disease, and multiple sclerosis. However, more research is needed to fully understand their mechanisms of action and to develop effective therapies.

Ubiquitin-protein ligases, also known as E3 ubiquitin ligases, are a group of enzymes that play a crucial role in the ubiquitination process. Ubiquitination is a post-translational modification where ubiquitin molecules are attached to specific target proteins, marking them for degradation by the proteasome or for other regulatory functions.

Ubiquitin-protein ligases catalyze the final step in this process by binding to both the ubiquitin protein and the target protein, facilitating the transfer of ubiquitin from an E2 ubiquitin-conjugating enzyme to the target protein. There are several different types of ubiquitin-protein ligases, each with their own specificity for particular target proteins and regulatory functions.

Ubiquitin-protein ligases have been implicated in various cellular processes such as protein degradation, DNA repair, signal transduction, and regulation of the cell cycle. Dysregulation of ubiquitination has been associated with several diseases, including cancer, neurodegenerative disorders, and inflammatory responses. Therefore, understanding the function and regulation of ubiquitin-protein ligases is an important area of research in biology and medicine.

A psychological interview is a clinical assessment tool used by mental health professionals to gather information about a person's cognitive, emotional, and behavioral status. It is a structured or unstructured conversation between the clinician and the client aimed at understanding the client's symptoms, concerns, personal history, current life situation, and any other relevant factors that contribute to their psychological state.

The interview may cover various topics such as the individual's mental health history, family background, social relationships, education, occupation, coping mechanisms, and substance use. The clinician will also assess the person's cognitive abilities, emotional expression, thought processes, and behavior during the interview to help form a diagnosis or treatment plan.

The psychological interview is an essential component of a comprehensive mental health evaluation, as it provides valuable insights into the individual's subjective experiences and helps establish a therapeutic relationship between the clinician and the client. It can be conducted in various settings, including hospitals, clinics, private practices, or community centers.

Positron-Emission Tomography (PET) is a type of nuclear medicine imaging that uses small amounts of radioactive material, called a radiotracer, to produce detailed, three-dimensional images. This technique measures metabolic activity within the body, such as sugar metabolism, to help distinguish between healthy and diseased tissue, identify cancerous cells, or examine the function of organs.

During a PET scan, the patient is injected with a radiotracer, typically a sugar-based compound labeled with a positron-emitting radioisotope, such as fluorine-18 (^18^F). The radiotracer accumulates in cells that are metabolically active, like cancer cells. As the radiotracer decays, it emits positrons, which then collide with electrons in nearby tissue, producing gamma rays. A special camera, called a PET scanner, detects these gamma rays and uses this information to create detailed images of the body's internal structures and processes.

PET is often used in conjunction with computed tomography (CT) or magnetic resonance imaging (MRI) to provide both functional and anatomical information, allowing for more accurate diagnosis and treatment planning. Common applications include detecting cancer recurrence, staging and monitoring cancer, evaluating heart function, and assessing brain function in conditions like dementia and epilepsy.

Dissociative disorders are a group of mental health conditions characterized by disruptions or dysfunctions in memory, consciousness, identity, or perception. These disturbances can be sudden or ongoing and can interfere significantly with a person's ability to function in daily life. The main types of dissociative disorders include:

1. Dissociative Amnesia: This disorder is characterized by an inability to recall important personal information, usually due to trauma or stress.
2. Dissociative Identity Disorder (formerly known as Multiple Personality Disorder): In this disorder, a person exhibits two or more distinct identities or personalities that recurrently take control of their behavior.
3. Depersonalization/Derealization Disorder: This disorder involves persistent or recurring feelings of detachment from one's self (depersonalization) or the environment (derealization).
4. Other Specified Dissociative Disorder and Unspecified Dissociative Disorder: These categories are used for disorders that do not meet the criteria for any of the specific dissociative disorders but still cause significant distress or impairment.

Dissociative disorders often develop as a way to cope with trauma, stress, or other overwhelming life experiences. Treatment typically involves psychotherapy, including cognitive-behavioral therapy (CBT) and dialectical behavior therapy (DBT), as well as medication for co-occurring conditions such as anxiety or depression.

Gamma-Aminobutyric Acid (GABA) is a major inhibitory neurotransmitter in the mammalian central nervous system. It plays a crucial role in regulating neuronal excitability and preventing excessive neuronal firing, which helps to maintain neural homeostasis and reduce the risk of seizures. GABA functions by binding to specific receptors (GABA-A, GABA-B, and GABA-C) on the postsynaptic membrane, leading to hyperpolarization of the neuronal membrane and reduced neurotransmitter release from presynaptic terminals.

In addition to its role in the central nervous system, GABA has also been identified as a neurotransmitter in the peripheral nervous system, where it is involved in regulating various physiological processes such as muscle relaxation, hormone secretion, and immune function.

GABA can be synthesized in neurons from glutamate, an excitatory neurotransmitter, through the action of the enzyme glutamic acid decarboxylase (GAD). Once synthesized, GABA is stored in synaptic vesicles and released into the synapse upon neuronal activation. After release, GABA can be taken up by surrounding glial cells or degraded by the enzyme GABA transaminase (GABA-T) into succinic semialdehyde, which is further metabolized to form succinate and enter the Krebs cycle for energy production.

Dysregulation of GABAergic neurotransmission has been implicated in various neurological and psychiatric disorders, including epilepsy, anxiety, depression, and sleep disturbances. Therefore, modulating GABAergic signaling through pharmacological interventions or other therapeutic approaches may offer potential benefits for the treatment of these conditions.

Sensory feedback refers to the information that our senses (such as sight, sound, touch, taste, and smell) provide to our nervous system about our body's interaction with its environment. This information is used by our brain and muscles to make adjustments in movement, posture, and other functions to maintain balance, coordination, and stability.

For example, when we walk, our sensory receptors in the skin, muscles, and joints provide feedback to our brain about the position and movement of our limbs. This information is used to adjust our muscle contractions and make small corrections in our gait to maintain balance and avoid falling. Similarly, when we touch a hot object, sensory receptors in our skin send signals to our brain that activate the withdrawal reflex, causing us to quickly pull away our hand.

In summary, sensory feedback is an essential component of our nervous system's ability to monitor and control our body's movements and responses to the environment.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

In medical terms, "volition" refers to the conscious and deliberate process of making decisions and initiating actions based on personal choice. It is the ability to choose or decide on a course of action and then carry it out willfully. Volition involves the integration of cognitive, emotional, and motor functions to achieve a specific goal-oriented behavior.

Volitional processes are often impaired in certain neurological and psychiatric conditions, such as dementia, Parkinson's disease, schizophrenia, and depression, among others. Assessing volition is important for evaluating an individual's capacity to make informed decisions and take responsibility for their actions.

A learning disorder is a neurodevelopmental disorder that affects an individual's ability to acquire, process, and use information in one or more academic areas despite normal intelligence and adequate instruction. It can manifest as difficulties with reading (dyslexia), writing (dysgraphia), mathematics (dyscalculia), or other academic skills. Learning disorders are not the result of low intelligence, lack of motivation, or environmental factors alone, but rather reflect a significant discrepancy between an individual's cognitive abilities and their academic achievement. They can significantly impact a person's ability to perform in school, at work, and in daily life, making it important to diagnose and manage these disorders effectively.

Kinesthesia, also known as proprioception, refers to the perception or awareness of the position and movement of the body parts in space. It is a type of sensory information that comes from receptors located in muscles, tendons, ligaments, and joints, which detect changes in tension, length, and pressure of these tissues during movement. This information is then sent to the brain, where it is integrated with visual and vestibular (inner ear) inputs to create a sense of body position and movement.

Kinesthesia allows us to perform complex movements and maintain balance without having to consciously think about each movement. It helps us to coordinate our movements, adjust our posture, and navigate through our environment with ease. Deficits in kinesthetic perception can lead to difficulties with motor coordination, balance, and mobility.

A "knockout" mouse is a genetically engineered mouse in which one or more genes have been deleted or "knocked out" using molecular biology techniques. This allows researchers to study the function of specific genes and their role in various biological processes, as well as potential associations with human diseases. The mice are generated by introducing targeted DNA modifications into embryonic stem cells, which are then used to create a live animal. Knockout mice have been widely used in biomedical research to investigate gene function, disease mechanisms, and potential therapeutic targets.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Visual perception refers to the ability to interpret and organize information that comes from our eyes to recognize and understand what we are seeing. It involves several cognitive processes such as pattern recognition, size estimation, movement detection, and depth perception. Visual perception allows us to identify objects, navigate through space, and interact with our environment. Deficits in visual perception can lead to learning difficulties and disabilities.

Schizotypal Personality Disorder is defined by the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-5) as a pervasive pattern of social and interpersonal deficits marked by acute discomfort with, and reduced capacity for, close relationships, as well as by cognitive or perceptual distortions and eccentricities of behavior. The disorder is often characterized by individuals having difficulty with expressing emotions and relating to others. They may also experience unusual perceptions, such as hearing voices or seeing things that aren't there, but these are not as severe as in Schizophrenia. It is important to note that this disorder can cause significant distress and impairment in social, occupational, and other areas of functioning.

Movement Disorders is a peer-reviewed medical journal, first published in 1986. The journal focuses on original research ... Official website The International Parkinson and Movement Disorder Society v t e (Articles with short description, Short ... "Movement Disorders". National Library of Medicine Catalog. Retrieved 2010-01-25. "Editorial Board". Wiley Online Library. Wiley ... relating to neurological movement disorders. The editor-in-chief is A. Jon Stoessl (University of British Columbia). The ...
... is marked by a practice that addresses the needs particular to people living with movement ... brain-health-article/why-yoga-can-be-helpful-to-those-living-with-parkinson-rsquo-s-disorder/526058 Movement Disorders Society ... Yoga for movement disorders includes focused breathing, flow of poses, and meditative practice of yoga, specifically designed ... Anxiety, a common symptom of a number of movement disorders, can heighten from the physical challenges of trying to move into a ...
In primary movement disorders, the abnormal movement is the primary manifestation of the disorder. In secondary movement ... Movement Disorders". Baizabal-Carvallo, JF; Jankovic J. (2012-07-18). "Movement disorders in autoimmune diseases". Movement ... Movement disorders are clinical syndromes with either an excess of movement or a paucity of voluntary and involuntary movements ... Movement disorders are synonymous with basal ganglia or extrapyramidal diseases. Movement disorders are conventionally divided ...
"Rhythmic movement disorder (head banging) in an adult during rapid eye movement sleep". Movement Disorders. 21 (6): 866-879. ... Rhythmic movement disorder (RMD) is a neurological disorder characterized by repetitive movements of large muscle groups ... Diagnosis of rhythmic movement disorder is done on an exclusionary basis in which other closely related movement disorders are ... "Rhythmic movements in idiopathic REM sleep behavior disorder". Movement Disorders. 22 (12): 1797-1800. doi:10.1002/mds.21622. ...
Children with stereotypic movement disorder do not always report being bothered by the movements as a child with tics might. ... Stereotypic movement disorder (SMD) is a motor disorder with onset in childhood involving restrictive and/or repetitive, ... The cause of stereotypic movement disorder is unknown. Stereotyped movements are common in infants and young children; if the ... Stereotypic movement disorder is classified in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders ...
... (CMM disorder) is a rare genetic neurological disorder which is characterized by mirrored ... "Congenital mirror movement disorder , Genetic and Rare Diseases Information Center (GARD) - an NCATS Program". rarediseases. ... "congenital mirror movement disorder". Genetics Home Reference. Retrieved 2017-12-06. Méneret, Aurélie; Trouillard, Oriane; ... It is important not to confuse congenital mirror movement disorders, a rare genetically based neurologic disease, with acquired ...
... (PLMD) is a sleep disorder where the patient moves limbs involuntarily and periodically during ... Periodic limb movement disorder is characterized by recurrent episodes of frequent limb movements while sleeping. It mostly ... each movement must happen within a 4 to 90 second interval from the previous movement. The periodic limb movement index (PLMI ... ICSD-3 is divided in 7 sections and PLMD is classified in the Sleep-Related Movement Disorders' section. There are some updates ...
... or REM behavior disorder (RBD) is a sleep disorder in which people act out their ... Such disorders include non-REM parasomnias (sleepwalking, sleep terrors), periodic limb movement disorder, severe obstructive ... "Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder". Mov. Disord. (review ... Rapid eye movement behavior disorder occurs when there is a loss of normal voluntary muscle atonia during REM sleep resulting ...
... is rapid eye movement sleep behavior disorder (RBD) that is ... Rapid eye movement sleep behavior disorder (RBD) is a sleep disorder characterized by the loss of normal skeletal muscle atonia ... Oslon E (2000). "Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases". Brain ... "Abnormal Gray Matter Volume and Functional Connectivity in Parkinson's Disease with Rapid Eye Movement Sleep Behavior Disorder ...
"The REM Sleep Behavior Disorder Screening Questionnaire-A New Diagnostic Instrument". Movement Disorders. 22 (16): 2386-2393. ... Ahmed, Syed M S. "REM Sleep Behavior Disorder". Retrieved 23 April 2014. (Sleep disorders, Mental disorders screening and ... Gagnon, JF; Postuma, RB; Mazza, S; Doyon, J; Montplaisir, J (May 2006). "Rapid-eye-movement sleep behaviour disorder and ... Rapid eye movement sleep (REM sleep) Non-rapid eye movement sleep (NREM) Stiasny-Kolster K, Mayer G, Schäfer S, Möller JC, ...
Movement Disorders. 27 (10): 1222-1229. doi:10.1002/mds.25103. PMID 22807284. S2CID 22422642. Fred R. Volkmar; et al. (2005). ... Thought Disorder (2016), 25.3. What Are the Boundaries of Thought Disorder?., pp. 498-499. Thought Disorder (2016), 25.4. What ... Schizophrenic Language Disorder, CLINICAL DESCRIPTION AND THOUGHT DISORDER, p. 167. ISBN 978-0-7020-5556-0. Thought Disorder ( ... Schizophrenia-spectrum disorders such as schizoaffective disorder and schizophreniform disorder typically consist of prominent ...
The DSM-5 motor disorders include developmental coordination disorder, stereotypic movement disorder, and the tic disorders ... These disorders can cause lack of intended movement or an excess of involuntary movement. Symptoms of motor disorders include ... "Functional Tremor/ Spasms / Walking Problems and Other Functional Movement Disorders." Movement Disorders. Neurology Research ... Motor disorders are disorders of the nervous system that cause abnormal and involuntary movements. They can result from damage ...
"From psychogenic movement disorder to functional movement disorder: it's time to change the name". Movement Disorders. 29 (7): ... "Psychopathology and psychogenic movement disorders". Movement Disorders. 26 (10): 1844-1850. doi:10.1002/mds.23830. PMC 4049464 ... Physiotherapy is particularly helpful for patients with motor symptoms (weakness, gait disorders, movement disorders) and ... Subsets of functional neurological disorders include functional neurological symptom disorder (FNsD), conversion disorder, ...
"Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study". Movement Disorders. 32 (11): 1557 ... antisocial personality disorder, borderline personality disorder, conduct disorder and some mood disorders. The fifth edition ... Mental disorders, Obsessive-compulsive disorder, Self-control, Conformity, Impulse-control disorders). ... attention deficit hyperactivity disorder, autism spectrum disorder, fetal alcohol spectrum disorders, ...
Singer HS (2011). "Tourette syndrome and other tic disorders". Hyperkinetic Movement Disorders. pp. 641-57. doi:10.1016/B978-0- ... Other disorders with similar symptoms include generalized anxiety disorder, major depressive disorder, eating disorders, tic ... major depressive disorder, bipolar disorder, generalized anxiety disorder, anorexia nervosa, social anxiety disorder, bulimia ... autism spectrum disorder (ASD), or disorders in which perseveration is a possible feature (ADHD, PTSD, bodily disorders, or ...
Singer HS (2011). "Stereotypic movement disorders". Hyperkinetic Movement Disorders. Handbook of Clinical Neurology. Vol. 100. ... hair pulling disorder), skin picking disorder, and stereotypic movement disorder: toward DSM-V". Depression and Anxiety. 27 (6 ... hair pulling disorder), skin picking disorder, and stereotypic movement disorder: toward DSM-V". Depression and Anxiety. 27 (6 ... Excoriation disorder occurs as the primary disorder and not as a subset of a larger disorder. Excoriation disorder has well- ...
... from other movement disorders or seizure disorders is via direct observation. Usually in cases of gratification disorder, the ... Wolf DS, Singer HS (August 2008). "Pediatric movement disorders: an update". Current Opinion in Neurology (Review). 21 (4): 491 ... a neurological disorder causing episodes of spastic movements that cause muscles to contract involuntarily; dyskinesia, a ... which is not something that would be seen in movement or seizure disorders. Several studies stress the importance of direct ...
"Gender as a Risk Factor for Functional Movement Disorders: The Role of Sexual Abuse". Movement Disorders Clinical Practice. 7 ( ... The ICD-10 classifies conversion disorder as a dissociative disorder, and the ICD-11 as a dissociative disorder with ... However, the DSM-IV classifies conversion disorder as a somatoform disorder. Conversion disorder begins with some stressor, ... Symptoms of conversion disorder usually occur suddenly. Conversion disorder is typically seen in people aged 10 to 35, and ...
It is often paired with rhythmic movement disorder. Most symptoms begin during the first week of abstinence and resolve after a ... Cannabis use disorder is recognized in the fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), ... cannabis use disorder. Cannabis use disorder is also recognized in the eleventh revision of the International Classification of ... Scales for general drug use disorders are also used, including the Severity Dependence Scale (SDS), Drug Use Disorder ...
... and other neurodevelopmental disorders (such as stereotypic movement disorder and Tourette's disorder), in addition to specific ... anxiety disorders, depressive disorders, bipolar disorder, disruptive mood dysregulation disorder, substance use disorder, ... Seok-Hyun N, Myung L, Tae P (1 April 2022). "Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder ... and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders". Journal of ...
Vinagre-Aragón A, Zis P, Grunewald RA, Hadjivassiliou M (2018). "Movement Disorders Related to Gluten Sensitivity: A Systematic ... Sporadic accidental contaminations with gluten can reactivate movement disorders associated with non-celiac gluten sensitivity ... Autoimmune disorders: celiac disease, dermatitis herpetiformis, gluten ataxia Non-autoimmune, non-allergic: disorder with ... Gluten-related disorders is the term for the diseases triggered by gluten, including celiac disease (CD), non-celiac gluten ...
... disorder Developmental coordination disorder and stereotypic movement disorder are also classified as motor disorders. ICD10 ... common in autism spectrum disorders) and tic disorders. Provisional tic disorder approximately replaced transient tic disorder ... 307.20 Unspecified tic disorder 307.21 Provisional tic disorder 307.22 Persistent (chronic) motor or vocal tic disorder ( ... F95.0 Transient tic disorder F95.1 Chronic motor or vocal tic disorder F95.2 Combined vocal and multiple motor tic disorder [ ...
Parker, Gordon; Hadzi-Pavlovic, Dusan; Eyers, Kerrie (1996). Melancholia: A disorder of movement and mood: a phenomenological ... Depressive and related disorders and bipolar and related disorders. Bipolar disorders fall in between depressive disorders and ... more than one mood disorder can be present in an individual, like bipolar disorder and depressive disorder. If a mood disorder ... A mood disorder, also known as an affective disorder, is any of a group of conditions of mental and behavioral disorder where a ...
The motor disorders described in the DSM-5 are Developmental Coordination Disorder and Stereotypic Movement Disorder. ... Other conduct disorders (F91.9) Conduct disorder, unspecified (F92.0) Depressive conduct disorder (F92.8) Other mixed disorders ... Sibling rivalry disorder (F93.8) Other childhood emotional disorders Identity disorder Overanxious disorder (F93.9) Childhood ... 307.23 Tourette's disorder 307.22 Chronic motor or vocal tic disorder 307.21 Transient tic disorder: Must meet the following ...
June 2012). "A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study". Mov. ... Articles with short description, Short description matches Wikidata, Sleep disorders, Mental disorders screening and assessment ... The RBD1Q can be used to establish a diagnosis of REM sleep behavior disorder in Parkinson's disease and dementia with Lewy ... The REM Sleep Behavior Disorder Single-Question Screen (RBD1Q) is a one-question screening tool for dream enactment behaviors ...
Meige syndrome Movement disorder that can involve excessive eye blinking (blepharospasm) with involuntary movements of the jaw ... Tourette syndrome Neurological disorder characterized by recurring movements and sounds (called tics). Tracheostomy Surgical ... Motor speech disorders Group of disorders caused by the inability to accurately produce speech sounds (phonemes) because of ... Throat disorders Disorders or diseases of the larynx (voice box), pharynx, or esophagus. Thyroplasty Surgical technique(s) to ...
Extrapyramidal and movement disorders, Rare diseases, Neurodegenerative disorders, Peripheral nervous system disorders). ... Aminoff MJ, Greenberg DA, Simon RP (2005). "Chapter 7: Movement disorders". Clinical Neurology (6th ed.). Lange: McGraw-Hill ... Parkinsonian syndromes are a group of movement disorders characterized by classical motor symptoms such as tremors, ... July 2020). "RFC1 Intronic Repeat Expansions Absent in Pathologically Confirmed Multiple Systems Atrophy". Movement Disorders. ...
Singer, Harvey S. (2011). "Tourette syndrome and other tic disorders". Hyperkinetic Movement Disorders. Handbook of Clinical ... "Deep Brain Stimulation for Movement Disorders". National Institute on Neurological Disorders and Stroke. U.S. Department of ... Treatment center for Deep Brain Stimulation of movement disorders, OCD, Tourette or depression. Treatment center for Deep Brain ... "Deep Brain Stimulation for Movement Disorders". University of Pittsburgh. Young RF, Brechner T (1986). "Electrical stimulation ...
Movement Disorders. 33 (6): 1000-1005. doi:10.1002/mds.27353. PMID 29624723. S2CID 4664990. Clinical trial number NCT04102501 ... particularly neurodegenerative disorders and clinical trials of RT001 begun in 2018. A double-blind comparator-controlled Phase ...
Movement Disorders. 20 (12): 1629-1633. doi:10.1002/mds.20632. PMID 16078200. S2CID 31508365. Lannuzel A, Höglinger GU, Champy ... The disorder is a so-called tauopathy associated with a pathologic accumulation of tau protein in the brain. Experimental ...
Movement Disorders is a peer-reviewed medical journal, first published in 1986. The journal focuses on original research ... Official website The International Parkinson and Movement Disorder Society v t e (Articles with short description, Short ... "Movement Disorders". National Library of Medicine Catalog. Retrieved 2010-01-25. "Editorial Board". Wiley Online Library. Wiley ... relating to neurological movement disorders. The editor-in-chief is A. Jon Stoessl (University of British Columbia). The ...
Learn about eye movement disorders, such as strabismus, where the eyes point in different directions, and nystagmus, which ... There are many kinds of eye movement disorders. Two common ones are:. *Strabismus - a disorder in which the two eyes dont line ... Nystagmus - fast, uncontrollable movements of the eyes, sometimes called "dancing eyes". Some eye movement disorders are ... There is no cure for some kinds of eye movement disorders, such as most kinds of nystagmus. ...
The Comprehensive Parkinsons Disease and Movement Disorder Center offers a one or two-year clinical fellowship in Movement ... movement disorder phenomenology along with medical and surgical management of Parkinsons disease and other movement disorders. ... Fellows will be exposed to a multitude of movement disorders at one of the largest centers of its kind nationwide. The ... This provides an ideal forum for trainees to gain a deeper understanding of the pathophysiology of movement disorders, basal ...
LaFaver and Indu Subramanian discuss highlights from the 2023 International Congress of Parkinsons Disease and Movement ... LaFaver: Theres a great gathering of great minds and movement disorders. Im happy to hear your takeaways and highlights from ... We will be talking on behalf of Medscape about highlights from the recent Movement Disorder Congress in Copenhagen, Denmark. ... Cite this: Highlights From the 2023 Movement Disorder Congress - Medscape - Oct 13, 2023. ...
... involuntary movements with symptom variability that cannot be explained by a conventional neurological or medical disorder. ... Functional movement disorders (FMD) are characterized by a sudden onset of neurological symptoms resulting in abnormal ... Functional Movement Disorders. Clinical Summary Created: Thursday, January 13, 2022. Author(s): Meghan Moore Burk, PT, DPT, ... Functional movement disorders (FMD) are characterized by a sudden onset of neurological symptoms resulting in abnormal ...
Movement Disorders Clinical Practice Publication Information. Title. Movement Disorders Clinical Practice [English] ...
Movement Disorders Centre. London Health Sciences Centre. 339 Windermere Road, A10-026, London, Ontario, Canada, N6A 5A5. tel: ... Ganguly J, Kulshreshtha D, Jog M. Mercury and Movement Disorders: The Toxic Legacy Continues. Can J Neurol Sci. 2021 Jun 24:1-9 ... Kulshreshtha D, Ganguly J, Jog M. Manganese and Movement Disorders: A Review. J Mov Disord. 2021 May;14(2):93-102. doi: ... Brain iron deposition and movement disorders in hereditary haemochromatosis without liver failure: A cross-sectional study. Eur ...
Unfortunately, due to the little-understood nature of the brain, neurological disorders such as these can be hard to diagnose ... Movement disorders such as Parkinsons disease and essential tremor affect millions of Americans. ... Early diagnosis of movement disorders is key. DBS works best if youre experiencing mild to moderate symptoms of movement ... Movement disorders such as Parkinsons disease and essential tremor affect millions of Americans. Unfortunately, due to the ...
Bucci, M. A metal movement disorder. Nat Chem Biol 10, 984 (2014). https://doi.org/10.1038/nchembio.1703 ...
Duke movement disorder specialists work together to identify movement disorders that are difficult to diagnose, including rare ... Treatments for Movement Disorders. The Duke movement disorder care team includes providers who specialize in a variety of ... Diagnosing Movement Disorders. Doctors typically diagnose movement disorders based on your symptoms, a complete medical history ... The Duke Movement Disorders Center offers events to support and educate people with movement disorders and their care partners. ...
Today well be discussing highlights in movement disorders from the recent American Academy of Neurology (AAN) annual meeting. ... In this study from the University of Pennsylvanias Parkinsons Disease and Movement Disorder Center, they looked specifically ...
NORD is not a medical provider or health care facility and thus can neither diagnose any disease or disorder nor endorse or ... National Organization for Rare Disorders (NORD). 1900 Crown Colony Drive. Suite 310. Quincy, MA 02169. Phone: 617-249-7300 ... Copyright ©2023 NORD - National Organization for Rare Disorders, Inc. All rights reserved. ... cure or treatment of a condition or disorder. ...
... is unique in that the movements occur during sleep. Most other movement disorders manifest during wakefulness. ... Periodic limb movement disorder (PLMD) is unique in that the movements occur during sleep. Most other movement disorders ... encoded search term (Periodic Limb Movement Disorder) and Periodic Limb Movement Disorder What to Read Next on Medscape ... Movement Disorders Neurologist, Binter Center for Parkinsons Disease and Movement Disorders, University of Vermont Medical ...
... purposeless movement. Examples of stereotypic movements include hand flapping, body rocking, head banging, and self-biting. A ... diagnosis is only given if the repetitive movement causes distress in a child and leads to impairment in day-to-day functioning ... Stereotypic movement disorder is a motor disorder that develops in childhood, typically before grade school, and involves ... Treatment for stereotypic movement disorder may include psychotherapy and behavioral strategies to reduce repetitive movements ...
Learn more about current fellows of the Cedars-Sinai Movement Disorders Fellowship. ... Meet the current fellows from the Movement Disorders Fellowship at Cedars-Sinai. ... Fellows Education Graduate Medical Education Fellowship Programs Movement Disorders Fellowship Fellows Movement Disorders ...
Before you can begin to treat a movement disorder, you need an accurate tool for diagnosis like the Kinesia™... Cleveland ... Wirelessly Monitoring Movement Disorders. May 4th, 2007 Josh Umbehr Neurology Before you can begin to treat a movement disorder ... Movement disorders, such as Parkinsons disease and essential tremor, affect millions of people worldwide. Associated with ... Press Release: Clevemed Receives FDA Clearance to Market Wireless Movement Disorder Monitor (PDF). (hat tip: Medical ...
... has evolved as an important and established treatment for movement disorders. While DBS is not a cure for movement disorders, ... A few weeks after surgery, the movement disorders specialist will use a hand-held programmer to test different electrodes and ... Jankovic J. Treatment of Movement Disorders. Neurol Clin. 2020;38(2):xiii-xiv. Jankovic J, Tan EK. Parkinsons disease: ... DBS therapy is currently offered to patients with movement disorders that are not sufficiently controlled with medications. ...
Retrieve data from the Apple Watchs movement disorder manager. ...
Twenty-three of the 34 patients had an organic movement disorder (OMD), five patients fulfilled the diagnostic criteria of ... We report on 34 patients with abnormal body movements (AMs; 11 females, 23 males; mean age 10 y 1 mo, range 3 y 6 mo-15 y 11 mo ... Psychogenic and organic movement disorders in children Dev Med Child Neurol. 2008 Apr;50(4):300-4. doi: 10.1111/j.1469- ... Twenty-three of the 34 patients had an organic movement disorder (OMD), five patients fulfilled the diagnostic criteria of ...
... is unique in that the movements occur during sleep. Most other movement disorders manifest during wakefulness. ... encoded search term (Periodic Limb Movement Disorder) and Periodic Limb Movement Disorder What to Read Next on Medscape ... Movement Disorders Neurologist, Binter Center for Parkinsons Disease and Movement Disorders, University of Vermont Medical ... Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child ...
Periodic limb movement disorder (PLMD) is a condition in which a persons legs, and sometimes arms, move ... What is periodic limb movement disorder (PLMD)?. Periodic limb movement disorder (PLMD) is a condition in which a persons legs ... How is periodic limb movement disorder (PLMD) treated?. Managing symptoms of periodic limb movement disorder (PLMD) may include ... Periodic limb movements of sleep are only thought to be a disorder (PLMD) when insomnia or daytime sleepiness cannot be ...
The Stanford Movement Disorders Center (SMDC) offers a 2 year Fellowship in Movement Disorders. Fellows will receive ... Disorders of gait, freezing, and balance (Stanford Balance Center). *Cognitive complications of movement disorders (with the ... Thank you for your interest in the Stanford Movement Disorders Fellowship Program. We participate in the San Francisco Movement ... Interdisciplinary Movement Disorders Surgical Review Board -Neurology, Neurosurgery, Neuropsychology, Psychiatry, movement ...
The exact prevalence of psychogenic movement disorders (PMD) is unknown. At tertiary care centers, 2-4% of movement disorders ... Symptoms may include one or several types of abnormal movements seen in organic movement disorders (tremor, dystonia, chorea, ... Psychogenic movement disorders. Disease definition A rare neurologic disease characterized by the manifestation of an ... usually incongruent with an organic movement disorder and affecting several body regions. Tremor appears to be the most ...
... such as increased movement (like spasms or shaking) and/or slow movement. ... Movement disorders are a group of neurological conditions that cause abnormal movements, ... The symptoms of movement disorders vary widely. All movement disorders cause abnormal movements. Some movement disorders have ... How are movement disorders treated?. The treatment for movement disorders varies based on the type. Most movement disorders ...
Click here to visit the Movement Disorders Fellowship (Non-ACGME) - Meet Us page and learn more about the opportunities for ... Home / Education / Residencies & Fellowships / Movement Disorders Fellowship (Non-ACGME) / Movement Disorders Fellowship (Non- ...
Parkinsons Disease and Other Movement Disorders Parkinsons disease, which occurs when certain nerve cells in the brain are ... However, it is estimated that gait disorders affect 8 to 19 percent of non-institutionalized older adults in the United States ... so symptoms could indicate a different disorder other than Parkinsons. Such gait disorders, all treated at the Berman Brain & ... damaged and cannot produce dopamine adequately, is one of the many brain disorders treated by neurologists at LifeBridge Health ...
Movement Disorders Associated With Atypical Antipsychotic Drugs. Stanley N. Caroff, MD; Stephan C. Mann, MD; E. Cabrina ... Thus, the risk of movement disorders has become only one of several considerations in choosing among antipsychoticdrugs. ... and other movement disorders. Atypical drugs have been shown to reduce all subtypes of acute EPS, the frequency of EPS-related ... Baclofen, a French Exception, Seriously Harms Alcohol Use Disorder Patients Without Benefit To the Editor: Dr Andrades ...
MCW staff provide many support options for movement disorders patients to cope with physical symptoms, emotional issues and ... Movement Disorders Program offers the broadest range of care options available in the region, helping people with movement ... Our Movement Disorders team is dedicated to helping patients improve all aspects of their health and wellbeing as they live ... How movement disorders symptoms are unique for every patient and how they typically progress ...
An examination of 50 relevant studies found that individuals with any of four major types of hyperkinetic movement disorders ... Hyperkinetic movement disorders encompass a group of neurological conditions characterized by excessive, involuntary movements ... Are Movement Disorders to Blame for a Lack of Social Awareness?. -An examination of 50 relevant studies found that individuals ... Individuals with hyperkinetic movement disorders may experience impaired social cognition, which includes a range of intricate ...
When patients complain of sleep disturbance, psychiatrists should consider,and question for, features of nocturnal movement ... Sleep-associated movement disorders are common in the general population. ... Neuropsychiatric Dimensions of Movement Disorders in Sleep. April 1, 2006. Perminder S. Sachdev, MD, PhD ... Sleep-associated movement disorders are common in the general population. When patients complain of sleep disturbance, ...
  • The Comprehensive Parkinson's Disease and Movement Disorder Center offers a one or two-year clinical fellowship in Movement Disorders. (jefferson.edu)
  • The fellowship offers training in diagnosis and recognition of movement disorder phenomenology along with medical and surgical management of Parkinson's disease and other movement disorders. (jefferson.edu)
  • The Center provides medical and surgical management for patients with Parkinson's disease, essential tremor, dystonia, Huntington's disease, ataxia and other movement disorders. (jefferson.edu)
  • The Center has a mature deep brain stimulation (DBS) practice, including patients with Parkinson's disease, dystonia and tic disorders. (jefferson.edu)
  • Movement disorders such as Parkinson's disease and essential tremor affect millions of Americans. (abc15.com)
  • As designated Centers of Excellence for both Parkinson's disease and Huntington's disease, Duke Health provides the highest level of testing, diagnosis, and management services for people with these and other movement disorders. (dukehealth.org)
  • Just to highlight a few key things that came up: I was really excited to see some representation around nonmotor issues in movement disorders and specifically, in Parkinson's disease . (medscape.com)
  • Movement disorders, such as Parkinson's disease and essential tremor, affect millions of people worldwide. (medgadget.com)
  • Dr. Peter LeWitt, Director, Division of Parkinson's Disease and Movement Disorders for Henry Ford Health Systems and Kinesia user said, "Progress in developing new therapies needs equipment that can reliably quantify movement and Kinesia has performed very well in clinical and research settings for high-quality physiological recordings of tremor and dyskinesia. (medgadget.com)
  • Objectively quantifying motor symptoms of movement disorders such as Parkinson's disease and essential tremor is critical to understanding changes in response to interventions. (medgadget.com)
  • Patients with Parkinson's disease, essential tremor, dystonia, and other movement disorders such as Tourette syndrome, who do not obtain a satisfactory response from optimal medical therapy, may be considered candidates for surgical intervention. (bcm.edu)
  • The Froedtert & Medical College of Wisconsin Parkinson's Disease & Movement Disorders Program offers the broadest range of care options available in the region, helping people with movement disorders cope with physical symptoms, emotional issues, social stigmas and other concerns related to these disorders. (froedtert.com)
  • Physicians and other program team members present community education programs on Parkinson's disease and other movement disorders as well as deep brain stimulation (for the treatment of Parkinson's disease, tremors and dystonia). (froedtert.com)
  • The focus of the current review is on Parkinson's disease and Huntington's disease as they are the most investigated hypokinetic and hyperkinetic movement disorders, respectively. (nih.gov)
  • Faculty and staff from the Parkinson's Disease and Movement Disorders Center will. (bu.edu)
  • Parkinson's disease may be the best-known movement disorder, but the term covers more than a dozen other conditions, including cerebral palsy, dystonia, epilepsy, and multiple sclerosis. (dignityhealth.org)
  • In clinical story after story (31 chapters in total), we explore all types of movement disorders, from the most familiar Parkinson's Disease to all that is unfamiliar, to a medical student at least. (acnr.co.uk)
  • When medication no longer offers relief, the technology of neuromodulation such as deep brain stimulation (DBS) seems to be an ideal alternative, which has been commonly used for the treatment of movement disorders such as Parkinson's disease (PD), and medication-resistant psychiatric disorders such as obsessive compulsive disorder (OCD). (frontiersin.org)
  • A movement disorder specialist is a neurologist with additional training in Parkinson's disease (PD) who personalizes care to an individual's symptoms and needs. (michaeljfox.org)
  • A movement disorder specialist is a neurologist who has completed a fellowship, which is one to two years of extra training in movement disorders, which is mainly in Parkinson's disease. (michaeljfox.org)
  • Every year, thousands of these professionals and researchers share their ideas to advance PD care and research at the International Congress of Parkinson's Disease and Movement Disorders. (parkinson.org)
  • We welcome Steve C. Han, MD, MBA to the Parkinson's Disease and Movement Disorder Center here at Boston University Medical Campus. (bu.edu)
  • Deep Brain Stimulation (DBS) has evolved into an effective therapeutic agent for movement disorders such as Parkinson's Disease (PD), Essential Tremor (ET), and Dystonia. (healthworldnet.com)
  • Deep brain stimulation, sometimes called a pacemaker for the brain, has helped halt tremors in more than 100,000 patients with Parkinson's disease and other movement disorders since 1997. (healthworldnet.com)
  • Movement Disorders is the leading journal on Parkinson's disease, neurodegenerative & neurodevelopmental disorders & abnormalities in motor control. (healthworldnet.com)
  • The International Parkinson and Movement Disorder Society (MDS) is a professional society of clinicians, scientists, and other healthcare professionals who are interested in Parkinson's disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and motor control. (healthworldnet.com)
  • What's new concerning Parkinson's disease and other movement disorders? (medscape.com)
  • WeMove produced these summaries on the basis of the data presented at the 8th International Congress of Parkinson's Disease and Movement Disorders, held in Rome, Italy, June 14-17, 2004. (medscape.com)
  • Manganese (Mn) toxicity is characterized by movement disorders resembling Parkinson's disease. (cdc.gov)
  • Learn more about movement disorders and deep brain stimulation on HonorHealth's website. (abc15.com)
  • Deep brain stimulation (DBS) has evolved as an important and established treatment for movement disorders. (bcm.edu)
  • Deep Brain Stimulation is currently being used in selected centers around the world, including the Baylor Medicine, to treat a variety of movement disorders. (bcm.edu)
  • Patients are most often referred for deep brain stimulation (DBS) surgery when they have experienced problems with dyskinesias (excessive involuntary movements that occur as a consequence of PD medications) and fluctuations (the beneficial effects of medications do not last long enough between doses). (bcm.edu)
  • Since the implementation of deep-brain stimulation as a therapy for movement disorders, there has been little progress in the clinical application of novel alternative treatments. (nih.gov)
  • A patient talks about her personal and challenging journey with dystonia and how her life changed after being treated with deep brain stimulation by Dr. David Barba at the UC San Diego Movement Disorder Center. (healthworldnet.com)
  • Studies of the systemic mechanisms of deep brain stimulation treatment in patients with movement disorders (incl. (unimedizin-mainz.de)
  • He developed with his team a prominent center for movement disorder patients and for advanced therapies particularly deep brain stimulation. (lu.se)
  • Abnormal movements may be the only part of a condition, such as in essential tremor. (clevelandclinic.org)
  • 2 Other movement disorders include Tourette syndrome (TS), essential tremor (ET), and dystonia, which is characterized by intermittent or sustained muscle contractions that result in abnormal and often repetitive movements or postures. (medpagetoday.com)
  • Essential tremor is the most common movement disorder that typically involves tremor of the hands during activities such as eating and writing. (rush.edu)
  • Hyperkinetic movement. (clevelandclinic.org)
  • Hyperkinetic movement disorders involve increased movement. (clevelandclinic.org)
  • An examination of 50 relevant studies found that individuals with any of four major types of hyperkinetic movement disorders consistently exhibited impaired social cognition. (medpagetoday.com)
  • Individuals with hyperkinetic movement disorders may experience impaired social cognition, which includes a range of intricate mental capacities that allow people to perceive and react to social cues. (medpagetoday.com)
  • I'd like to underscore the significance of adopting multifaceted approaches in the study and management of hyperkinetic movement disorders. (medpagetoday.com)
  • Hyperkinetic movement disorders encompass a group of neurological conditions characterized by excessive, involuntary movements. (medpagetoday.com)
  • One of the most well-known hyperkinetic movement disorders is Huntington disease (HD), a rare hereditary condition caused by a mutated HTT gene. (medpagetoday.com)
  • The brain regions impacted by hyperkinetic movement disorders hold significance for social cognition, even though this connection has not always been acknowledged in the literature," says Alessio Avenanti, PhD, one of the new study's authors. (medpagetoday.com)
  • This systematic review screened 1137 studies that analyzed the impact of various hyperkinetic movement disorders on social cognition. (medpagetoday.com)
  • In this, individuals from all four groups of hyperkinetic movement disorders exhibited impairment of social perception and ToM. (medpagetoday.com)
  • The insights gleaned from our study carry valuable implications for clinicians dedicated to treating individuals with hyperkinetic movement disorders," says Dr. Avenanti, who is professor of cognitive neuroscience at the University of Bologna, Italy. (medpagetoday.com)
  • For healthcare teams that manage patients with neurological conditions, the authors emphasize the importance of treating nonmotor symptoms of hyperkinetic movement disorders. (medpagetoday.com)
  • [ 6 ] Voderholzer et al noted an increased incidence of periodic limb movements during sleep in patients with Gilles de la Tourette syndrome . (medscape.com)
  • Some research suggests that periodic limb movements with arousals are associated with subsequent nonsustained ventricular tachycardia (NSVT). (medscape.com)
  • A study of older men in their 70s and 80s found that periodic limb movements during sleep with arousal was associated with a threefold increased risk for NSVT shortly after the episode. (medscape.com)
  • Periodic limb movement disorder (PLMD) is characterized by periodic episodes of repetitive limb movements during sleep, which most often occur in the lower extremities. (medscape.com)
  • [ 11 ] Researchers report that sleep changes induced by periodic limb movements during sleep are associated with decreased physical and psychological fitness on awakening. (medscape.com)
  • Occasionally, a bed partner may provide the history of limb movements. (medscape.com)
  • [ 15 ] There also appears to be a high prevalence of periodic limb movements of sleep in children with Down syndrome . (medscape.com)
  • PLMD and epilepsy are both common at the population level, however, little research has been done to establish the prevalence of periodic limb movements during sleep in people with a history of epilepsy. (medscape.com)
  • RLS and periodic limb movements during sleep are also common in patients with a history of spinal cord injury. (medscape.com)
  • While some patients with increased periodic limb movements during sleep may have an underlying etiology, it is important to recognize that these movements are not always indicative of a medical condition and have been shown to occur in up to 7.7% of healthy children. (medscape.com)
  • Vetrugno R, D'Angelo R, Montagna P. Periodic limb movements in sleep and periodic limb movement disorder. (medscape.com)
  • Hoque R, Chesson AL Jr. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. (medscape.com)
  • Voderholzer U, Müller N, Haag C, Riemann D, Straube A. Periodic limb movements during sleep are a frequent finding in patients with Gilles de la Tourette's syndrome. (medscape.com)
  • Periodic limb movements of sleep are only thought to be a disorder (PLMD) when insomnia or daytime sleepiness cannot be explained by any other problem, such as restless legs syndrome . (healthlinkbc.ca)
  • In addition to five fellowship-trained Movement Disorder neurologists, the Center is also home to two functional neurosurgeons, two PhD neuroscientists, as well as clinical and research collaboration with neuropsychology and cognitive neurology. (jefferson.edu)
  • While there is no overnight or weekend call, the fellow will also have the opportunity to provide inpatient consultations for a variety of movement disorders, as requested by the inpatient neurology service. (jefferson.edu)
  • Our specialized Movement Disorders Center is located at Duke Neurology Morreene Road. (dukehealth.org)
  • Today we'll be discussing highlights in movement disorders from the recent American Academy of Neurology (AAN) annual meeting. (medscape.com)
  • I'm a movement specialist in Saratoga Springs, New York, and I have the pleasure of talking today with Dr Subramanian, who is the director of the PADRECC Center in LA and also a clinical professor of neurology at UCLA. (medscape.com)
  • The classification of jerky movements is a clinical challenge on the border of neurology and psychiatry. (bmj.com)
  • We spoke with Katherine Leaver, MD, Assistant Professor of Neurology in the Division of Movement Disorders at Mount Sinai Beth Israel in New York, about how movement disorder specialists can help people with Parkinson's and their families. (michaeljfox.org)
  • Dr. Steve Han is board-certified in Neurology and is fellowship trained in Movement Disorders. (bu.edu)
  • He completed his Neurology residency and movement disorders fellowship at New York University Grossman School of Medicine. (bu.edu)
  • He is Past Editor of the 'Movement Disorder Journal', past president of the German Society of Neurology and past president the International Movement Disorder Society. (lu.se)
  • While DBS is not a cure for movement disorders, it can successfully treat symptoms by disrupting the abnormal patterns of brain activity that become prominent in these diseases. (bcm.edu)
  • Tremor appears to be the most commonly observed phenomenon, followed by dystonia, bradykinesia, myoclonus, and other unclassifiable abnormal movements. (orpha.net)
  • The differential diagnosis of PMD lies in the organic counterparts of each individual presenting abnormal movement. (orpha.net)
  • Movement disorders are a group of neurological conditions that cause abnormal movements. (clevelandclinic.org)
  • Movement disorders cause abnormal, unwanted movements. (clevelandclinic.org)
  • What are the types of abnormal movements? (clevelandclinic.org)
  • Dystonia is sustained or intermittent muscle contractions causing abnormal, often repetitive movements or postures. (clevelandclinic.org)
  • Abnormal movements that arepresent during the day, such as the motordisturbance of PD or TS, are usuallyquiescent during sleep, while those occurringprimarily in sleep (eg, nocturnalepilepsies, parasomnias, restless legssyndrome [RLS], periodic limb movementsof sleep [PLMS]) rarely intrudeinto awake periods. (psychiatrictimes.com)
  • A functional movement disorder means that there is abnormal movement or positioning of part of the body due to the nervous system not working properly (but not due to an underlying neurological disease). (healthworldnet.com)
  • Periodic limb movement disorder (PLMD) and restless legs syndrome (RLS) are characterized by abnormal motions of and, for RLS, usually sensations in the lower or upper extremities, which may interfere with sleep. (msdmanuals.com)
  • They are typically unaware of the movements and brief arousals that follow and have no abnormal sensations in the extremities. (msdmanuals.com)
  • Vetrugno et al report that evidence supports neuronal hyperexcitability with involvement of the central pattern generator for gait as the pathophysiology of periodic limb movement. (medscape.com)
  • It interferes with movement and can also affect your speech and how you walk (gait). (clevelandclinic.org)
  • Botulinum toxin ("Botox") injections can help reduce muscle contractions in movement disorders like dystonia. (dukehealth.org)
  • Our centre focuses on treatment of patients with neurological movement disorders, including Parkinson Disease, Dystonia, Tremor, Torticollis and many related diseases. (healthworldnet.com)
  • Patients must rely on the personal and individualized medical advice of their qualified health care professionals before seeking any information related to their particular diagnosis, cure or treatment of a condition or disorder. (rarediseases.org)
  • A diagnosis is only given if the repetitive movement causes distress in a child and leads to impairment in day-to-day functioning or results in self-injury . (psychologytoday.com)
  • Fellows will receive comprehensive training in diverse aspects of movement disorders that include: the diagnosis and treatment of a wide range of adult and pediatric movement disorders, botulinum toxin administration in adults and children (offering training in both EMG and ultrasound guidance), pre- and post-surgical management of patients undergoing functional neurosurgery, multidisciplinary clinical exposure, clinical research, and intra-operative electro-physiological recording. (stanford.edu)
  • Prenatal diagnosis does not exist for this disorder. (orpha.net)
  • 2-4 The diagnosis of psychogenic jerks is based on positive clinical clues, such as acute onset of the disorder, spontaneous (albeit temporarily) remissions, distractibility, variability (over time) and inconsistency. (bmj.com)
  • 3 The diagnosis of Gilles de la Tourette syndrome (GTS) is based on clinical criteria as specified in the Diagnostic and Statistical Manual of Mental Disorders - IV (DSM-IV), with an onset of tics prior to the age of 18 and at least multiple motor and one or more vocal tics. (bmj.com)
  • The key to the diagnosis of tics is the presence of a premonitory urge preceding the movements and the ability of suppression. (bmj.com)
  • Anyone with Parkinson's - it doesn't matter how early after the diagnosis or how mild the symptoms - should see a movement disorder specialist. (michaeljfox.org)
  • 1 , 4 Another commonly encountered feature is psychiatric comorbidity, such as anxiety disorders, obsessive-compulsive disorder (OCD) and major depressive disorder. (bmj.com)
  • Hypokinetic movement. (clevelandclinic.org)
  • The goal of this project is to elucidate cellular and circuit dysfunctions underlying hypokinetic, hyperkinetic, and dystonic movement disorders in Parkinson´s Disease and L-DOPA-induced dyskinesia. (lu.se)
  • Movement disorders are a group of neurological conditions, which are characterised with impairment of voluntary movement and share similar anatomical loci across the basal ganglia. (nih.gov)
  • The type of repetitive movement varies widely and each child presents with their own individually patterned, "signature" behavior. (psychologytoday.com)
  • They also often occur in narcolepsy, sleep apnea syndrome, and rapid eye movement (REM) sleep behavior disorder (RBD). (medscape.com)
  • thecondition is rare before the age of 30.PLMS occur in a number of sleep disorders,particularly RLS, but alsonarcolepsy, REM sleep behavior disorder(RSBD), and obstructive sleep apnea.PLMS also occur in awake subjectswith RLS but only rarely in controls. (psychiatrictimes.com)
  • abstract = 'Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by a history of recurrent nocturnal dream enactment behavior and loss of skeletal muscle atonia and increased phasic muscle activity during REM sleep: REM sleep without atonia. (ku.dk)
  • Rapid eye movement (REM) sleep behavior disorder Parasomnias are undesirable behaviors that occur during entry into sleep, during sleep, or during arousal from sleep. (msdmanuals.com)
  • Stereotypic movement disorder is a motor disorder that develops in childhood , typically before grade school, and involves repetitive, purposeless movement. (psychologytoday.com)
  • Stereotypic movement disorder can be categorized as mild, moderate, or severe. (psychologytoday.com)
  • How is stereotypic movement disorder diagnosed? (psychologytoday.com)
  • The primary way to tell if an individual has stereotypic movement disorder is the presence of the aforementioned stereotypic movements. (psychologytoday.com)
  • The cause of stereotypic movement disorder is unknown, but several factors are connected to its development. (psychologytoday.com)
  • The risk for stereotypic movement disorder is greater among individuals with severe intellectual disabilities. (psychologytoday.com)
  • The exact prevalence of psychogenic movement disorders (PMD) is unknown. (orpha.net)
  • Periodic limb movement disorder (PLMD) is unique in that the movements occur during sleep. (medscape.com)
  • PLMD may occur with other sleep disorders and is related to, but not synonymous with, restless legs syndrome (RLS), which is a movement disorder with sensory features that manifest during wakefulness. (medscape.com)
  • The etiology of the primary form of periodic limb movement disorder (PLMD) is uncertain. (medscape.com)
  • [ 3 ] Many authors report an association between attention deficit hyperactivity disorder (ADHD) and PLMD. (medscape.com)
  • Some patients with otherwise unexplained insomnia or excessive daytime sleepiness exhibit an elevated number of PLMS, a condition defined as periodic limb movement disorder (PLMD). (medscape.com)
  • The idiopathic form of periodic limb movement disorder (PLMD) may be chronic. (medscape.com)
  • Picchietti et al suggested that the sleep disruption in periodic limb movement disorder (PLMD) could contribute to the inattention and hyperactivity of some children who have ADHD . (medscape.com)
  • Leg movements associated with PLMD are stereotyped and involve one or both limbs. (medscape.com)
  • Nozawa et al studied arousal index and movement index in PLMD and noted that the sleep-wake disorders associated with periodic limb movement relate to threshold of awakening. (medscape.com)
  • Walters et al provide an association between ADHD and sleep movement disorders including PLMD. (medscape.com)
  • What is periodic limb movement disorder (PLMD)? (healthlinkbc.ca)
  • Periodic limb movement disorder (PLMD) is a condition in which a person's legs, and sometimes arms, move repetitively and uncontrollably during sleep. (healthlinkbc.ca)
  • The exact cause of periodic limb movement disorder (PLMD) is unknown. (healthlinkbc.ca)
  • PLMD shares many underlying factors with restless legs syndrome, such as a hereditary link, nerve problems, kidney disorders, and others. (healthlinkbc.ca)
  • People who have periodic limb movement disorder (PLMD) have trouble falling or staying asleep (insomnia), or they feel sleepy during the day because the movements disrupt their sleep. (healthlinkbc.ca)
  • Periodic limb movement disorder (PLMD) is diagnosed with a medical history, often including a sleep history from a bed partner, and a physical examination. (healthlinkbc.ca)
  • How is periodic limb movement disorder (PLMD) treated? (healthlinkbc.ca)
  • Slides from the migraine presentation at the 2022 Movement Disorders+ Summit. (clinicaloptions.com)
  • The journal focuses on original research relating to neurological movement disorders. (wikipedia.org)
  • Fellows will be exposed to a multitude of movement disorders at one of the largest centers of its kind nationwide. (jefferson.edu)
  • This is achieved through movement control centers in the brain. (dukehealth.org)
  • At tertiary care centers, 2-4% of movement disorders patients are diagnosed with PMD. (orpha.net)
  • Most academic medical centers, which are hospitals affiliated with a university, have a division of movement disorders. (michaeljfox.org)
  • Since launch in 2014, The Edmond J. Safra Fellowship in Movement Disorders annually awards funding to distinguished medical centers around the world to usher in new a generation of talented movement disorder specialists - neurologists with additional training in Parkinson's and other movement disorders. (michaeljfox.org)
  • Associated with these disorders are motor symptoms, most commonly tremor, bradykinesia (slowed movements) and dyskinesias (exaggerated, involuntary movements) that can change rapidly and affect quality of life for many individuals. (medgadget.com)
  • Tremor involves involuntary trembling or shaking movements. (clevelandclinic.org)
  • Identifying the biomarkers closed related to the motor (tremor, rigidity and dyskinesia etc.) and non-motor features (anxiety, depression and apathy etc.) in the related brain circuits is important to develop closed-loop neuromodulation systems in movement disorders and psychiatric disorders. (frontiersin.org)
  • Tics are patterned, repetitive, nonrhythmic movements. (clevelandclinic.org)
  • Underlying causes encompass a spectrum of neuropsychiatric disorders ranging from myoclonus to motor tics and psychogenic jerks. (bmj.com)
  • Myoclonic jerks are brief, irregular muscular contractions, whereas psychogenic jerks and motor tics are repetitive stereotyped movements that vary in frequency, distribution, and severity. (bmj.com)
  • Said non-movement symptoms are the most challenging aspect of Parkinson's and wanted neurologists to routinely assess and provide ways to manage these symptoms. (parkinson.org)
  • Rush's Movement Disorders Program serves patients who benefit from collaboration between neurologists and neurosurgeons, and is led by neurologist Leonard Verhagen, MD, PhD, and neurosurgeon Sepehr Sani, MD . These specialists have the expertise to evaluate each person and determine whether MR-guided focused ultrasound is the best approach. (rush.edu)
  • The repetitive movements may increase with boredom , stress , excitement, and exhaustion. (psychologytoday.com)
  • Symptom fluctuation patterns are difficult to capture during an office visit", said Joseph Giuffrida, PhD, Director of the Division of Movement Disorders at CleveMed. (medgadget.com)
  • Pediatric periodic limb movement disorder: sleep symptom and polysomnographic correlates compared to obstructive sleep apnea. (medscape.com)
  • Most cases fall in the psychiatric diagnostic category of conversion disorder, also referred to as functional neurological symptom disorder. (orpha.net)
  • Underlying causes for PMD fall into three categories: Conversion disorder (also referred to as functional neurological symptom disorder), somatic symptom disorders, or, in rare cases, factitious disorder, and malingering. (orpha.net)
  • In addition, certain movement disorders can be both a condition by themselves and a symptom of other conditions, like myoclonus. (clevelandclinic.org)
  • Movement disorders can have a variety of underlying causes and factors that can exacerbate the disease progression, so symptom monitoring and adjustment of therapeutic regiments can be a challenge. (medgadget.com)
  • Do not rate two or more particular movements, postures, or utterances on the same sheet. (medscape.com)
  • [ 4 ] Iron deficiency anemia has a well-known association with RLS, but more recently has also been found to be associated with periodic limb movement, with some studies suggesting a possible benefit to iron supplementation in patients with documented deficiency. (medscape.com)
  • In addition to continued clinical training, fellows in their second year would have time to devote to scholarly research projects in clinical movement disorders with a faculty mentor. (jefferson.edu)
  • Fellows will train with our diverse Movement Disorders faculty , with clinic opportunities 5 days a week and DBS procedures 1-2 days a week. (stanford.edu)
  • The fellows will also engage in research opportunities directed toward their personal area of academic interest, with faculty mentors available both within the Movement disorders division and throughout Stanford University. (stanford.edu)
  • Dr. Han is also actively involved in the training of movement disorders fellows, residents and medical students. (bu.edu)
  • The prevalence of periodic leg movements in sleep (PLMS) is estimated to be 4-11% in adults. (medscape.com)
  • A movement disorder specialist is expertly trained to address the various motor and non-motor symptoms that can occur through a holistic and individualized approach to improve quality of life. (michaeljfox.org)
  • Mrs. Lily Safra, chairwoman of the Edmond J. Safra Foundation has said: "This growing global network of expertly trained movement disorder specialists will help ensure that people and families living with Parkinson's receive comprehensive and compassionate care and that critical research moves forward to meet their most pressing needs. (michaeljfox.org)
  • Medications, including MAO and COMT inhibitors and dopamine agonists, increase levels of dopamine, the brain chemical that helps control symptoms like difficulty walking or tremors that occur in parkinsonian disorders. (dukehealth.org)
  • Complex stereotypic movements, however, are less common and occur in 3 to 4 percent of children. (psychologytoday.com)
  • The movements are said to occur mainly in non-REM sleep. (medscape.com)
  • These movements usually are in the legs and occur in some type of pattern. (healthlinkbc.ca)
  • In addition to total body movements,limb jerks and twitches also occur innormal sleepers. (psychiatrictimes.com)
  • When considering disorders ofmovement during sleep, the physicianshould ascertain whether abnormalmovements also occur during awakeperiods. (psychiatrictimes.com)
  • Flexion at the kneeand hip may occur, and movements may involve the upper limbs. (psychiatrictimes.com)
  • Motor stereotypies are involuntary, rhythmic, repetitive, predictable movements that appear purposeful but serve no obvious function or purpose. (psychologytoday.com)
  • Stereotypies are complex and usually bilateral (both sides of your body) movements. (clevelandclinic.org)
  • Stereotypies can be a feature of many conditions, including autism spectrum disorder and Rett syndrome. (clevelandclinic.org)
  • This provides an ideal forum for trainees to gain a deeper understanding of the pathophysiology of movement disorders, basal ganglia anatomy, identification of potential DBS candidates, and surgical target selection. (jefferson.edu)
  • Some patients with PMD have movements that resemble seizures, and epilepsy should be ruled out. (orpha.net)
  • Some disorders,such as seizures, manifest predominantlyduring sleep, but may occasionallyoccur during periods ofwakefulness. (psychiatrictimes.com)
  • Strokes, seizures, memory and movement disorders among problems that develop in first year after infection. (wustl.edu)
  • Chorea is a movement disorder that causes involuntary, unpredictable muscle movements. (clevelandclinic.org)
  • Results of search for 'su:{Movement disorders. (who.int)
  • These movements may cause awakening during the night resulting in excessive daytime sleepiness. (medscape.com)
  • Right now, it's considered an additional treatment beyond medication for certain people with involuntary movement disorders," Dr. Tamm said. (abc15.com)
  • It can affect voluntary movement (actions you choose to take) or cause involuntary movement (actions that are out of your control). (clevelandclinic.org)
  • Dr. Han has special interest in using chemodenervation to treat movement disorders, particularly with ultrasound and EMG Guidance. (bu.edu)
  • Doctors typically diagnose movement disorders based on your symptoms, a complete medical history, and physical and neurological exams. (dukehealth.org)
  • Stereotypic movements are typically observed within the first three years of life. (psychologytoday.com)
  • In typically developing children, stereotypic movements can often be suppressed or lessened over time. (psychologytoday.com)
  • Typically, PMD present with complex movements of multiple different phenomenologies, usually incongruent with an organic movement disorder and affecting several body regions. (orpha.net)
  • 3 The electromyographiccharacteristics of the movements arevaried and are usually of longer durationthan those of classic myoclonus,typically 1.5 to 2.5 seconds long (range,0.5 to 5 seconds). (psychiatrictimes.com)
  • Reduction of the movements when the patient was distracted and variability of AMs during full relaxation, sleep, and stress were reported among patients with both PMD and OMD. (nih.gov)
  • Other typical features are: deliberate slowness of movement, distractibility, variability, suggestibility, paroxysmal symptoms, and resolution with placebo administration or when the patient is unaware of being observed. (orpha.net)
  • A mild case will allow the individual to suppress the body movements with ease. (psychologytoday.com)
  • The disorder is more pronounced, particularly in young children, if body movements such as the biting of lips or poking of eyes that can lead to self-injury are present. (psychologytoday.com)
  • This Research Topic aims to explore the up-to-date progress in biomarkers for closed-loop neurostimulation in movement disorders and psychiatric diseases. (frontiersin.org)
  • In addition to our clinical work , scientific research plays an important role in the Section for Movement Disorders and Neurostimulation of the University Medical Center Mainz. (unimedizin-mainz.de)
  • 2 Such movements in sleep areincreased in persons who have movementdisorders while awake, such asthose with Parkinson disease (PD) orTourette syndrome (TS). (psychiatrictimes.com)
  • Movement disorders and psychiatric disorders have been progressively impacting the world population. (frontiersin.org)
  • As the modulated targets and brain networks for movement disorders and psychiatric disorders partially overlap and some patients have both physical and psychological disorders, it is valuable to discuss the biomarkers of neuromodulation in these diseases together. (frontiersin.org)
  • DBS works best if you're experiencing mild to moderate symptoms of movement disorders, and that is why it's important to notice and report possible symptoms to your doctor as soon as you notice them. (abc15.com)
  • Signs and symptoms of movement disorders vary depending on the underlying cause. (dignityhealth.org)
  • In general, signs and symptoms of movement disorders include problems with physical coordination, trouble walking, episodes of uncontrolled movements (such as during a seizure), muscle weakness, twitching, or muscle spasm. (dignityhealth.org)
  • The Duke Movement Disorders Center offers events to support and educate people with movement disorders and their care partners. (dukehealth.org)
  • Our highly trained therapists specialize in treating people with movement disorders and are a highly integrated part of our movement disorder care team. (dukehealth.org)
  • Hornyak M, Feige B, Riemann D, Voderholzer U. Periodic leg movements in sleep and periodic limb movement disorder: prevalence, clinical significance and treatment. (medscape.com)
  • Our program team understands that helping movement disorders patients and families successfully navigate treatment and learn strategies for optimal living leads to better outcomes. (froedtert.com)
  • The Movement Disorder Program (MDP) is a specialist outpatient program that provides client centred assessment, treatment and advice to assist people who have Parkinson's or Parkinson's related disorders. (easternhealth.org.au)
  • Neurons under genetic control: What are the next steps towards the treatment of movement disorders? (nih.gov)
  • The review emphasises recent technical breakthroughs that could initiate a notable leap in the treatment of movement disorders. (nih.gov)
  • At Dignity Health, we care for patients with a range of movement disorders in AZ, CA, and NV, offering them personalized treatment. (dignityhealth.org)
  • Eye Movement Desensitization and Reprocessing (EMDR) is a treatment technique for Posttraumatic Stress Disorder (PTSD). (bvsalud.org)